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INTRODUCTION. 
The  work  in  experimental  chemotherapy  of  certain  protozoan 
infections which has  been  in  progress at  the Rockefeller Institute 
for several years, has resulted in the development of a large series of 
compounds, of which one at least was found to possess a high degree 
of  therapeutic  activity  in  experimental  trypanosomiasis.  This 
substance,  N-phenylglycineamide-p-arsonic acid,  was  first  made  in 
1915 by Dr. WalterA. Jacobs and Dr. Michael Heidelberger (1 and 2) 
and studied biologically in collaboration with Dr.  Wade H.  Brown 
under its serial number of A  63; its  sodium salt has recently been 
named  "Tryparsamide."  The  biological  investigations  included 
toxicologic experiments (3) in which it was shown that the reaction 
of different species of laboratory animals to the drug was of a favorable 
character.  The substance lends itself well to almost any method of 
administration and can be given to animals in large doses.  Moreover, 
toxic effects were  confined to  doses relatively close to  the minimum 
lethal dose and the recovery of animals from sublethal intoxication 
was remarkably rapid and complete, thus making possible the repeti- 
tion of large doses at  comparatively short intervals  of time.  The 
therapeutic activity of the drug in experimental trypanosomiasls (4) 
was particularly  evidenced by  the relative  speed and  sharpness of 
action in  the acute  blood infections of mice  and  rats  and  by  the 
potency and  duration  of action  in  the subacute and chronic tissue 
infections of  guinea  pigs  and  rabbits.  The accomplishment of  a 
permanent cure was obtained in the experimental infections produced 
by five strains of pathogenic trypanosomes, Tr. brucel, Tr. gambiense, 
Tr. evansi, Tr. equiperdum, and Tr. equinum, but, on the other hand, 
infections produced by Tr. rhodesiense were more difficult to influence 
(5).  Comparative  experiments  in  laboratory  animals  with  well 
known drugs such as atoxyl, arsacetin, arsenophenylglycin, salvarsan, 
neosalvarsan, luargol, and galyl, all of which have been used in the 
treatment of human trypanosomiasis, showed that tryparsamide was 
in many respects their superior. 
An appraisal of the probable value of any drug, with a view to its 
use  in  the  treatment  of  human  beings  or  animals  suffering from 
naturally acquired trypanosomal infections, must be based upon the 
interpretation of the experimental results obtained with the drug in L.  PEA~CE  3 
the laboratory.  The various attributes or features of the  toxicologic 
and therapeutic action of tryparsamide, as brought out by laboratory 
investigation  and  briefly  enumerated  above,  constituted  a  logical 
basis  for  its  application  to  the  treatment  of  human  and  animal 
trypanosomiasis.  This  conclusion is  emphasized  by  recalling  the 
results of the use of several drugs in human trypanosomiasis, for which 
various claims had been made on the basis of limited or mistakenly 
interpreted  experimental  data.  For  instance,  arsacetin,  arseno- 
phenylglycin, salvarsan, and neosalvarsan all possess a high curative 
ratio in experimental trypanosomiasis of mice and largely upon this 
basis were transferred to the field of human therapy and that of the 
large  domestic  animals.  The  regrettable  toxic  effects  sometimes 
noted and the failure to obtain the desired therapeutic action under the 
conditions imposed by the disease, might have been foretold if requisite 
laboratory experiments had been carried out and correctly interpreted. 
A similar statement may be made of so called trypanocidal tests made 
in vitro.  On the other hand, the better therapeutic results  obtained 
with atoxyl are entirely in accord with the results of the laboratory 
experiments carried out by Thomas and Breinl (6 and 7)  and aptly 
illustrate the point in question. 
At  the  present  time,  human  trypanosomiasis, or  the  so  called 
Mrican sleeping sickness,  is very prevalent in tropical  Africa, par- 
ticularly in the central and western portions of the continent, in the 
French and Belgian Congos.  Epidemics of varying degrees of severity 
are  widespread and  constitute  one  of  the  most pressing  problems 
confronting colonial governments.  Although great progress has been 
made in the fight against the disease and notably so in the treatment 
of patients in the early stages of the infection by the use of atoxyl or 
by  the  combined  treatment  with  atoxyl  and  tartar  emetic,  it  is 
apparent that the means of combating the disease, particularly in its 
more advanced stages and in prophylaxis against its spread, are not 
at present adequate.  Whether the ideal control of an infection of the 
nature of trypanosomiasis will ever be accomplished by a single drug, 
in the sense that quinine is used to control malaria, is problematical. 
In any event, the various aspects of the situation in Africa today are 
such that the colonial officials are very ready to try any new remedy, 
itself harmless, for the treatment of sleeping sickness which holds out TREATMEBIT  OF  HUMAN  TRYPANOSOMIASIS 
a  promise of  some degree  of  success.  The  biological  experiments 
referred to indicated that tryparsamide might fill some place in the 
therapy of the disease and consequently a  mission was sent by the 
l~ockefeller Institute to the Belgian Congo in May, 1920, to study the 
effect of the drug in patients suffering with trypanosomiasis. 
It is obvious that any extended application of a  new remedy for 
administration in human beings must be preceded by a  careful study 
of its action in relatively few patients irrespective of the scope of the 
initial investigations in  the laboratory.  In a  problem such as  the 
therapy of human trypanosomiasis as just indicated, it is of the utmost 
importance to ascertain such fundamental facts as the initial speed of 
therapeutic activity of various sized-single doses, as measured by the 
length of time required to clear the superficial lymph glands and blood 
of trypanosomes and the permanency of this effect; the action of the 
drug, if any, in the advanced stages of the disease~as indicated by 
examination of the spinal fluid and the mental and nervous response 
of the patient; the general physical reaction of the patient as shown 
by weight observations, Mood counts  , etc.; and finally, the determina- 
tion of any untoward observable effects.  On the basis of a  series of 
such facts obtained in a certain number of patients, a rational system 
of therapeutic procedure can then be logically attempted. 
The object of the mission sent to the Belgian Congo was the obtain- 
ing of concrete facts and observations as outlined above.  All of the 
work was done at the government laboratory and H6pital de la Reine 
in L6opoldville.  The helpful cooperation of the Belgian and Colonial 
Governments made it possible to accomplish a  considerable amount 
of work in a  comparatively short time and it is a pleasure to express 
here our appreciation.of the aid so cordially extended to us, first in 
Brussels and then in the Congo.  We also wish to acknowledge the 
assistance  given  us  by  Professor  Rodhain,  Chief  of  the  Colonial 
Medical Service, and by Dr. van den Branden, Director, and Dr. van 
Hoof, Assistant Director of the Laboratory in L6opoldville. 
SOURCE AND TYPE OF PATIENTS. 
The observations which form the basis of this report were made on 
77  native  cases of  trypanosomiasis caused by Tr. gamblense which 
were treated with tryparsamide in L~opoldville, Belgian Congo.  The "L. PEAI~CE  S 
civil  service  of  the  Belgian  Congo has  established  throughout the 
colony, medical stations and posts under the charge of government 
physicians  and  traveling  sanitary  agents,  in  addition  to  which  a 
considerable amount of medical work is  done by  various religious 
missions.  The native population  is thus examined for trypanosomiasis 
at more or less regular intervals, the routine procedure consisting of 
the palpation of the cervical lymph glands and the microscopic exami- 
nation of lymph gland juice from those individuals having one or more 
palpable cervical glands.  At the present time, there is no widespread 
epidemic of a severe character in the immediate vicinity of L~opoldville 
but there are many endemic loci of the disease in this district, while a 
few days' travel brings one into active epidemic areas.  The patients 
treated with tryparsamide were entirely typical of the routine run 
of trypanosomiasis cases met with in Ltopoldville.  The population 
of the nearby native villages comes en  masse  to the laboratory every 
3 months for examination and several cases were obtained in this way. 
Moreover,  Ltopoldville is  the  terminus  of  one  of  the  large  river 
transportation companies and a medical passport issued after exami- 
nation for trypanosomiasis, is required of any native traveling from 
one part  of  the colony to  another.  The entire  crew of each boat 
is examined the day before sailing and this source fielded a  number 
of cases from distant parts of the colony.  Finally, several advanced 
cases under treatment in the native H6pital de la Reine and lazaret 
in Ltopoldville  were transferred to us for treatment with tryparsamide. 
All of the patients studied thus fell into three general classes:  First, 
those who were sent to the lazaret, which is in reality a native village 
under nominal native police control on the outskirts of L@opoldville, 
and who came to the laboratory when sent for; second, patients in 
the H6pital de la Reine, over whom a closer supervision could be main- 
mined;  and  third,  ambulatory  cases,  corresponding  to  dispensary 
patients, who continued to live in their own villages and who came to 
the laboratory at certain fixed times. 
According to the recognized authorities on human trypanosomiasis, 
the course of the disease may be divided into two periods, the glandular 
or blood infection stage and the cerebral  stage.  The first stage is 
characterized  principally  by a  polyadenitis,  most  apparent  in  the TREATMENT  OF  I:ITYMAN TRYPANOSOMIASIS 
cervical glands, an irregular intermittent fever, a rapid pulse (the rate 
of which is usually out of proportion to the fever), an enlarged spleen, 
an erythematous eruption in whites, a  fine tremor of the  tongue, a 
deep hyperesthesia, and asthenia.  Localized edemas are sometimes 
seen.  Trypanosomes are present in the hypertrophied lymph glands 
and in the blood.  The number of lymphocytes in the spinal fluid is 
normal.  The second period, in which the infection has invaded the 
cerebrospinal  system,  is  characterized  by  the  aggravation  of  the 
general symptoms such as fever, emaciation, loss of strength, and by 
the predominance  of  cerebrospinal symptoms such as tremors, paralysis, 
mental disturbances, apathy, somnolence, lethargy, and finally coma 
and death.  In this period, the spinal fluid is pathologically altered, 
the conspicuous feature of which is an increase in the lymphocytic 
(small  mononuclear)  cell  content  with  other  types  of  cells  (large 
mononuclears and  so  called mulberry cells)  in  the more advanced 
cases (8 and 9).  Trypanosomes are present in the spinal fluid of the 
most advanced cases while they are said to be less numerous in the 
lymph glands and blood than in the early cases. 
The 77 cases treated with tryparsamide represented all grades of the 
infection and included previously untreated patients as well as several 
who had been treated with one or more drugs for varying lengths of 
time.  With the exception of 8 patients who were being treated at 
the time of their transfer to us, trypanosomes were demonstrated in 
every case as follows: in 67 cases by gland punctures; in 1 case in the 
centrifuged blood; in 1 case in the spinal fluid.  A lumbar puncture 
was done before treatment in 72 instances--it was omitted in the case 
of 1 infant and 4 ambulatory patients. 
The study of tryparsamide was carried out under the same conditions 
that prevail in the laboratory, lazaret, and native hospital in L6opold- 
ville, under which the routine treatment with atoxyl and tartar emetic 
is given.  Under the conditions prevailing, complete clinical records 
were not obtainable and the observations were necessarily confined 
to certain definite fields.  In addition, mention should be made of the 
fact  that  the native population of West Africa suffers widely from 
other affections such as subacute and chronic malaria,  filariasis,  and 
intestinal parasites, of which little or no attention could be taken. L. P~u~c~  7 
ADMINISTRATION O1~ TRYPARSAMIDE. 
Tryparsamide, or the sodium salt of N-phenylglycineamide-p-arsonic 
acid, is a pentavalent arsenic compound having the following struct- 
ural formula: 
As  ---OH 
NHCH~CONH2 
Its preparation  and  chemical properties  have been fully described 
by Jacobs and Heidelberger in previous publications (1  and 2).  It 
is a white crystalline substance of stable character and has  been  kept 
in ordinary tightly stoppered bottles for long periods of time and  under 
various  climatic  conditions  without  appreciable  change.  It  was 
found  that the  same  procedures  of  preparation  of  drug  solution 
employed in the experimental work (3 and 4) were entirely applicable 
to the preparation of the drug for human therapy. 
As  the drug is bottled under aseptic  conditions,  the addition of 
sterile  distilled  water  with  the  usual  precautions  for  preventing 
contamination is all that is required.  Sterilization of the drug solution 
is not necessary.  The dose for each patient was in most instances 
weighed out separately on a balance and dissolved in a  small sterile 
petri  dish or flask with  the appropriate  amount of  sterile distilled 
water.  It is entirely feasible, however, to prepare the doses for several 
patients at one time and to administer the requisite amount of the 
drug to each.  The drug is extremely soluble in  water  in  concentrations 
as high as 50  per cent.  In most instances, a  20  per cent solution 
was used,  but varying strengths,  from  10 to 40  per cent, were also 
employed. 
The  drug  is  readily  administered  intravenously  and  this  route 
obviously offers  the most uniform condition for  the observation of 
various  sized doses.  When injected directly into  the tissues,  it  is 
quickly absorbed and produces but slight irritation or local injury. 
However, the African native exhibits little objection to  intravenous 8  TREATMENT  OF  H'UMAN  TRYPANOSOMXASIS 
medication while opposing injection into the subcutaneous or intra- 
muscular tissues.  In a few patients injections deeply intQ the muscles 
of the buttocks could be made and the effects studied. 
ADMINISTRATION OF  SINGLE DOSES IN EARLY  CASES. 
Initial  Peripheral  Sterilization. 
The  characteristics  of  human  trypanosomiasis  would  seem  to 
preclude any idea of materially influencing the course of the disease 
by the administration of a single dose of any drug and the experience 
of tropical workers indicates that a  series of treatments covering a 
period of months or years is necessary.  Untreated cases eventually 
die and it is the general opinion that only comparatively slight and 
temporary benefit accrues to patients in the advanced or cerebrospinal 
stage of the disease from the drugs hitherto in use.  Before any system 
of treatment can be intelligently attempted, it is necessary to deter- 
mine  the  duration  of  therapeutic  action  of  single  doses  skice the 
TABLE  I. 
Results  of  Early  Gland  Puncture  After  Single  Doses  of  Tryparsamide. 
Number of pafients--55. 
Size of doses--0.3 to 7.0 gin. or 4.7 to 112 nag. per kilo of body weight. 
Routes of administration--Intravenous  51. 
Intramuscular 4. 
Results: 
All examinations negative within 24  hours after treatment. 
20  "  "  "  4{  to  9 hours after treatment. 
10  "  "  "  10  to 15  "  "  " 
13  "  "  "  15½ to 20  "  "  " 
12  "  "  "  21  to 24  "  "  " 
Time of negative examination 
after treatment. 
I.  4½  to  9hours ...... 
II.  10  to 15  " 
[II.  15½ to 20  " 
IV.  21  to 24  " 
Total ...... 
Doses of 
0.3 to 1.0 gin. 
4.7 to 25  nag. 
per kg, 
11 
Doses of 
L0 to 3.0gin. 
33 to 50 rag. 
per kg. 
10 
3 
3 
4 
20 
Doses of 
2.0 to S.O gin. 
54 to 70 rag. 
per kg. 
12 
Doses of 
4.0 to 7.0 gm. 
80 to 112 nag. 
per kg. 
6 
'1 
3 
2 
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giving  of  succeeding  doses  should  be  governed  by  this  factor..In 
addition,  this information is of importance in the prophylactic use of 
a  drug.  Incidentally,  it was desirable to ascertain  the approximate 
rapidity  of the preliminary  or so called  sterilizing  effect of a  ~ven 
dose as shown by repeated microscopic examinations of lymph gland 
juice or of centrifuged blood.  A  number  of such observations were 
made,  which  are  summarized  in  Tables  I  and  II.  The  patients 
represent  both  early  and  advanced  periods  of  the  disease  in  which 
trypanosomes  were  demonstrated  before  treatment  in  the  lymph 
glands or blood. 
The  gland  punctures  of  55  patients  were  all  negative  within  24 
hours after treatment with single doses of tryparsamide varying from 
0.3 to 7.0 gin. or 4.7 to 112 rag. per kilo of body weight; 30 examinations 
were negative within the first 15 hours, 25 from 15 to 24 hours after 
treatment, irrespective of the size of the dose (Table I).  It should be 
pointed out that these results do not imply that an examination one or 
more hours previous to  the negative finding was positive, as it was 
not  always possible  to  make  a  complete  series  of  examinations  at 
frequent intervals  since microscopic work could only be done in the 
daytime and consequently a  relative and not absolute interpretation 
must  be placed upon  the  observations.  In  14  cases,  trypanosomes 
were found microscopically in lymph gland  juice 3  to 8  hours  after 
doses of 1.0 to 5.0 gm.,  while the examinations  repeated within  the 
succeeding 21  to  16 hours were invariably negative.  The  following 
examples are typical of the results obtained: 
Makalamba ~ 49.  +.  T .ryparsamide 1.0 gm. or 19 mg. per kilo. 
Gland puncture:  6  hours +;  19½ hours 0. 
Mondeke ~ 47.  +.  Tryparsamide 2.0 gm. or 33 mg. per kilo. 
Gland puncture:  5½ hours +;  6 hours 0. 
Moaimango  g~ 16.  + +.  Tryparsamide 2.0 gin. or 42 rag. per kilo. 
Gland puncture:  6  hours +;  20 hours 0. 
Tono  ~ 14.  + +.  Tryparsamide 2.0 gin. or 44 rag. per kilo. 
Gland puncture:  8  hours +; 9 hours 0. 
Loyoko  g~ 18.  + +.  Tryparsamide 3.0 gm. or 50 rag. per kilo. 
Gland puncture:  5  hours +; 8 hours 0. 
Kaniki ~ 58.  + + +.  Tryparsamide 2.5 gm. or 58 nag. per kilo. 
Gland puncture:  5  hours +; 21 hours 0. I0  TP,~EATMENT  OF  HUMAN  I"RYPANOSO~IASIS 
Tuarnene ~ 68.  + +.  Tryparsamide 5.0 gin. or 82 mg. per kilo. 
Gland puncture:  3  hours  +;  8 hours 0. 
N'Si,  ola ~ 32.  +.  Tryparsamide 4.0 gra. or i00 rag. per kilo. 
Gland puncture:  4  hours +; 6 hours 0. 
In contrast to the above examples, the following 3 cases are of interest 
in that gland punctures were positive 14 and 19 hours after treatment. 
The  doses used however,  in  terms  of amounts  of drug  per  kilo  of 
body weight were comparatively small and the infection of 2 patients 
was unusually severe. 
Bikoko  ~ 55.  + + +.  Tryparsamide 0.3 gin. or 4.7 rag. per kilo. 
Gland puncture:  19 hours +;  22 hours 0. 
Molalo ~¢ 60.  +.  Tryparsamide  1.0 gin. or 20 rag. per kilo. 
Gland puncture:  14 hours +;  16 hours 0. 
Tsarjembe ~¢ 74.  + + +.  Tryparsamide 2.0 gin. or 37 rag. per kilo. 
Gland puncture:  14 hours  +;  15 hours 0. 
Thus, it is seen that with amounts above 25 rag. per kilo, 27 of the 
examinations were negative within  the  first  15  hours,  while  9  were 
negative  in  from  15½  to  20  hours.  20  patients  were  treated  with 
doses of 1.0  to 3.0 gm.  or 33  to 50 mg.  per kilo  of body weight, of 
which  10  were negative Within  9  hours,  3  within  10  to  15  hours,  3 
within  15½  to  20  hours, and  4  within  21  to  24  hours.  Considering 
together the doses of from 33 to 70 mg. per kilo of body weight and 
combining  the  results  of the  second  and  third  columns  of Table I, 
it is seen that  14 of the 32 patients,  or approximately one half, were 
negative within the first 9 hours, while there were 6 negative examina- 
tions  each  in  the  succeeding  periods  of  time.  Concerning  smaller 
doses (4.7 to 25 rag.  per kilo), all that can be said at present is that 
the examinations  of the 11 patients so treated were all negative within 
24 hours and there was practically no difference between the second, 
third,  and fourth periods of time, i. e., it is probable that all 11 were 
negative within  15 hours after treatment.  With  the larger  doses of 
80 to 112 mg. per kilo of body weight 6 of the 12 patients gave negative 
gland punctures within the first 9 hours after treatment.  4 patients 
were given  doses of  1.0,  2.0,  and  3.0  gm.  intramuscularly  with  no 
delay in negative gland puncture. L.  PEARCE  11 
The preliminary effect of the drug upon the blood infection may 
next be considered, since in reality so called peripheral sterilization 
includes both the superficial lymph glands and the circulating blood. 
The patients in this group represent both early and advanced periods 
of the disease of  different  degrees of  severity.  Doses  of 1.0  to 5.0 
gin.  or  18  to  109  rag.  per  kilo  of  body weight were  administered 
intravenously, and at periods ranging from 15 minutes to 30  hours 
afterwards 9 cc. of blood were withdrawn in a syringe containing 1 cc. 
TABLE  II. 
Results of Early Blood Examination after Single Doses of Tryparsam~le. 
Number of patients--35. 
Size of dose---1.0 to 5.0 gin. or 18 to 109 nag. per kilo of body weight, 
Intravenous administration. 
Results: 
All negative within 21 hours after treatment. 
14  "  "  3½ to  9 hours after treatment. 
13  "  "  10 to 15 hours  "  " 
8  "  "  16 to 21hours  "  " 
Time of negative  examination 
after treatment. 
I.  3½ to  9 hours... 
II.  10to15  "  .... 
[II.  16 to 21  "  ..... 
Total ..... 
Doses of 
1.0  gin. 
18 to 25 rag. 
per kg. 
Doses of 
1,0 to 2.5 gm. 
33 to 48 rag. 
per kg. 
11 
Doses of 
3,0 to 5.0 gin. 
51 to 70 rag. 
per kg. 
Doses of 
2;0 to 5.0 gnL 
71  to 109 rag. 
per ks. 
of a  6  per cent sodium citrate  solution and  the mixture was  then 
centrifuged three times according to the method described by Broden 
(10).  The three sediments  were examined microscopically  for trypano- 
somes.  The results of these examinations of 35 patients are condensed 
in Table II and may be described briefly:  All the examinations were 
negative in 21 hours, 14 were negative in 3½ to 9 hours,  13 in  10 to 
15  hours, and  8  in  16  to  21  hours, irrespective  of  the  size  of  the 
dose  administered.  There  were  11  patients  treated  with  single 
doses of 1.0  to 2.5  gm. or 33  to 48 rag. per kilo of body weight and 12  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
5 of the 11  showed negative blood examinations within 9 hours after 
treatment,  and  10  were  negative  within 15 hours.  Combining the 
results of these doses  with  those of 51  to  70 rag. per kilo as  shown 
in the second and third columns, 15 out of the 20 patients so treated 
were  negative within  15  hours.  Somewhat larger  doses of 2.0  to 
5.0  gm or 71 to  109  rag. per  kilo of  body  weight were  given  to  9 
patients,  all of whom  were  negative  in  15  hours  and  6  negative 
within 9 hours after treatment. 
As in  the  microscopic examination of lymph gland juice,  it  was 
not possible  to make complete series  of observations.  In  these 35 
patients,  the  last  positive  blood  examinations occurred  from  3  to 
8 hours after treatment with doses of 1.0 to 3.0  gin. or 18 to 51  rag. 
per kilo.  The following examples illustrate these points: 
Molalo ~ 60.  Tryparsamide 1.0 gin. or 20 nag. per kilo. 
Centrifuged blood: 16 hours 0. 
Maf~xtla ~¢ 30.  Tryparsamide 1.0 gin. or 25 nag. per kilo. 
Centrifuged blood:  6 hours 0. 
Mago lg 28.  Tryparsamide 1.0 gin. or 33 rag. per kilo. 
Centrifuged blood: 7½ hours 0. 
Messamba ~ 57.  Tryparsamide 2.0 gin. or 39 rag. per kilo. 
Centrifuged blood:  7 hours +; 21 hours 0. 
Mtmdi ~ 75.  Tryparsamide 2.0 gin. or 44 rag. per kilo. 
Centrifuged blood: 3½ hours 0. 
Mulamba ~39.  Tryparsamide 3.0 gin. or 51 rag. per kilo.: 
Centrifuged blood: 3  hours  +; 8 hours 0. 
Mom~eke ~t 47.  Tryparsamide 4.0 gin. or 66 rag. per kilo. 
Centrifuged blood: 6½ hours 0. 
Mambula ~¢43.  Tryparsamide 2.0 gin. or 71 nag. per kilo. 
Centrifuged blood: 6  hours +; 8 hours 0. 
Bajaka ~¢ 41.  Tryparsamide 4.0 gin. or 76 rag. per kilo. 
Centrifuged blood: 15 hours 0. 
Bikoko ~t 55.  Tryparsamide 5.0 gin. or 80 nag. per kilo. 
Centrifuged blood:  5 hours 0. 
The negative gland and blood findings after treatment were con- 
trolled  by  subsequent  examinations as  indicated  by  the  following 
examples: L.  PEARCE 
Biko~  ~  55. 
13 
Admitted to lazaret September 22, 1920.  54.5 kilos. 
Cervical lymph glands markedly enlarged.  Gland puncture -t--I-+. 
~umbar puncture normal. 
19~.0 
Sept. 22,  5 p.m. Tryparsamide 0.3 gin. (4.7 mg. per kg.) adm. i.v. 
"  23,  7 a.m.  14 hours after treatment  G. P.  +  (2 tryp.) 
9a.m.  16  "  "  "  "  "  -.}- (2  "  ) 
12n.  19  "  "  "  "  "  -I-  (1  "  ) 
3p.m.  22  "  "  "  "  "  0 
5p.m.  24  "  "  "  C.B.  0 
"  24,  9a.m.  40  "  "  "  "  "  0 
"  25,  3days  "  "  "  "  0 
"  27,  5  "  "  "  "  "  +  (ltryp.)"  "  -[- 
"  27,  11.30 a.m.  Tryparsamide 5.0 gln. (80 mg. per kilo) adm. i.v. 
4.30 p.m.  5 hours after treatment  C.B.  0 
5  p.m.  5½  "  "  "  G.P.  0 
"  28,  7  a.m.  19½  "  "  "  "  "  0 
10  a.m.  22}  "  "  "  "  "  0 
Oct.  2,  4days  "  "  "  "  0 
"  4,  6  "  "  "  "  "  0  ""  0 
Tsarjembe ~  74. 
Admitted for ambulatory treatment October 11, 1920.  53½ kilos. 
Cervical lymph glands enlarged,  typical  chains.  Ghmd puncture  -t-+-t-. 
Centrifuged blood  -I-+. 
Lumbar puncture 19 lymphocytes per cmm.  Large mononuclears -l--I-. 
1920 
Oct. 11, 
"  12, 
5 p.m. Tryp~samide 2.0 gin. (37 mg. per kg.) adm. i.v. 
7  a.m.  14 hours after treatment  G.  P.  +  (2 tryp.) 
8a.m.  15  "  "  "  "  "  0  C.B.O 
9a.m.  16  "  "  "  "  "  0 
lOa,m.  17  "  "  "  "  "  0 
lla.m.  18  "  "  "  "  "  0 
13,  7 days after treatment  "  "  0  "  "  0 14  TREATMENT  OF  HU~  TRYPANOSOMIASIS 
Mondongo  ~  5. 
Admitted to lazaret July  14,  1920.  47 kilos. 
Cervical  lymph  glands  enlarged.  Gland  puncture  q-. 
Lumbar puncture  7.5 lymphocytes per cram. 
lOgO 
July  14, 10 a.m.  Tryparsamide 2.0 gin. (13 nag. per kg.) adm. i.v. 
11 a.m.  1 hour after treatment  G. P.  -b 
12  m.  2  "  "  "  "  "  -b 
3 p.m.  5  "  "  "  "  "  q- 
5 p.m.  7  "  "  "  "  " 
"  15,  7a.m.  21  "  "  "  "  "  0 
9a.m.  23  "  "  "  "  "  0 
11 a.m.  25  "  "  "  "  "  0 
"  16,  2days  "  "  "  "  0 
"  19,  5  "  "  "  "  "  0 
"  20,  6  "  "  "  "  "  0 
~'  21,  7  "  "  "  "  "  0 
"  22,  8  "  "  "  "  "  0 
"  27,  13  "  "  "  "  "  0 
Aug.  3,  20  "  "  "  "  "  0 
"  9,  26  "  "  "  "  "  0 
"  17,  34  "  "  "  "  "  0 
"  24,  41  "  "  "  "  "  0 
"  31,  48  "  "  "  "  "  0 
Sept.  2,  50  "  "  " 
"  7,  55  "  "  "  "  "  0 
"  14,  62  "  "  "  "  "  0 
"  22,  70  "  "  "  "  "  0 
"  29,  77  "  "  "  "  "  0 
Oct.  5,  83  "  "  "  "  "  0 
"  6,  84  "  "  " 
"  13,  91  "  "  "  "  "  0 
"  15,  93  "  "  " 
"  21,  99  "  "  " 
"  23,  Tryparsamide 0.5 gin. (Provocative  dose). 
"  26,  G.P.  0  C.B.  0 
"  30,  Tryparsamide 0.5 gin. (2nd Provocative dose). 
Nov.  2,  G.P.  0C.B.  0. 
C.B.O 
~¢  ~¢  0 
g~  ~g  0 
~  ¢¢  0 
~¢  ¢¢  0 
"  "  0 
"  "  0 L. PEARCE 
Mondi  ~  75. 
15 
Admitted for ambulatory treatment  October  22,  1920.  45 kilos. 
Cervical  lymph glands  enlarged. Gland puncture +. 
Centrifuged  blood -{-. 
Lumbar puncture not done. 
1920 
Oct. 22, 11.45 a.m.  Tryparsamide 2.0 gin. (44 rag. per kg.) adm. i.v. 
3.15 p.m.  3½ hours after treatment  'C. B. 0 
4  p.m.  42  "  "  "  G.P.  0 
5  p.m.  52  "  "  "  C.B.  0 
"  23,  7  a.m.  18~  "  "  "  "  "  0 
9  a.m.  20i  "  "  "  "  "  0 
Victor Makau  ~  77. 
Admitted as ambulatory patient October 27, 1920.  57 kilos. 
Cervical lymph glands enlarged.  Gland puncture -t-q-+. 
Centrifuged blood +++. 
Lumbar puncture 3.8 lymphocytes per cram.  (1 large mononuclear seen.) 
1920 
Oct. 28,  9  a.m.  Tryparsamide 1.0 gm. (18 rag. Perkg.) adm. i.v. 
9.15 a.m.  15 minutes after treatment  C.B.  ++-b 
10  a.m.  1 hour  "  "  "  "  -b+-b 
11  a.m.  2  hours  "  "  "  "  -l- 
12  n.  3  "  "  "  "  "  + 
3.30 p.m.  6½  "  "  "  "  "  ++-b 
4  p.m.  7  "  "  "  G.P.  +++ 
5  p.m.  8  "  "  '<  '<  "  ++ 
"  29,*8  a.m.  23  "  "  "  "  "  0 
3  p,m.  30  "  "  "  "  "  0 
*  Patient  was quite ill the second day and only a  glandpuncture  could be done 
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Itoma  ~  7o  °. 
Admitted for ambulatory  treatment October 29,  1920.  5,2 kilos. 
Cervical lymph glands enlarged. Gland puncture ++. 
Lumbar puncture deferred. Very  advanced  stage. 
192o 
Oct. 29, 5.30 p.m.  Tryparsamide 1.0 gin. (19 rag. per kg.)  adm. i.v. 
"  30, 6.30 a.m.  13  hours after treatment  C.B.  0 
7  a.m.  13½  "  "  ,c  G.P.  0 
9  a.m.  15½  "  "  "  "  "  0  u  "  0 
Tuame~ /i 68. 
Admitted to lazaret October 5,  1920.  62.5 kilos. 
Cervical lymph glands enlarged. 
Gland puncture ++.  Centrifuged blood  ++. 
Lumbar  puncture  5  lymphocytes  per  cmm.  (1  large  mononuclear  seen.) 
1920 
Oct.  5, 11 a.m.  Tryparmmide 5.0 gin. (80 rag. per kg.) adm. i.v. 
5 p.m.  6 hours after treatment  G.P.  0  C.B.  0 
"  6,  8a.m.  21  "  "  "  "  "  0 
"  14,  9days  "  "  "  "  0 
"  21~  16  "  "  "  "  "  0 
"  22,  17  "  "  "  "  "  0 
"  28,  23  "  "  "  "  "  0  "  "  0 
"  30,  25  "  "  "  "  "  +  "  "  + 
Nov.  1,  8  a.m.  Tryparsamide 5.0 gin. (82 rag. per kilo)  adm. i.v. 
11 a.m.  3  hours after treatment  G.P.  + 
12n.  4  "  "  "  C.B.  + 
3p.m.  7  "  "  "  "  "  + 
4p.m.  8  "  "  "  "  "  0 
5p.m.  9  "  "  "  "  "  0 
~  2,  8a.m.  24  "  "  "  ,  ~c  0 
The deduction  from this  series of observations on the effect of a 
single dose  of tryparsamlde administered intravenously to  a  mixed 
group of patients infected with Tr. gambieme is, briefly expressed, as 
follows:  Doses of tryparsamide of 1.0 to 5.0 gm. bring about peripheral 
sterilization  as  indicated by negative  findings for  trypanosomes in 
lymph gland  juice and  centrifuged blood  in  an  average of 6  to  12 
hours.  It  would appear  that  a  similar speed of action follows  the 
intramuscular injection of the drug. L. PE~CE  17 
Duration of Peripheral Sterilization after Single Doses. 
21 patients were treated with single doses of tryparsamide of 0.5 
to 5.0 gin. or from 9 to 83 rag. per kilo of body weight and followed 
with  frequent microscopic examinations of lymph gland juice  and 
centrifuged blood to ascertain the permanence of therapeutic effect 
as expressed by the duration of the peripheral sterilization.  Table 
III summarizes the protocols of the 12 patients who relapsed after 
single doses of from 0.5 to 5.0 gin. of tryparsamide or from 17 to 83 
nag. per kilo of body weight, while Table IV summarizes the records 
of 9 patients who showed no demonstrable relapse following treatment 
with single doses of 0.5 to 3.0 g~a. or 9 to 68 rag. per kilo.  All patients 
were either in the first period of the disease or at the beginning of the 
second as shown by the slight excess in the cell count of the spinal 
fluid, 3  lymphocytes per cram. being considered normal (10).  The 
drug was administered intravenously except in 4  cases in which the 
intramuscular route was employed. 
TABLE  HI. 
Relapses after Single  Doses of rryparsamide. 
Intra~enoua Administration. 
me  No.  Name. 
50  Moangolo ....... 
48  M'Bondo. 
28  Mago.. 
47  •  Mondeke  ....... . 
43  Mambuls  ....... 
36  Sudila. 
63  N'Kaka 
39  Mulamba.. 
41  Bajaka.  .. 
42  N'Keta 
68  Tuamene. 
53  Ganzema. 
Weight. 
kg. 
•  29.5 
•  .50 
33 
.  61 
•  27 
46 
42.5 
55.5 
•  53 
36 
62.5 
36 
Spinal fluid. 
Normal. 
5 
5 
7.5 
7.5 
2O 
Normal. 
4 
15 
10 
5 
3.4 
(I  L m.) 
Dose. 
0,5 
1,0 
1.0 
2.0 
1.0" 
2.0 
2.0 
3.0" 
3.0" 
2.0" 
5.0 
3,0 
[ Do~ 
17 
20 
33 
33 
37 
44 
!  47 
!  54 
57 
57 
:  80 
83 
Time 
Relapse.  after 
treat- 
menu 
4ays 
C.B.  -t-  G.P.  --  29 
C.B.  +  G.P.  +  23 
C.B.  -~  G.P.  +  19 
C.B.  +  G~.P.  +  26 
C.B.  +  G.P.  --  58 
C.B.  +  G.P.  --  50 
C.B.  +  G.P.  +  17 
C.B.  +  G.P.  --  45 
C.B.  -~  G.P.  --  37 
C.B.  +  G.P.  +  51 
C.B.  +  G.P.  +  25 
C.B.  +  G,P.  -~-  21 
1. m.mLarge mononuclear. 
* Intramuscular administration. 18  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
In the first group as shown in Table III, there were 2 relapses at 
17 and 19 days (Mago #28 and N'Kaka  #63), 5 from 21  to 29 days 
(Ganzema  ~53, M'Bondo ~48,  Mondeke #47,  Tuamene #68,  and 
Moangolo  #50),  2 at  37  and 45  days  (Bajaka  #41  and Mulamba 
#39), and 3 from  50  to  58  days  (Sudila  #36,  N'Keta  #42,  and 
:~¢Iambula #43).  The  following protocols  illustrate  the method of 
determining the time of relapse after treatment. 
Moangolo  ~  50. 
Admitted  to hospital September 7,  1920.  29.5  kilos. 
Cervical lymph glands vnlarge.d.  Gland puncture q-. 
Lumbar puncture normal. 
19go 
Sept.  7, 
"  10, 
"  15, 
"  17, 
"  20, 
"  24, 
"  25, 
Oct.  1, 
"  4, 
"  6, 
11.30  a.m. 
3 days after treatment  G.P.  0 
8  "  "  "  "  "  0 
10  "  "  "  "  "  0 
13  "  "  "  "  "  0 
17  "  "  "  "  "  0 
18  "  "  "  "  "  0  C.B.  0 
24  "  "  "  "  "  0 
27  "  "  "  "  "  0  "  "  0 
28  "  "  "  "  "  0 
29  "  "  "  "  "  +  "  "  + 
Tryparsamide 0.5 gin. (17 rag. per kg.) adm. i.v. 
M'Bondo  ht 48. 
Admitted to lazaret August 30,  1920.  50 kilos. 
Cervical lymph glands enlarged.  Gland puncture +q--t-. 
Lumbar puncture 5 lymphocytes per cram. 
1920 
Aug  31,  11.45  a.m.  TD~parsamide 1.0 gin. (20 rag. per kg.) adm. i.v. 
3.15 p.m.  3½ hours after treatment  G. P.  q-q- 
4.45p.m.  5  "  "  "  "  "--}-.-l- 
Sept.  1,  7  a.m.  19  "  "  "  C.B.  0 
9  a.m.  21  "  "  "  "  "  0 
"  6,  6days  "  "  "  '~  0 
"  11,  11  "  "  "  "  "  0 
"  17,  17  "  "  "  "  "  0  "  "  0 
"  20,  20  "  "  "  "  "  0 
"  23,  "23  "  "  "  "  "  q-  "  "  q- L.  PEARCE  19 
Mondeke  ~  47 
Admitted to lazaret August 28,  1920.  61 kilos. 
Cervical lymph glands enlarged.  G.P.  +. 
Lumbar puncture 7.5 lymphocytes per cram. 
19ZO 
Aug.  28, 11 
Sept.  6 
"  10, 
"  11, 
"  17, 
"  20, 
"  23, 
a.m.  Tryparsamide 2.0 gin. (33 nag. per kg.) adm. i.v. 
4.30 p.m.  5½ hours after treatment  G.P.  +  (1 tryp.) 
5  p.m.  6  "  "  "  "  "  0  C.B.  0 
9 days  "  "  "  "  0 
13  "  "  "  "  "  0 
14  "  "  "  "  "  0 
20  "  "  "  "  "  0  "  "  0 
23  "  "  "  "  "  0 
26  "  "  "  "  "  +  (ltryp.)  "  "  +  (2 tryp.) 
Sudila  ~i 36. 
Admitted for ambulatory  treatment  August  19,  1920.  46  kilos. 
Gland puncture +. 
Lumbar puncture 20 lymphocytes per cram. 
19ZO 
Aug.  19, 5  p.m.  Tryparsamide 2.0 gin. (44 rag. per kg.) adm. i.v. 
"  20, 6  a.m.  13  hours after treatment  G. P.  0 
6.30 a.m.  13½  "  "  "  C.B. 0 
"  26  7  days  "  "  "  "  0 
"  31,  12  "  "  "  "  "  0 
Sept.  2,  14  "  "  "  "  "0 
"  7,  19  "  "  "  "  "  0 
"  14,  26  "  "  "  "  "  0 
"  21,  33  "  "  "  "  "  0 
"  22,  34  "  "  "  "  "  0 
"  28,  40  "  "  "  "  "  0 
Oct.  5,  47  "  "  "  "  "  0 
"  8,  50  "  "  "  "  "  + 
"  9,  51  "  "  "  "  "  0 
It so happens that 8  of the 12 relapsed cases, including Tuamene 
#68  and  Ganzema #53, who were given the largest amounts of drug 
per kilo, came from so called "virulent"  districts or viUages  1 and  that 
1 Certain sections of the Belgian Congo  are known as  "severe" or  "virulent" 
districts because the infection acquired there is more difficult to  influence  thera- 
peutically than that of other  places. 20  TREATMENT O:F  HUMAN TRYPANOSOMIASIS 
M'Bondo #48, Mago #28,  and Tuamene  #68  showed  an  unusually 
heavy  gland  infection  at  the  time  of treatment,  in  fact  the  most 
marked  of  any of  the  21  patients  considered  in  these  two  groups. 
The  spinal  fluids  of  the  relapsed  cases,  moreover,  showed  greater 
abnormality than  those  of  the  non-relapses  (Table  IV).  Doubtless 
these  factors  contribute  towards  the  shortening  of  the  duration  of 
action of the drug but it is not possible  to  define their effects  with 
accuracy and the point is merely alluded to here. 
The  duration of negative gland and blood examinations resulting 
from the intramuscular injection of tryparsamide  in 4  patients was 
appreciably longer than that observed after the intravenous route and 
since  this  mode  of  administration  possesses  obvious  advantages, 
particularly in field work, abstracts of these cases are given: 
Mamb,la ~ 43.--Young boy from a  "virulent" region.  Severe lymph gland 
infection.  Spinal fluid, 7.5 lymphocytes  per cram.  Treated with 1.0 gin. trypar- 
samide (37 rag. per kilo of body weight) in 3.0 cc. of water, injected into the deep 
muscles of the left buttock.  Slight  transitory local  tenderness lasting a  few 
hours. 
Gland puncture negative 21½ hours after treatment;  12 subsequent microscopic 
gland examinations and 5 examinations of centrifuged blood were negative during 
56 days.  A second lumbar puncture 34 days after treatment showed a normal cell 
count (2.1 lymphocytes  per cmm.)--a decrease from the initial count. 
A relapse was finally detected 58 days after treatment by the finding of 1 try- 
panosome in he centrifuged blood.  Gland puncture was negative. 
Mulamba  ~39.--Soldier  who  had  been  in  a  "virulent" region  during the 
previous  year.  Moderate  lymph  gland  infection; spinal  fluid  contained  4 
lymphocytes per  cram.  Treated with 3.0  gm. tryparsamide (54 rag. per kilo) 
in I0 cc. of water injected deeply into muscles of the fight buttock.  The following 
morning, 14½ hours after treatment, gland puncture Was negative and there was no 
induration or tenderness of the injection area.  Patient reported slight local dis: 
comfort after the injection lasting a few hours.  No cells were found in the spinal 
fluid examined 35 days after treatment, contrasting with the 4 per cram. before 
treatment.  9 gland punctures and 3 examinations of centrifuged blood during the 
succeeding 42 days were negative but on the 45th day after treatment, one try- 
panosome was found in the centrifuged blood.  Gland puncture negative. 
Bajaka  ~41.--Adult  man from  a  "virulent" region.  Severe  lymph gland 
infection;  spinal  fluid contained 15 lymphocytes per cmm.  Treated with 3.0 
gin. tryparsamide in 9  cc. of water (57 rag. per kilo), injected deeply into the 
muscles of the left buttock.  Gland puncture negative 6 hours later at which time 
patient complained of soreness in the injection area.  During the next 2 days, L.  ~ARCE  21 
soreness disappeared and 6 days after injection, there was only a slight induration 
and slight tenderness on deep pressure of this area. 
During  35  days  after  treatment,  the microscopic  examination of 8  gland 
punctures and 3 centrifuged bloodswere negative but on the 37th day, 2 trypano- 
somes were found in the centrifuged blood.  Gland puncture was negative. 
A second examination of the spinal fluid 35 days after treatment showed 7.5 
lymphocytes--a 50 per cent decrease--but 2 large mononuclear  cells were also 
seen indicating the continued involvement of the cerebrospinal  system. 
N'Keta/~ 42.--Young woman from a "virulent" region  Suffering from exten- 
sive  craw-craw.  Severe  lymph  gland  infection.  Spinal  fluid  contained  10 
lymphocytes per cram.  Treated with 2.0 gm. tryparsamide (57 mg. per kilo) 
in 6.0 cc. of water injected deeply into the muscles of the left buttock.  Gland 
puncture negative 7 hours later. 
During the following week, injection area became considerably indurated and 
quite tender although patient was able to walk;  there was considerable loss of 
weight (2.5 kilos), a rapid pulse, subnormal temperature and patient appeared 
ill.  By the end of the second week after treatment, there was but slight residual 
tenderness on deep pressure, very little induration of a small area and patient's 
general  condition had improved. 
Microscopic examination of 9 specimens of lymph gland juice and 5 of centri- 
fuged blood over a period of 48 days were negative but 51 days after treatment 
1 trypanosome  was'found  in both the lymph gland and centrifuged blood examina- 
tions. 
A second spinal fluid examination 34 days after treatment showed  a normal 
cell conten  t  (0.6 lymphocytes per cram.), contrasting with the original count of 
10 lymphocytes  per cram. 
Several points of interest are brought out in the above four abstracts: 
In only 1 patient was there any considerable discomfort lasting more 
than a few hours in the area of intramuscular injection.  Tiffs patient 
had a  marked case of craw-craw and in  addition  was indescribably 
dirty.  Although  the  skin  of  the  injection  area  was  cleansed  with 
iodine and alcohol, probably an infection of some kind was set up in 
the deep muscles, resulting in a  tender area of induration which was 
absorbed within 2 weeks.  Similar effects following the intramuscular 
injection of other  drugs  are  not unusual under  such  clrcumstances 
according to the experience of the physicians in L~opoldvilte.  Next, 
the time of initial therapeutic action of the drug is comparable  with 
that observed after intravenous administration of the drug.  Thus in 
these 4  cases with severe lymph gland infection, negative  punctures 
were  obtained  within  21½  hours  and, in  the  cases  in  which  earlier 22  TREATMENT  OF  HUMAN"  TRYPANOSOM-IASIS 
examination  could  be  made,  6  to  14½  hours  after  intramuscular 
injections of doses of 54 and 57 nag. per kilo of body weight.  Moreover, 
the action of single doses of from 1.0 to 3.0  gTn. (37  to 57 rag. per kilo 
of body weight)  lasted  from 37  to  58  days.  These 4  patients  came 
from a  region in which the trypanosomal disease is  recognized as more 
difficult to influence  than in other places and, although all 4  patients 
ultimately  suffered  relapses,  it  is  noteworthy  that  moderate  sized 
doses controlled the recurrence of lymph gland and blood infection for 
from 5 to 8 weeks.  Finally, a  distinct effect was observed in the spinal 
fluid  in  that  the  cell  count  was  decreased  in  all  four  patients,  the 
second lumbar puncture  being done 5  weeks after treatment.  Thus, 
Mambula  #43,  showed  a  decrease  from  7.5  to  2.1  lymphocytes per 
cmm.;  Mulamba  #39  from 4.0  to 0  lymphocytes; N'Keta  #42  from 
10 to 0.6  lymphocytes and  Bajaka #41  from  15  to  7.5  lymphocytes 
per  cram.  Although  the  patients  treated  intramuscularly  are  com- 
paratively  few  in  number,  the  results  obtained  are  clear  cut  and 
suggest  that  with  this  method  of  administration  the  drug  may 
remain  available  in  a  biologically  active  state  for a  period  of  time 
perhaps exceeding that of the intravenous  route. 
TABLE IV. 
Non-Relapses  after Single  Doses of Tryparsamlde. 
Intravenous  Administration. 
Case No.  Name. 
40  Esombo ........ 
38  Dale ........... 
30  ]  2¢iafuala  ........ 
46  Bokao  ...... :.. 
5  Mondongo  ...... 
45  K, Georges  ..... 
37  Bukasa ....... 
51  Gwamuntele... 
31  Lubaki ....... 
Weigh1 
kg. 
51 
46 
39.6 
50 
47 
38.5 
54.5 
44 
44.5 
Sphml fluid. 
Normal. 
(?)R.B.C. 
5 
5 
7.5 
Normal. 
12.5 
Normal. 
Normal. 
)ose.  Dose 
g~.  ~f~ 
0.5  9 
1.0  22 
1.0  25 
2.0  40 
2.0  43 
2.0  52 
3.0  55 
3.0  67 
3.0  68 
Time 
N'on-relapse.  after 
treat- 
ment. 
days 
C.B.  --  G.P.  --  109 
C.B.  --  G.P.  --  40* 
C.B.  --  G.P.  --  75 
C.B.  --  G.P.  --  67 
C.B.  --  G.P.  --  111 
C.B.  --  G.P.  --  68 
C.B.  --  G.P~  --  69 
C.B.  --  G.P.  -  54 
C.B.  --  G.P.  --  75 
* Considered  a  relapse because of probable increase of cell content  of spinal 
fluid, 37 days after treatment. L. PE~CE  23 
Table IV summarizes the records of 9 patients treated intravenously 
with single doses of tryparsamide of from 0.5 to 3.0 gm. or from 9 to 
68 rag. per kilo of body weight, in whom return of trypanosomes in, 
the lymph glands or blood from 40 to 111  days after treatment was 
not demonstrable.  As will be seen by comparing Tables III and IV, 
similar sized doses were given to the two groups of patients.  The type 
and stage of the infection of the non-relapsed patients were as follows: 
4 showed slightly abnormal spinal fluids, Mafuala #30, 5; Bokao #46, 
5; Mondongo #5, 7.5; and Bukasa #37,  12.5  lymphocytes per cram.; 
while 4 had normal spinal fluid cell counts--Esombo  #40,  K. Georges 
#45, Gwamuntele #51, and Lubaki #31.  In one instance, Daie #38, 
the spinal fluid was contaminated with blood so that an accurate cell 
count  could  not  be  made.  Although  trypanosomes  were  readily 
found by microscopic examination of  the lymph gland juice or  of 
centrifuged blood before treatment, in general, the lymph gland infec- 
tion was  not a  heavy one  except in  the case  of Bukasa  #37.  In 
addition, none of these patients had  come, as far as could be ascer- 
tained, from the "virulent" regions referred to.  Hence,  these cases 
may represent a less advanced period of the disease and a somewhat 
less virulent type of infecting organism than the majority of patients 
listed in Table III. 
Although patient Dale  #38  is  included in Table  IV because  no 
trypanosomes were found in the lymph  ~"  "  "  gland~]ulce, centrifuged blood, 
or centrifuged spinal fluid for 40 days after treatment with 1.0  gm. 
of tryparsamide, the probable increase in the cells of the spinal fluid, 
together with an increased pulse rate,  loss of weight, and  negative 
malarial examination made it seem probable that a relapse had really 
occurred and  consequently a  system of repeated dose therapy was 
begun. 
With this exception, the 8 patients who were under close observation 
for 54 to 111  days and who received  a  single dose  of  tryparsamide 
of from 9.0 to 68 rag.  per kilo suffered no relapse as  far  as could be 
discovered.  For  comparison, one other case may be  mentioned in 
which no  relapse  occurred although the period of  observation was 
only 26  days.  This  patient, Talamene #73,  came  from  an  active 
epidemic area with a  severe lymph gland infection; his spinal fluid 
was normal.  He was given 4.0 gin. of tryparsamide or 109 nag. per • 24  TREATMENT  OF  HUM.AN  TRYPANOSO~IASI$ 
kilo  intravenously.  Gland  puncture  was  negative  14  hours  and 
centrifuged blood 15 hours after treatment.  Subsequent examinations 
were also negative for 26  days but as it .was  feared that he would 
run away,• the drug was repeated systematically.  The observations 
on this patient may be compared with those on 2 others, Tuamene 
#68 and Ganzema #53, who relapsed  (Table III); the lymph gland 
infection of Talamene #73 and Tuamene #68 were both severe, while 
Ganzema  #53  came  from  a  village  known to  furnish  particularly 
difficult cases.  They were given doses of 80 and 83 rag. per kilo which 
produced  peripheral  sterilization  for  25  and  21  days respectively. 
In  the case of Talamene #73,  the larger  dose of  109  rag.  per kilo 
resulted  in  negative  lymph  gland  and  blood  examinations  for  at 
least 26 days. 
The following protocols illustrate the time and frequency of exami- 
nations carried out with the patients who showed no return of trypano- 
somes during the period of observation: 
Esombo  g~ 40. 
i 
Admitted for ambulatory treatment August 24,  1920.  51.0 kilos. 
Cervical lymph glands enlarged.  Gland puncture +. 
Lumbar puncture normal. 
lPgO 
Aug.  24, 4.30 p.m.  Tryparsamide 0.5 gm. (9.0 nag. per kg.) adm. Lv. 
"  25, 7.30 a.m.  15 hours after treatment  G.  P. 0 
Sept.  1,  8days  "  "  "  "  0 
"  7,  14  "  "  "  "  "  0 
"  13,  20  "  "  "  C.B.  0 
"  14,  21  "  "  "  "  "  0 
"  21,  28  "  "  "  "  "  0 
"  22,  29  "  "  "  "  "  0 
"  25,  32  "  "  "  "  "  0 
"  28,  35  "  "  "  "  "  0 
Oct.  5,  42  "  "  "  "  "  0 
"  8,  45  "  "  "  "  "  0 
"  12,  49  "  "  "  "  "  0 
"  19,  56  "  "  "  "  "  0  "  "  0 
"  20,  57  "  "  "  "  "  0 
"  21,  58  "  "  "  "  "  0 
"  26,  63  "  "  "  "  "  0 
Dec.  11,  109  "  "  "  u  "  0 Mafuala  ~  30. 
Admitted  to  lazaret  August  16,  1920.  39.6  kilos. 
Cervical  lymph  glands  enlarged.  Gland  puncture  +. 
Centrifuged  blood  +.  Lumbar  puncture  normal. 
1920 
Aug.  16,  11 a.m.  Tryparsamide  1.0 gin.  (25 rag. per kg.)  adm.  i.v. 
5  p.m.  6  hours  after  treatment  G.  P.  0  C.B.  0 
"  17,  8a.m.  21  "  "  "  "  "  0 
"  19,  3days  "  "  "  "  0 
"  24,  8  "  "  "  "  "  0 
"  31,  15  "  "  "  "  "  0 
Sept.  3,  18  "  "  "  "  "  0 
"  6,  21.  "  "  "  "  "  0 
"  14,  29  "  "  "  "  "  0 
"  20,  35  "  "  "  "  "  0 
"  23,  38  "  "  "  "  "  0  "  "  0 
"  27,  42  "  "  "  "  "  0 
Oct.  1,  46  "  "  "  "  "  0 
"  6,  51  "  "  "  "  "  0 
"  12,  57  "  "  "  "  "  0 
",  15,  60  "  "  "  "  "  0 
"  19,  64  "  "  "  "  "  0 
"  20,  65  "  "  "  "  "  0 
"  21,  66  "  "  "  "  "  0 
"  25,  70  "  "  "  "  "  0 
"  30,  75  "  "  "  "  "  0  "  "  0 
Bukasa  gg 37. 
Admitted  to lazaret  August  21,  1920.  54.5  kilos. 
Cervical  lymph glands  enlarged. Gland puncture Jr-{-. 
Lumbar puncture 12.5  lymphocytes per  cram. 
19ZO 
Aug. 21,  5.30  p.m. Tryparsamide  3.0  gin.  (55  rag.  per  kg.)  adm. Lv. 
"  22, 6  a.m.  12½ hours  after  treatment  G.  P.  0 
7  a.m.  13½  "  "  "  C.B.  0 
Sept.  3,  13  days  "  "  "  "  0 
"  10,  20  "  "  "  "  "  0 
"  17,  27  "  "  "  "  "  0 
"  20,  30  "  "  "  "  "  0 
"  28,  38  "  "  "  "  "  0 
Oct.  4,  44  "  "  "  "  "  0 
"  6,  46  "  "  "  "  "  0 
"  7,  47  "  "  "  "  "  0 
"  14,  54  "  "  "  "  "  0 
"  15,  55  "  "  "  "  "  0 
"  19,  59  "  "  "  "  "  0 
"  25,  65  "  "  "  "  "  0 
"  29,  69  "  "  "  "  "  0 
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Lubaki  ~  31. 
Admitted to hzaret August 16,  1920.  44.5  kilos. 
Cervical lymph glands palpable.  Gland puncture 0. 
Centrifuged blood 4-.  Lumbar puncture normal. 
19:20 
Aug.  16, 11.15 a.m.  Tryparsamide 3.0 gin. (68 mg. per kg.) adm. i.v. 
"  17,  8.30 a.m.  21 hours after treatment  C.B.  0 
"  24,  8 days  "  "  G.P.  0  "  "  0 
Sept.  4,  19  "  "  "  "  "  0 
"  14,  29  "  "  "  "  "  0  "  "  0 
"  23,  38  "  "  "  "  "  0  "  "  0 
"  30,  45  "  "  "  "  "  0 
Oct.  7,  52  "  "  "  "  "  0 
"  12,  57  "  "  "  "  "  0 
"  15,  60  "  "  "  "  "  0 
"  21,  66  "  "  "  "  "  0 
"  25,  70  "  "  "  "  "  0 
"  30,  75  "  "  "  "  "  0  "  "  0 
TABLE V. 
Summary  of  Relapses  and  Non-Relapses  after  Single  Doses  of  Tryparsamide. 
Doses of from 9 to 33 rag. per  Doses of from 37 to 52 rag. per  Doses of from 54 to 83 rag. per 
kg. of body weight,  kg. of body weight,  kg. of body weight. 
Name.  Result.  Name.  Result.  Name. 
40 Esombo  ....  " g~ 
50 Moangolo..]  0. 
48 M'Bondo...[  1. 
30 Mafuala... I 1. 
28 Mago ......  1. 
47 Mondeke...  2. 
Result. 
days 
0  109 
4-  29 
+  23 
0  75 
-4-  19 
+  26 
2 Non-relapses. 
4 Relapses in average of 24 
days or 3 weeks. 
43 Mambula.. 
46 Bokao  ..... 
5 Mondongo. 
36 Sudila ..... 
63 N'Kaka ... 
45 K. Georges 
d 
gm. 
1.C 
2.( 
2.C 
2.C 
2.( 
2.C 
days 
+  58 
0  67 
0  111 
4-  5C 
+  17 
0  68 
3 Non-relapses. 
39 Mulamba... 
37 Bukasa ..... 
41 Bajaka ..... 
42 N'Keta ..... 
51 Gwamuntele 
31 Lubaki ..... 
68 Tuamene... 
53 Ganzema... 
3 Non-relapses. 
d 
8 
gm, 
3.0 
3.0 
3.0 
2.0 
3.0 
3.0 
5.0 
3.0 
3 Relapses in average of 42 
days or 6 weeks. 
days 
+  45 
069 
+  37 
+  51 
0  54 
0  75 
+  25 
+  21 
5 Relapses in average of 36 
days or 5 weeks. 
In  considering  the  length  of  time  of  peripheral  sterilization  in 
relation  to  the  size  of  the  dose,  it  will  be  of  assistance  to  glance  at 
Table  V  which  groups  together  the  instances  of  relapse  and  non- L.  P~ARCE  27 
relapse of Tables  III  and  IV  according  to  the  amount of  drug 
administered.'  Daie #38 is not included since we were uncertain of the 
result.  The  first  column  of  Table  V contains  the  results  of  the 
treatment of 6  patients with doses of ~rom 9  to 33  rag.  per kilo of 
body weight or, with the usual size of the native in the lower Congo, 
a dose of from 0.5 to 2.0 gin.  Of these 6 patients, 4 suffered a relapse 
in from  19  to  29  days or on an average of 24  days, a  little over a 
3  weeks'  period.  The 2  non-relapsed  patients,  of  whom  one  had 
received the small dose of 9.0 rag. per kilo of body weight, were still 
clear 109 and 75 days after treatment.  In the second group, 6 patients 
were  treated  with  amounts  ranging  from  37  to  52  rag.,  usually  a 
2.0 gm. dose, and 3 relapsed in from 17 to 58 days or on an average of 
42  days or 6 weeks.  The instances of non-relapse in this group had 
been under observation respectively for 67, 68, and 111  days.  In the 
third group comprising 8 patients who received 2.0, 3.0,  and 3.0 gin. 
doses, or from 54  to 83  rag. per kilo of body weight, 3  relapsed in 
from 21 to 51 days or on an average of 36 days or practically 5 weeks. 
The 3 non-relapsed  patients  were  clear  54,  69,  and  75  days  after 
treatment. 
Speaking generally, there is apparently not a great deal of difference 
between the results obtained with what might be called average doses, 
that is, 2.0 and 3.0 gm.--as shown in columns 2 and 3 of Table V-- 
since  the  average  negative period  for  trypanosomes  was  6  and  3 
weeks respectively.  There is  a  distinct  shortening of this  period, 
however, after the smaller doses of 0.5 and 1.0 gm. as shown by the 
average figure of 3 weeks.  Thus it appears that once a certain amount 
of  drug  is  biologically available  for  therapeutic  action,  it  may be 
unnecessary to increase the size of the dose above this amount which 
represents a favorable ratio between rate of abgorption and elimination 
and duration of action on the parasites. 
However, from the point of view of planning a  system of repeated 
doses, especially with a  new or little tried drug, one is not justified 
in  the beginning in working with averages of duration of peripheral 
sterilization.  The shortest period of sterilization was 17 days after a 
dose of 2.0  gin.  or 47  rag. per kilo of body weight and  accordingly 
two principal systems of therapy were planned.  These consisted in 
giving average doses of 2.0,  3.0,  and 4.0,gma. according to the weight 28  TREATMENT  Ole  HUMAN  TRYPANOSOMIASIS 
of the patient at weekly or fortnightly intervals for 4 to 8 injections. 
A  number of patients were thus treated toward the end of our stay 
in the Congo, the results of'which will be sent to us by the Belgian 
physician in charge of the cases in L6opoldville. 
Effect of Single Doses upon the Spinal Fluid. 
The effect of a drug upon the spinal fluid of patients suffering from 
trypanosomiasis is  of great importance,  since  the natural  evolution 
of  the  disease  is  toward  involvement of  the  cerebrospinal  system. 
The ultimate outcome of certain cases is at once problematical if the 
therapeutic field of action of a  drug is  limited,  practically speaking, 
to that of so called peripheral sterilization, while if the cerebrospinal 
system is included in its sphere of action and the effect of its adminis- 
tration is reflected in the spinal fluid, the therapeutic possibilities of 
the drug are at  once extended.  Thus,  in cases of human trypano- 
somiasis in  the first stage in which the spinal fluid is  normal,  it is 
essential to ascertain if that condition continues so or whether, despite 
the negative blood and lymph gland examination, the  cerebrospinal 
axis may be invaded. 
Moreover, in those cases in which some invasion has already taken 
place as indicated by a slight pleocytosis, the selection of a drug which 
tends  to  limit  the further progress  of the disease is  urgently called 
for.  Finally, in the advanced cases with more or less cerebrospinal 
involvement  and  alteration  of  the  spinal  fluid,  such  an  agent  is 
obviously indicated. 
Broden  and  Rodhain  (8,  9,  and  10)  have  shown  that  in  human 
trypanosomiasis,  the cell content of the spinal fluid may be looked 
upon  as  an  index  of  the  extent of  cerebrospinal  involvement, thus 
serving  as  a  diagnostic  criterion  and  a  therapeutic  guide.  They 
consider that a normal spinal fluid contains no more than 3 lympho- 
cytes (small mononuclears) per cram.;5 and that in the cerebrospinal 
stage of the disease, the first abnormality to be noted is an increase 
in the lymphocytes which is followed in the more advanced cases by 
2  The ceils are counted  directly  by means of a  Fuchs-Rosenthal chamber, 
immediately after the withdrawal of a few cubic centimeters of spinal fluid which 
is not centrifuged. L. PEAgCE  29 
the  appearance  of  medium  sized  mononuclear  ceils  and  so  called 
mulberry  cells  or  large  vacuolated  mononuclear  cells  (cellules  en 
mare).  The  very advanced  cases,  on  the  other hand,  may show 
extremely large vacuolated cells, rare polymorphonuclear cells with 
eosinophilic granules and cells which apparently have become detached 
from the surface of the meninges.  Although minor variations in the 
cell count of the spinal fluid occurs from time to  time, in  general, 
once the cerebrospinal system has become affected, progress tends to 
be continuous with iricreasing abnormality of the spinal fluid.  Trypa- 
nosomes may be found in  the centrifuged spinal fluid of the more 
advanced cases, but it is not always practical to withdraw the necessary 
amounts of fluid for this procedure.  The nature of the infection in 
these cases is usually readily established by gland puncture or exami- 
nation of centrifuged blood so that demonstration of trypanosomes 
in the spinal fluid was not attempted as a routine measure. 
The effect, therefore, of the adm~nistration of tryparsamide upon 
the spinal fluid was  carefully followed.  The  usual procedure was: 
A  lumbar puncture was done before treatment and from 3 to 10 cc. 
of fluid removed and the cells counted.  The period of the disease 
was based on the results obtained irrespective of other clinical findings. 
The manner of treatment was also determined by this procedure since 
when a  moderate or marked alteration in the cell content was found 
more vigorous treatment than a single dose of the drug was indicated. 
A  second lumbar puncture was done about 5 weeks later, and when 
possible,  again at some more remote date; more frequent punctures 
were not made as the patients were ambulatory, and, in addition, we 
wished to avoid so called drainage changes which might result from 
such a procedure. 
In Table VI are given the cell counts of 14 patients before and after 
treatment with single doses of tryparsamide.  This number includes 
9 patients in whom no return of trypanosomes ~n the blood or lymph 
glands was detected during the period of observation after treatment 
and 5  who eventually relapsed but whose second lumbar puncture 
was done before this occurred.  The cell content of the spinal fluids 
was normal or showed a slight increase up to 20 lymphocytes per cmm. 
Single does of 0.5  to 3.0 gm. or 9 to 68 mg. per kilo of body weight 
were  administered intravenously  to  10  and  intramuscularly  to  4 
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The second lumbar puncture was done approximately 5 weeks after 
treatment  in  all  the  patients  except  Sudila  #36  and  Gwamuntele 
#51,  in  whom  the  interval  between  the  first  and  second  lumbar 
puncture  was  40  and  47  days  and in  the case of  Mondongo #5, in 
~¢bAch it was  26  days.  It will be noted  that  with  the  exception  of 
Daie  #38,  the  second  examinations  showed  no  increase  in  the  cell 
TABLE  VI. 
Cell Content of Spinal Fluid after Single  Doses. 
~alne. 
Z  _ 
kg, 
40 Esombo  ....  51 
38 Daie ........  46 
30 Mafuala.... 39. 
43 l~ambula... 27 
46 Bokao  ...... 50 
5 Mondongo.. 47 
36 Sudila  ...... 46 
45 K. Georges.. 38. 
39 Mulamba... 55. 
37 Bukasa  ..... 54. 
42 N'Keta ..... 36 
41  Bajaka ..... 53 
51  Gwamuntele.  44 
31 Lubaki ..... 44. 
------4 
Cell content  Cell content 
before  after 
treatment,  treatment. 
Normal.  Normal. 
(?)R.B.C.  35 (1 1.m.) 
5  4.6 
7.5  I  Normal. 
5  Normal. 
7.5  5 
3  (2 l.m.) 
20  Normal. 
Normal.  Normal. 
4  Normal. 
12.5  Normal. 
10  Normal. 
15  7.5 (2 1.m.) 
Normal.  Normal. 
Normal.  Normal. 
Remarks. 
days 
No relapse  109 
No relapse (?)J~ 
No relapse  73 
Relapse  58 
No relapse  67 
No relapse  111 
Relapse  50 
No relapse  58 
Relapse  45 
No relapse  69 
Relapse  51 
Relapse  37 
No relapse  54 
No relapse  75 
1.m.--Large mononuclears. 
* Intramuscular administration. 
f CL Table IV. 
content; but 4, Esombo #40, K. Georges #45,  Gwamuntele ~51, and 
Lubaki #31, continued to be normal; and 2, Mafuala  #30 and Mon- 
dongo  ~5,  whose  original  counts  were  5  and  7.5  lymphocytes per 
cram., showed practically no change, 4.6 and 5 lymphocytes per cmm. 
respectively.  On  the  other  hand,  5  patients  whose  spinal  fluids 
showed slight changes before  treatment  (Mambula ~43,  7.5; Bokao T..  eEARC~  31 
#46, 5; Sudila #36, 20; lV[ulamba #39, 4; Bukasa #37, 12.5; N'Keta 
#42, 10)  all had normal cell counts at the time of the second exami- 
nation.  One patient, Bajaka #41, with an initial cell content of 15, 
showed  7.5  lymphocytes 35  days  after  treatment  but  as  2  large 
mononuclears were seen in the counting chamber, it is probable that 
the influence of  the  drug was  less marked than in the other  cases. 
.This patient came from a "virulent" region and at the time of treat- 
menthad  a  very  severe  lymph  gland  infection.  A  third  lumbar 
puncture done 93  days after  a  single dose of 2.0 gin. in one patient, 
Mondongo #5,  showed 3 lymphocytes or a  normal count but, as in 
the  case  of  Bajaka #41,  2  large  mononuclears having been  seen, 
according to the standards established by Broden and Rodhain, the 
possibility  of  some  degree  of  cerebrospinal  involvement must  be 
considered.  Finally,  one  patient,  Dale  #38,  showed  what  was 
apparently  a  progression  of  the  disease.  An  accurate  initial cell 
count  was  impossible  because  the  spinal  fluid was  contaminated 
with blood but the second cell count, done 37  days after treatment 
with the small dose of 22  rag.  per kilo of body weight, showed 35 
tymphocytes per  cmm.,  and  1  large  mononuclear in  the  counting 
chamber.  No  trypanosomes were found  in  centrifuged specimens 
of  the spinal fluid and  repeated examinations of lymph glands and 
blood had been negative since treatment.  As there had been a loss 
of 1.5 kilos in weight and no malarial parasites were found and as 4 
days before the second lumbar puncture the pulse had risen from the 
usual rate of 72 to 80 to 92, tMs man was transferred to the group of 
patients being treated with repeated doses of tryparsamide. 
The observations just described indicate that in the first period of 
,the disease or in the very early stages of the second period, single 
small and medium doses of tryparsamide will in  nearly all  cases be 
followed by beneficial effects as indicated by the influence upon the 
cell content of the cerebrospinal fluid.  Perhaps it may be permissible 
to go even further than this and to state that in these early stages 
an arrest of the disease has been achieved although it must be remem- 
bered that there is no criterion of the time of occurrence of cerebro- 
spinal involvement and no prediction of the duration of the observed 
effect can be made. 32  TREATMENT  OF  HUMAN  TRYPANOSOM'IASIS 
Effect of Single Doses upon  the Blood. 
The blood condition of natives suffering from trypanosorniasis is 
often complicated by the presence of one or more other infections.  In 
the lower and middle Congo regions, almost every native shows an 
enlarged  spleen  and  chronic  malaria;  moreover,  skin  infections, 
filariasis,  intestinal  parasites,  and  amcebiosis  are common,  and 
venereal  disease  is  frequent.  Keeping  in  mind  these  facts,  most 
authorities agree that the blood changes in human trypanosomiasls 
consist of diminution of red cells, decrease in hemoglobin, and normal 
or slightly subnormal white cells associated with a  relative increase 
of mononuclear cells and a decrease Of granular leukocytes. 
Blood counts were followed in 12 patients in the early period of the 
disease or at  the period of slight abnormality of  the  cerebrospinal 
fluid.  Single doses of  tryparsamide, ranging from 0.5 to 5.0 gin. were 
given intravenously to  10 and intramuscularly to 2 patients  (Table 
VII)  including  8  non-relapsed  subjects  who  had  negative  lymph 
gland  and  blood examinations during the period of observation;  1 
patient, who had not r.elapsed 26 days after treatment but who was 
transferred to the series of repeated doses at this time and 3 relapsed 
patients from whom a  second blood count had been obtained before 
trypanosomes were again found in the lymph glands or blood.  The 
time of the second blood examination in relation to the first, taken on 
the day of treatment, ranged from 26 to 63 days. 
At the first count, there was in these cases a  marked decrease in 
hemoglobin and a somewhat less decrease in the red cells or an anemia 
of the secondary type.  Only 2 patients showed an original increased 
or normal red cell count; 4 showed counts of 4 million; 4 showed counts 
between 3 and 4 million, and 2 patients showed only 2 and 2½ million 
red cells. 
The injection of a single dose of tryparsamide (0.5 to 5.0 gm.) was 
followed in 41  to 63 days by an increase in the number of red cells 
in 7 patients ranging from 10 to 60 per cent as shown in Table VIII. 
One patient, Tuamene #68, showed an increase of 15 per cent in 28 
days, while in two others, Bukasa #37 and Mondongo #5, the increase 
was 47 and 60 per cent in 60 and 41 days respectively.  In 3 patients 
with initial counts of 4 million, Talamene #73, Lubaki #31, K. Georges L. PEARCE 
TABLE VII. 
Changes in Blood Counts after Single Doses of Tryparsamide. 
33 
d 
L~ 
40 
30 
43 
46 
45 
37 
42 
N~  1st blood count. 
Esombo  R.B.C. 5,760,600 
sl I  Hb.  ss % 
W. B.C.  10,800 
Mafuah  R.B.C. 4,960,000 
39.6  HI).  65 % 
w.  B.c.  6,4oo 
Mambul  R.B.C. 4,000,000 
271  Hb.  60% 
W.B.C.  4,200 
Bokao.  R.B.C.  3,840,000 
50  Hb.  60  % 
W.B.C.  S,000 
Mondos  R.B.C. 2,000,000 
47  Hb.  35~ 
W.B.C.  5,4OO 
K. Geor  R.B.C. 4,032,000 
38..  ~  Hb.  50 ~c 
W.B.C.  8,200 
Bukasa.  R.B.C. 2,490,000 
54.~  Hb.  40 % 
W. B.C.  5,200 
N'Keta  R.B.C. 3,200i060 
36  I-lb.  35 % 
W. B.C.  4,OOO 
2rid blood count. 
6,400,000 
70 % 
9,600 
4,048,000 
7O % 
8,000 
4,480,000t 
65 % 
8,000 
4,800,000 
8o% 
6,000 
4,640,000 
7O % 
6,600 
3,200,000 
55 % 
9,800 
3,360,000"]" 
55 % 
12,000 
4,000,000 
60 % 
9,000 
3,656,000 
70 % 
6,000 
3,200,000 
45 % 
7,600 
~o. 
63~ 
37§ 
~t 
S4 
4111 
lOSt 
56~ 
6O 
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TABLE  VII--Continued. 
51 
31 
68 
73 
Dose.  1st blood  count.  Name.  adm. i. v. 
Gwamtmtde  ....  3.0 gin.  R.B.C. 3,200,000 
44 kg.  67 nag.  Hb.  40 % 
per kg.  W.B.C.  3,600 
Lubakl ....  3.0 gin.  R.B.C. 4,000,000 
44.5 kg.  68 rag.  Hb.  65 % 
per kg.  W.B.C.  4,700 
Tuamene .......  5.0 gin.  R.B.C. 3,680,000 
62.5 kg.  80 nag.  HI).  50 % 
per kg.  W.B.C.  8,000 
Tahmene ........  4.0 gin.  R.B.C. 4,000,000 
36.5 kg.  109 nag.  Hb.  50 % 
per kg.  W.B.C.  4,000 
2nd blood  count. 
4,000,000 
55 % 
5,000 
4,000,000 
70 % 
5,600 
4,800,000f 
65 % 
8,000 
4,240,000 
60% 
8,000 
4,000,000 
65 % 
6,000 
Change. 
pet  cent 
+25 
+38 
+39 
m 
+8 
+19 
+20t 
+7O 
+15 
+20 
B 
+30 
+50 
days 
37t 
70t 
28 
26 
* Administered intramuscularly. 
t 3rd blood count. 
Estivo-autumnal malaria. 
§ Estivo-autumnal malaria (?). 
[] Multiple skin ulcers; filariasis; chronic amcebiosis (?). 
** Craw-craw; intramuscular abscess. 
tt Filariasis. 
#45,  and  in one, N'Keta  ~42, with  a  count of  3  million  red  cells, 
there was no change noted after 26  to  56 days;  2 of these patients, 
K.  Georges  #45  and  N'Keta  #42,  suffered  from  acute  concurrent 
infections during this period; Lubakl ~31 ultimately showed an increase 
of 20 per cent, 70 days after treatment;  and in the case of Talamene 
#73 the interval between the counts was comparatively short, 26 days. 
One patient,  Mafuala  #30, whose first count was 5 million red  cells, 
showed a decrease of 18 per cent in 37 days but in a third count 6"6 days 
after treatment the decrease amounted to 10 per cent. L.  PEARCE  35 
TABLE  VIII. 
Changes in the Red Blood Cell Counts of Patients Treated with Single Doses of 
Tryparsamide. 
Caee 
No. 
5 
37 
42 
51 
68 
46 
43 
31 
73 
45 
30 
40 
Name. 
Mondongo .... 
Bukasa... 
N'Keta .... 
Gwamuntele ......... 
Tuamene... 
Bokao .... 
Mambula. 
Lubakl  ........ 
Talamene. 
K. Georges .... 
Mafuala... 
Esombo 
"l 
I 
"l 
..! 
I 
Dose. 
rag. perk&. 
43 
55 
57 
67 
80 
40 
37 
68 
109 
52 
25 
9 
Original R. B.C.R.B.C.  after 
before 
treatment,  treatment. 
3,200,6O0 
2,00O,0O0  3,36O,0O0 
2,490,000  3,656,000 
3,200,000  3,200,000 
3,200,000  4,000,000 
3,680,000  4,240,000 
3,840,000  4,640,000 
4,000,000  ~4,800,000 
4,OOO,0OO  {  4,OOO,0OO 
4,800,000 
4,000,000  4,000,000 
4,032,000  4,000,000 
4,960,000  {  4,0t-8,0170 
4,480,000 
5,76O,0OO  6,4O0,000 
Change. 
per ~:enlt 
+60 
+68 
i+47 
+25 
+15 
+2'1 
+20 
{ +20 
--18 
-10 
+lO 
Interval 
between 
counts. 
d4~$ 
I05 
6O 
30 
5! 
28 
54 
48 
7O 
26 
56 
65 
63 
TABLE  IX. 
Changes in Hemoglobin Content of Blood after Single Doses of Tryparsamide. 
Case 
No. 
5 
42 
37 
51 
45 
68 
73 
40 
43 
46 
30 
31 
Name. 
Mondongo... 
N'Keta.. 
Bukasa ...... 
Gwamuntele  ........ 
K. Georges ..... .... 
Tuamene ....... 
Talamene .......... 
Esombo .... 
Mambula  .... 
Bokao. 
Mafuala ....... .  ..... 
Lubaki .......... 
Do~e. 
rag. f~er  kg. 
43 
57 
55 
67 
52 
80 
109 
9 
37 
4O 
25 
68 
Original 
hemoglobin 
[  content 
[ before  treat- 
Eaent. 
per cent 
35 
35 
4O 
40 
50 
50 
50 
55 
6O 
6O 
65 
65 
Hemoglobin 
content 
after treat* 
ment. 
~r ~ 
55 
45 
7O 
55 
6O 
6O 
65 
7O 
8O 
7O 
65 
65 
Interval 
Change +.  between 
examinations 
per  cent  days 
.57  41 
29  30 
75  6O 
38  51 
20  56 
20  28 
30  26 
27  63 
33  48 
17  54 
--  66 
--  70 36  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
The  hemoglobin  content  of  the  blood,  determined  by  a  Sahli 
hemoglobinometer, was  generally  increased after  treatment  with 
tryparsamide as shown in Table IX.  In  10 of the patients in  this 
group, the hemoglobin content rose from 17  to  75  per cent during 
periods of from 26  to  63  days after  single dose treatment while 2 
patients each with an original hemoglobin of 65 per cent showed no 
change.  As might be expected, the greatest gains were in those patients 
with the lowest hemoglobin.  Thus, in the first 4  cases with 35 and 
40 per cent hemoglobin, the average gain was 50 per cent and in 6 
TABLE  X. 
Changes  in the  White Blood Cell Counts after Single Doses of TryparsarMde. 
Case 
No. 
51 
42 
73 
43 
31 
46 
37 
5 
30 
68 
46 
40 
Name. 
Gwamuntele... 
N'Keta .... 
Talamene ..... 
Mambula... 
Lubaki.. 
Bokao .... 
Bukasa... 
Mondongo .......... 
Mafuala ........ 
Tuamene ....  "i 
K. Georges .........  i 
Esombo ....... 
Dose. 
rag. per kg. 
67 
57 
109 
37 
68 
4O 
55 
43 
25 
80 
52 
9 
Original 
W. B.  C. 
before 
treatment. 
3,600 
4,000 
4,000 
4,200 
4,700 
5,000 
5,200 
5,4O0 
6,400 
8,000 
8,200 
10,800 
W. B. C. 
after 
treatment. 
5,000 
7,600 
6,000 
6,000 
5,500 
8,000 
6,600 
6,000 
I 
9,800 
12,000 
8,000 
8,000 
8,000 
9,000 
9,600 
Change  +. 
39 
9O 
3O 
43 
70 
32 
15 
122 
20 
20 
10 
-ll 
Interval 
between 
counts. 
days 
51 
30 
26 
48 
70 
54 
60 
105 
37 
66 
28 
55 
63 
patients with original values of 50 to 60 
per cent in an average of 46 days. 
No direct relation was  detected between  the 
tryparsamide and the changes in the red cells or 
probable,  however,  that  such  improvement as 
from the trypanocidal action of the drug. 
The initial leucocyte counts of this group were less than 8,000 in 9 
of the 12 patients; there were 2 counts of 8,000 and 8,200 and one of 
10,800  (Table X).  Examinations made at varying intervals of time 
per cent the increase was 23 
size of the dose of 
the hemoglobin; it is 
takes  place  results L. 1,~Axc~  37 
after treatment with single doses of tryparsamide showed an increase 
of white blood cells of from 10 to 122 per cent in 10 patients, no change 
in an original count of 8,000 cells per cram. and a Ii per cent decrease 
in the patient who had an original slight leucocytosis. 
The upshot of the observations of these patients is that, despite 
other concurrent infections, a tendency is  to be discerned toward a 
normal blood picture once the trypanosomal infection is  controlled 
for even a few weeks by a single dose of tryparsamide. 
Effect of Single Doses upon the Weight. 
The effect upon the weight of all patients treated with tryparsamide 
was followed and the observations made on 21 patients treated with 
single doses are shown in Table XI.  These patients were in the first 
period or in the beginning of the second stage of the disease as indicated 
by the cell content of the spinal fluid and were treated with single 
doses of  from 0.5 to  5.0 gm.  given intravenously in  17  and intra- 
muscularly in 4  cases.  The group includes 9  non-relapsed cases in 
whom no trypanosomes were demonstrated microscopically in lymph 
glands, centrifuged blood or centrifuged spinal fluid, Ii relapsed cases 
and I in whom the result was uncertain. 
Considering the group as a  whole, 5 patients showed no change of 
weight in 3 to 12 weeks, 2 showed a loss of 0.5 and 1.5 kilos respectively 
in 3 and 6 weeks and 14 showed a gain of 0.5 to 8.4 kilos in from 3 to 
I0 weeks after treatment.  Generally speaking, patients who gained 
little or no weight had intercurrent infections or suffered an ultimate 
relapse. 
Of the 14 patients who gained weight, 7 remained negative during 
the period of observation and 7 ultimately relapsed.  These cases are 
c6ntrasted in Table XII.  The increase in weight of the 7 non-relapsed 
patients ranged from 0.5 to 8.4 kilos or an average of 3.3 kilos in 4 
to I0 weeks.  The relapsed patients on the other hand showed smaller 
gains ranging from 0.5 to 2.5 kilos or an average of 1.4 kilos in 3 to 
8 weeks. 
General Effects FoUouring Single  Doses. 
The preceding sections o5  this paper have dealt with a  series of 
observations  carried  out  on  a  number  of  patients  suffering  with 38  TREATMENT  O]F  HUMAN  TRYPANOSOMIASIS 
trypanosomlasis treated  with  single doses of  tryparsamide.  These 
observations consisted of the results of microscopic examinations for 
trypanosomes in aspirated lymph gland juice and in centrifuged blood, 
TABLE  XI. 
Changes ~  Weight after  Single  Doses of  Tryparsamide. 
40 
50 
48 
38 
30 
28 
47 
43 
46 
5 
36 
45 
39 
37 
41 
42 
51 
31 
68 
53 
73 
gm.  kg.  kg.  kg.  kg.  kg.  kg.  kg.  kS'.  /~g-I  kg. 
Esombo ......  3.5  51.0  ~9.~ 51.551.C  51.051.{3  51.5  +0.5  0~ 
Moangolo ....  0.5  29.5  .~9.5 30.030.5  30.5  +1.0  + 
M'Bondo- ....  1.0  50.0  51.C 51.051.5  52.0  +2.0  +:~ 
Daie ..........  1.0  46.0  16.5  14.044.5  14.544.5  --1.5  0(?) 
Mafuala ......  1.0  39.6  I0.¢ ~0.040.5  14.043.0  15.5  48.0  +8.4  0 
Mago.  1.0  33.0  ~3.(~32~533.5  +0.5  + 
Mondeke .....  2.0  61.0  Jl.5 51.060.5  --0.5  +~ 
iYf~mbula.  1.0' 27.0  ~-6.5 26.5 25.5  .~6.0 27.5 27.5j  ] +0.5  +~ 
Bokao .......  2.0  50.0  ~9.C ~9.549.0  30.050.555.0  +5.0  0 
Mondongo ....  2.0  ~7.0  ~7.0 t7.045.0  t4.044.545.5116.547.C  None.  01] 
Sudila.  2.0  ~6.0  16.G ~6.5 47.0  ~9.048.0  +2.0  + 
K. Georges ....  2.0  38.5  ~9.0 38.5 36.5  37.0 38.543.0  +4.5  0t 
Mulamba .....  3.0* 55.5  56.5  57.058.5  57.558.0  +2.5  +~: 
Bukasa.  3.0  54.5  ~4.0 55.0 54.0  52.5  53.0 53.5j54.5  None.  0 
Bajaka ........  3.0* 53.0  ~3.0 52.5 52.5  53.0 53.0  I None.  +§ 
N'Keta.  2.0* 36.0  t5.0  33.5 34.5  34.0:34.5 36.0  ! None.  +** 
Gwamuntele..  3.0  44.0  L5.(} 14.044.0  t4.545.044.5  +0.5  0t 
Lubaki.  3.0  14.5  ~3.S ~2.543.0  14.5 46.046.0  47.0  +2.5  05 
Tuamene .....  5.0  [62.5  ~2.(] 51.5 62.5  None.  + 
Ganzema..  3.0  36.0  ~7.{~ 37.037.0  +1.0  + 
Talamene .....  4.0  36.5  ~6.5 37.037.5  38.0  +1.5  0 
* Intramuscular administration. 
t  Estivo-autumnal malaria. 
$ Filariasis. 
§ Fflariasis; malaria (?). 
II Diffuse skin infection; filarlasis; chronic diarrhoea. 
** Craw-craw; intramuscular  abscess. 
cell counts of the spinal fluid, cell counts and hemoglobln estimations 
of  the  blood,  and  finally weight determinations--information of a 
fundamental character to be used in devising an effective system of L.  VV.ARC~  39 
repeated dose therapy.  In addition, other effects of treatment may 
be briefly considered. 
Adenitis.--Polyadenitis  is a  constant symptom of human trypano- 
somiasis and of all of the superficial lymph glands those of the neck 
are most regularly involved.  Palpation of these glands constitutes 
the general diagnostic method for the disease in the Belgian Congo, 
and  enlarged  cervical  glands  were  present  in  all  cases  treated 
with  tryparsamide except in  4  advanced patients who were  being 
treated with other drugs.  The glands most frequently hypertrophied 
TABLE  XII. 
Increases in Weigkt of Non-Relapsed and Relapsed Patients after Single Doses.  of 
Tryparsamide. 
Case 
No. 
Non-relapses.  Relapses. 
Name. 
40  Esombo  ....... 
30  Mafuala ...... 
46  Bokao ........ 
45  K. Georges .... 
51  Gwamuntele... 
31  Lubaki ........ 
73  Talamene ..... 
)ose, 
9 
25 
68 
109 
.'otal 
;sin. 
kg. 
0.5 
8.4 
5.0 
4.5 
0.5 
2.5 
1.5 
Time. 
~veeks 
st 
10 
8 
st 
st 
10 • 
4 
Case 
No. 
50 
48 
28 
43 
36 
39 
53 
Name. 
Moangolo ...... 
M'Bondo ..... 
Mago.  ........ 
Mambula ..... 
Sudila ......  .. 
Mulamba ..... 
Ganzema ...... 
Dos¢ 
17 
20 
33 
37 
44 
54 
83 
,~o.tal  Time. 
jam. 
kg.  ~eks 
1.0  4 
4* 
3 
8t 
6 
2.5  6* 
1.0  3 
2.0 
0.5 
0.5 
2.0 
Average  gain  of  3.3  kg.  in  4  to  10  Average gain of 1.4 kg. in 3  to 8 weeks. 
weeks. 
* Filariasis. 
t  Estivo-autumnal malaria. 
in our series were those of the posterior cervical triangle; in several 
cases a  chain of enlarged glands were felt along one or both sides of 
the posterior portion of the neck, while the majority showed one or 
more enlarged glands at the base, either in the anterior or posterior 
cervical triangle.  Usually the glands were about the size of a  large 
pea or filbert, often slightly fusiform and of a peculiar soft but elastic 
consistency which has been compared to that of a  ripe plum.  In the 
cerebrospinal cases, the glands were usually smaller and firmer.  Other 
superficial lymph glands are not commonly used as diagnostic signs. 40  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
Under treatment with single doses of tryparsamlde, a marked reduction 
of the enlarged cervical glands was observed in all cases which did 
not relapse.  They became much smaller and firmer and in certain 
patients whom we were able to follow for 2 or 3 months gland puncture 
was carried out with considerable di~culty.  In relapsed patients, the 
condition of the glands was directly related  to  the duration of the 
peripheral sterilization; if this extended over 4 or 3 weeks, a  distinct 
reduction was noticeable. 
Temperature.--An irregular intermittent fever and rapid pulse are 
characteristic of human trypanosomiasis and during  febrile  periods 
the temperature is more often elevated in the afternoon than morning. 
Because one is obliged to take the temperatures in the axilla of the 
natives, correct readings are difficult to obtain and the readings are 
lower  than  they  should be.  The highest fever noted was  usually 
around 38.5 °  C.;  after  treatment,  a  sharp  drop occurred as  shown 
in Charts I  to III.  The temperature charts of Bikoko #55 (Chart I) 
is interesting as it shows the prompt cessation of fever after the adminis- 
tration of the dose of only 0.3 gin. or 4.7 mg. per kilo; this patient had 
an unusually severe lymph gland infection but the dose was sufficient 
to produce a  negative gland examination in 19 hours.  Three other 
patients, M'Bondo #48, Yala #70, and Kakuma #65 (Chart I), show 
a  similar drop in the temperature curve following the administration 
of 1.0, 3.0, and 4.0 gin. doses of tryparsamide.  The charts of Esombo 
#40  (Chart II)  and K.  Georges #45  (Chart III) treated with single 
doses of 0.5 and 2.0 gm. cover periods of 6½ and 9 weeks in which no 
trypanosomes were found in the lymph glands or blood.  The inter- 
current fever with increased pulse rate in these patients was  due to 
an acute  attack of  estivo-autumnal malaria.  K.  Georges #45  was 
admitted during an afebrile period but it should be noted that his 
pulse rate was increased to 96 per minute. 
Pulse.--The pulse rate in human trypanosomiasis is of considerable 
importance in  diagnosis and in many of our  cases it served as  an 
index of the effect and duration of action of tryparsamide.  The pulse 
itself is regular with a small volume and generally a lowered tension. 
The  rate  is  usually disproportionately increased  in  relation  to  the 
fever and may persist above normal in afebrile periods. 0 
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In the charts of the above 6 patients  (Charts I  to III), the effects 
of tryparsamide upon the pulse rate may be seen.  Usually within 24 
to 48 hours after treatment with a single dose, the pulse rate became 
normal or subnormal,  unless  some complicating infection or patho- 
logical condition existed--as for instance an acute or subacute malaria 
which was the case with Esombo #40 (Chart II) and K. Georges #45 
Patient 40, Esombo  51.0K. 
~UG,  3EPT.  0CT. 
:425  7  2z  28 5  6  8 
0 ....  O 
130  40  ~  ~-~  '~ 
,~"  :~. 
120  39.5  [.~ 
!2  ¢ 
,  ,1,  i18  39  ~,  ?, 
38.5  i,  :j  ,  q  ~.~.C  S  I00  .  ~.  , 
38  ~,i.i  ,,, 
i~  7't  ',  p.o.~.  90  37.5  ~  ~  ,,,,  -,o 
80  37  ~  I  ~  '-"&  ,, 
'TO  35.5  ~ .... 
L,p 
60  36  - 
5i 
50  35,5  ~, 
4I)  35 
CIZAI~T II. 
(Chart III).  In a  few patients in whom no complicating condition 
was found, the possibility of a  still operative trypanosomal infection 
must  be  considered,  although  repeated microscopic examinations of 
lymph gland juice and centrifuged blood  were negative.  Such cases 
ultimately relapsed but the duration of peripheral sterilization varied 
widely.  An increased pulse rate with slight or no fever during the L. PEARCE  43 
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period of peripheral sterilization was found to possess considerable 
importance as an indication of a  relapse, provided that other patho- 
logical factors were excluded as shown in Charts IV to VII. 
Mambula #43 (Chart IV) after treatment on August 26, 1920, with 
1.0  gm.  of  tryparsamide  administered  intramuscularly,-showed  a 
subnormal temperature and  fairly normal pulse rate  with negative 
Pulse 
13o 
120 
Ii0 
I00 
9O 
80 
7O 
6O 
50 
40 
Patient 50,rioan~olo  29.5 K, 
~EPT.  OCT. 
7 I0  15  17  20  24  25 1 4 5  A £  8 11  13  16  20  Zl  27 
40  .  ~  ,  ,  ~  ,  ~- 
39.5  ~_~  ~  ~  ~  ~ 
t~  "o "~  "~  6  r, 
38.~  ol  I  P 
,,  ,j 
38  '"  '  I  ~  i 
37.5  ': 
%- J  V  . 
L  ;  36.6 
I  T 
36  d 
35.5  ~ 
35  ~I 
Cmu~ V. 
lymph gland and blood examinations until October 4, 1920, at which 
time he developed fever and a pulse rate of 116 per minute,  iV~ala- 
rial parasites were found on October 6 and quinine therapy resulted 
in the return to a normal pulse rate until OctoBer 15, when an increase 
again  occurred.  During  the  following  week,  the  pulse  rate  was 
irregularly increased without a proportionate rise in temperature and 46  TREATMENT  OF  HUMAN"  TI~YPANOSOMIAS1S 
trypanosomes  were  found  on  October  23.  After  retreatment,  the 
pulse rate promptly fell to normal. 
The  chart of Moangolo #50  (Chart V) illustrates  the type of case 
which leads one to suspect that the trypanosomal infection may still 
be active within the body although no organisms can be found in the 
lymph glands  or blood.  This  boy was  given 0.5  gm.  of tryparsa- 
Patient 39, Malamba  55.5K. 
kUG.  ~EPT  OCT  iXl  OV. 
4 ~5 3171314 2122  ~ 29 2 5 8 9121623301  :Da~e 
Poise 
0  ....  0 
130  40 
1~0  ~9.5 
II0  39 
38.5 
100 
35 
90 
37.5 
80  37 
~(0  36.5 
60  36 
50  35.5 
40  35 
°l 
"i  I~  -~  ~  ..... 
\  p':  'a 
CHART  VI. 
mide on September 7.  After an initial drop in pulse rate and tempera- 
ture the pulse became disproportionately rapid,  varying from 96  to 
120  per  minute  for  16  days,  and  the  temperature  was  somewhat 
irregular.  No complicating infections could be found, however, and 
trypanosomes were not seen until October 6, 29 days after treatment. 
Retreatment had a very prompt effect upon both pulse and tempera- 
ture as may be seen by referring to Chart V. L.  PEARCE  47 
Charts  VI  and  VII  are  illustrative  of  the  less  common  type  of 
reaction  in which little or no  increase in pulse rate  takes place  with 
a  return  of trypanosomes to  the lymph  glands  or  blood.  1Viulamba 
#39  (Chart  VI) was treated  August 24 with 3.0 gan. and during the 
following 6  weeks the  pulse  rate  was irregular,  varying  from  72  to 
92, but on the whole was not remarkable and no fever was observed. 
Patient 66,Tuarnene 
Date 
Pulse  Tem  m~p. 
0----0 
130  40 
120  39.5 
110  39 
38.5 
100 
38 
90  37.5 
8O  37 
70  36.5 
60  36 
50  35.5 
40  35 
62.5 K. 
CHAleT VII. 
Trypanosomes were  found  on  October 8  and  retreatment  with  try- 
parsamide  caused  a  prompt  cessation  of pulse rate  irregularity.  A 
somewhat similar  course of events is  seen in  the  chart  of  Tuamene 
#68  (Chart VII),  in whom a peripheral relapse was detected 25 days 
after treatment  although  the pulse rate  had  not been above  normal 
for 23 days. 48  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
Symptoms.--Finally,  as  a  result  of  the  single  dose  treatment, a 
noticeable  and continuous general improvement  occurred  in all patients 
in the first or beginning of the second stage of sleeping sickness leading 
them to wish to leave the lazaret or hospital or to cease coming to the 
laboratory.  Conspicuous improvement was naturally most apparent 
in  those  patients  whose  ill  appearance  on  admittance  was  most 
noticeable.  The more definite symptoms of pains in the legs, arms, 
and  joints,  headaches,  weakness,  and  general malaise  disappeared 
during the first week after treatment and did not return even in those 
cases which eventually relapsed, presumably because retreatment was 
immediately instituted.  Within 1 or 2 weeks, all the patients in this 
group  appeared well and  it  was in  many instances  only with  the 
greatest difficulty that further visits were secured. 
ADMINISTRATION  OF P,  EI~ATED  DOSES IN EARLY  CASES. 
The consensus of opinion is that human trypanosomiasls can best 
be influenced by a  system of repeated doses of the drugs commonly 
employed and several courses of atoxyl alone or combined with tartar 
emetic are recommended  both in early and late cases.  Treatment with 
repeated doses  of  tryparsamide given  intravenously was regularly 
carried out as  soon  as  the  duration of action  of  single doses  was 
determined in a number of instances.  The patients thus treated fall 
into two main groups according to the period of the disease as deter- 
mined by the spinal fluid.  The first group consisted of patients in the 
first stage of the disease or in the beginning of the second period and 
included those who suffered a  relapse after single  doses  as well as a 
number of previously untreated cases  and  the observations carried 
out on this group will be considered first. 
Early Cases Previously Treated with One Dose. 
This group consists first of 12 patients treated with a single dose of 
tryp~/rsamide of from 17 to 83 rag. per kilo, who showed a return of 
trypanosomes  in the blood and lymph glands after periods of peripheral 
sterilization varying from  17  to  58  days,  and were retreated with 
repeated doses of the drug given at weekly or fortnightly intervals as 
shown in Table XIII.  2 other patients are also  considered in  this L. PEARCE 
TABLE  XIH. 
Treatment of Relapsed Early Cases witk Repeated Doses of Tryparsamide. 
Weekly Administration. 
49 
No. of  cells  in 
spinal  fluid 
per cram. 
before 
treatment. 
3.4 (I  l.m.) 
o  .~ 
kg. 
28  Mago ...... 33  5 (1 l.m.) 
50  M0angolo.  29.5  Normal. 
39  Mulamba.. 55.5  4 
36  Sudila.  46  20 
42  N'Keta  36  l0 
43  Mambula.. 27  7.5 
53  Ganzema..  36 
68 i  Tuamene..  62.5 5 (1 1.m.) 
Doses of try.l~rsamide 
adm. 1. v. 
gm. 
1.0 (33 nag. per kg.) Aug. 16 
2.0 Sept. 4, 11, 18, 25 
Total 9.0 gin. 
0.5 (17 nag. per kg.) Sept. 7 
2.0 Oct. 6, 13, 20, 27 
Total 8.5 gm. 
3.0 (54 nag. per kg.) Aug. 24* 
3.0 Oct. 9, 16, 23, 30 
Total 15.0 gm. 
2.0 (44 nag. per kg.) Aug. 19 
3.0 Oct. 9 
2.0 Oct. 16, 23, 30 
2.0 to be given Nov. 6, 13, 20 
Total 17.0 gin. 
2.0 (57 nag. per kg.) Aug. 26* 
2.0 Oct. 16, 23, 30 
2.0 to be given Nov. 6, 13 
Total 12.0 gin. 
1.0 (37 nag. per kg.) Aug. 26* 
2.0 Oct. 23, 30 
2.0 to be given Nov. 6, 13, 20 
Total 11.0 gin. 
3 0  (83 rag. per kg.) Sept. 13 
4,0 Oct. 4, 18, 25 
4.0 to be given Nov. 4 
Total 19.0 gin. 
5.0 (80 nag. per kg.) Oct. 5 
5.0 Nov. 1 
3.0 to be given Nov. 8, 15, 23, 30 
Total 22.0 gin. 
Rema~s. 
L.P.  Oct. 16 
Normal. 
2,5 lymph. 
L.P.  Oct. 16 
1.2 lymph. 
1 1.m. 
L.P.  Sept.  2~ 
Normal. 
L.P.  Sept.  2~ 
Normal. 
2.5 lymph. 
L.P.  Sept, 2  ~. 
Normal. 
o. 6 lymph. 
2.1 lymph. 
L.P.  Sept.  2  c. 
Normal. 50  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
TABLE  XIII--Conlinued. 
d 
¢, 
63 
38 
Name. 
N'Kaka... 
Daie ...... 
kg. 
42..  c 
46 
No. of cells in 
spinal fluid 
per cmm. 
before 
treatment. 
Normal. 
(?) 
R. B. C. 
Doses of tryparsamide 
adm. i. v. 
gm. 
2.0 (47 nag. per kg.) Oct. 4 
3.0 Oct. 21.  Did not return 
Oct. 28 
3.0 to be given weekly for 5 inj. 
Total 20.0 glu. 
1.0 (22 rag. per kg.) Aug. 21 
3.0 Sept. 30 
1.0 Oct. 7, 14, 21, 28 
1.0 to be given Nov. 4, 11, 18, 25 
Total 12.0 gm. 
Remarks. 
L.P.  Sept. 27 
35 lymph. 
1 1.m. 
Fortnightly Administration. 
48  M'Bondo.  50  5.0 
47 
41 
55 
Mondeke.. 
Bajaka ..... 
Bikoko. 
51  7.5 
53  15.0 
54.5[ Normal. 
1.0 (20 lug. per kg.) Aug. 31 
2.5 Sept. 24, Oct. 8, 22 
2.5 to be given Nov. 5 
Total 11.0 gin. 
2.0 (33 nag.  per kg.) Aug. 28 
4.0 Sept. 24, Oct. 8, 22 
4.0 to be given Nov. 5 
Total 18.0 gin. 
3.0 (57 rag. per kg.) Aug. 26* 
4.0 Oct. 2, I6, 30 
4.0 to be given Nov. 13 
Total 19.0 glu. 
0.3 (4.7 nag. per kg.) Sept. 22 
5.0 Sept. 27, Oct. 11, 25 
5.0 to be given Nov. 5 
Total 20.3 glu. 
L.P.  Oct. 6 
Normal. 
1 lymph. 
L.P.  Oct.  6 
Normal. 
3 lymph. 
L.P.  Sept. 31) 
7.5 lymph. 
21. m. 
* Intramuscular administration. 
section:  Bikoko #55, who was given the small dose of 0.3 gin. (4.7 rag. 
per kilo)  which produced a  peripheral  sterilization  for 5  days  and 
Dale #38, whose second spinal fluid examination showed an increased 
cell content, although no trypanosomes were detected in the lymph L.  PEARCE  51 
glands, blood, or spinal fluid.  10  of these patients were treated  at 
weekly intervals with 4  to 9 injections of doses varying from 20  to 
111 mg. per kilo, while 4 were placed on a fortnightly schedule.  The 
drug was given intravenously in all instances. 
The observations at present available may be  considered briefly. 
In 8 patients who could be examined shortly after the administration 
of the first dose, no trypanosomes were found in the lymph glands or 
centrifuged blood at 5, 6, 7, 8, and 15 hours after treatment, showing 
that  the initial effect of the drug in retreatment is similar to  that 
observed in  previously untreated  cases.  Several  examinations for 
trypanosomes carried  out on all  the patients  during the  course  of 
retreatment were uniformly negative.  In one case,  Mago  #28, the 
course of 4 doses of 2.0 grn. given at weekly intervals, was completed 
so  that  subsequent observation can be  reported here.  During  the 
following 6  weeks,  examinations of  lymph glands  and  blood  were 
negative and in addition a  lumbar puncture done 61  days after the 
i 
first single dose showed a  normal spinal fluid--2.5 lymphocytes per 
cmm.--whereas the original count was 5 lymphocytes per cram. with 
1 large mononuclear in the preparation (Table XIV). 
The spinal fluid of 3 other patients, Moangolo #50, M'Bondo #48, 
and Mondeke #47, examined 10 and 12 days after the beginning of the 
course of repeated doses and approximately 5 weeks after the initial 
single dose, showed that the disease had not progressed to the second 
stage and in 2 patients the  slightly increased cell counts had become 
normal (Table XIV). 
Thus  in  these  4  instances  the  administration of 2  to 5  small  or 
medium sized  doses  of  tryparsamide,  though widely  spaced apart 
and covering a  period in which a peripheral relapse occurred, had an 
apparent effect in arresting further cerebrospinal involvement. 
Effect  on  Blood  Count.--The  blood  was  studied  in  10  patients 
retreated  with  repeated  doses  at  weekly  or  fortnightly  intervals 
following a  relapse  after  a  previous  single  dose.  The  first  blood 
examination was made before the initial single dose while the second 
occurred about 2 months later during or at the end of the course of 
repeated doses, as shown in Table XV.  A marked secondary anemia 
was the outstanding abnormality of the blood count on admittance. 52  TREATMENT  OF  HUMAN  TRYPANOSOMIASIS 
For convenience of comparison,  the changes noted in  the red and 
white  cell  counts  and  hemoglobin  estimation  have  been  tabulated 
separately (Tables XVI to XVIII).  It was found that after treatment 
with tryparsamide, an increase in the number of red cells of from 3 to 
47 per cent occurred in 8 patients.  The most marked improvement 
was usually  observed in those patients  who had  the lowest  original 
counts.  In 2 patients, Moangolo #50 and Bikoko #55, the first count 
was practically normal  and  the  second count made 50 and  33  days 
TABLE  XIV. 
Changes in Cell Count, Spinal  Fluid of Relapsed Cases During Retreatment with 
Repeated Doses of TryparsarMd  e. 
Case 
No. 
28 
50 
48 
47 
Name. 
Mago... 
] Moangolo. 
M'Bondo... 
Mondeke. 
•  50 
Initial 
weight. 
33 
29.5 
61 
Doses adm. i. v. 
gm. 
lxl.O  9.0 
4x2.0 
in 40 days. 
1  x  0.5  4.5 
2x2.0 
in 36 days• 
Ix1.0  3.5 
lx2.5 
in 25 days. 
lx2.0  6.0 
lx4.0 
in 27 days. 
Cell count 
spinal  fluid 
initial  L.P. 
S (1 1.m.) 
Normal. 
7.5 
Cell count 
spinal fluid 
2nd L. P. 
Normal. 
.1.2  lymph. 
1 l.m. 
Normal. 
Normal. 
Interva] 
betwee~ 
L.P. 
days 
61 
39 
37 
39 
after the administration  of the single dose of tryparsamide showed a 
slight decrease of 5 and 8 per cent respectively. 
The  improvement  in  hemoglobin  content  of  the  blood was  even 
more striking as may be seen in Table XX.  Each patient showed a 
gain ranging from 7 to 71 per cent.  As was the case after the adminis- 
tration  of single  doses,  the most marked  increase occurred  in  those 
patients whose hemoglobin was below 60 per cent before treatment, 
while  the  two  patients,  Moangolo  #50  and  Bikoko  #55,  with 
normal red cell  counts showed an improvement of 45 and  7 per cent 
respectively. 28 
50 
39 
35 
42 
38  ¸ 
48! 
47 
41 
55 
TABLE  XV. 
Changes in Blood Count of Relapsed Early Cases after Retrexttmen~. 
Total No. 
Name.  of doses  1st blood count. 
adm. i. v. 
~ffl. 
Mago ..........  1 x 1.0  R.B.C. 4,320,000 
33kg.  4x2.0  Hb.  55% 
W.B.C.  5,700 
Moangolo ......  1 x 0.5  R.B.C. 5,056,000 
29.5 kg.  3 x 2.0  1-119..  55 % 
W.B.C.  11,200 
Mulamba .......  1 x 3.0*  R.B.C. 3,840,000 
55.5 kg.  2 x 3.0  Hb.  52 %[ 
W. B.C.  12,800 
Sudila.  lx2.0  R.B.C. 4,150,000 
46kg.  Ix3.0  Hb.  60~ 
lx2.0  W.B.C.  8,500 
N'Keta.  1 x 2.0"  R.B.C. 3,200,000 
36kg.  2x2.0  Hb.  35% 
W.B.C.  4,000 
Daie ............  lxl.0  R.B.C. 3,720,000 
46kg.  lx3.0  Hb.  60% 
3xl.0  W.B.C.  7,000 
M'Bondo ........  1 x 1.0  R.B.C. 3,200,000 
50 kg.  2 x 2..5  Hb.  50 % 
W. B.C.  9,200 
Mondeke.  ix2.0  R.B.C. 4,480,000 
61kg.  2x4.0  Hb.  65% 
W.B.C.  8,400 
Bajaka..  1 x 3.0*  R.B.C. 3,044,000 
53kg.  2x4.0  Hb.  45% 
W.B.C.  4,800 
Bikoko .........  1 x 0.3  R.B.C. 5,240,000 
64.5kg.  3x5.0  Hb.  75% 
W.B.C.  8,000 
Time 
after ls! 
2nd  blood  count.  ~  treat-  ment o| 
2nd 
if,  B.c. 
per ce~  ~y~ 
4,800,000  -}-  11  68 
70 %  +  27 
8,000  +  4O 
4,800,000  -  S  50 
80%  q- 45! 
10,000  --  11! 
4,0OO,0OO  +  4  59 
8O%  +  54 
7,000  --  4~ 
5,120,000  +  23  6st 
65%  +  8 
8,000  -  7 
4,000,000  +  25  6S~ 
60%  +  71 
8,00O  +100 
4,000,000  -1-  8  67 
70%  +  17 
6,000  --  14 
3,680,000  -F  15  53§ 
65 %  +  30 
8,000  --  13 
4,640,000  +  3  55§ 
75%  +  15 
8,000  --  5 
4,480,000  -'1-" 47  60** 
75 %  -k  67! 
9,000  -'I'- 88 
4,830,000  --  8  3311 
80%  +  7 
8,000 
* Intramuscular admirdstration. 
t  Malaria (?). 
Intramuscular abscess; craw-craw. 
§ Filariasis. 
II Malaria. 
** Filariasis; malaria (?). 
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TABLE  XVI. 
Changes in Red Blood Cell Counts of Patients Previously Treated with  Single 
Doses--Retreated with Repeated'Doses. 
Case 
No. 
41 
42 
48 
38 
39 
36 
28 
47 
50 
55 
Name. 
Bajaka ............... 
N'Keta ............. 
M'Bondo ............. 
!Dale ................ 
Mulamba ........... 
! Sudila .............. 
IMago ............... 
I Mondeke ............ 
I Moangolo ........... 
I  .  Bikoko .............. 
Time 
Total  between 
amount  1st and 
tryparsa-  R2~  d. C  mide.  .  .  . 
rag.  per  kg  days 
209  ~35  171 
120 
154  67 
162  59 
154  65 
297  68 
165  55 
201  50 
244.7  33 
ist R. B. C. 
before 
treatment. 
3,044,000 
3,200,000 
3,200,000 
3,720,000 
3,840,000 
4,160,000 
4,320,000 
4,480,000 
5,056,000 
5,240,000 
R.B.C. 
after 
treatment. 
4,480,000 
4,000,000 
3,680,000 
4,000,000 
4,000,000 
5,120,000 
4,800,000 
4,540,000 
4',800,000 
4,830,000 
Change. 
+47 
+25 
+15 
+8 
+4 
+23 
+11 
+3 
--5 
--8 
TABLE  XVII. 
Changes in Hemoglobin  Content  o] Patients Previously Treated with Single 
Doses--Retreated with Repeated Doses. 
Case 
No. 
42 
41 
48 
39 
50 
28 
38 
36 
47 
55 
Name. 
N'Keta.. 
Bajaka ....... 
M'Bondo .......... 
Mulamba... 
Moangolo ..... 
Mago.  .. 
Dale. 
Sudila. 
Mondeke .......... 
Bikoko .... 
Total 
amount 
tryparsa- 
mide. 
rag. per kg. 
171 
209 
"1  120 
"1  162 
•  201 
• -I  297 
154 
I54 
165 
244.7 
Interval 
between 1st 
and 2nd 
hemoglobin 
examinations. 
days 
65 
6O 
53 
59 
5O 
68 
67 
65 
55 
33 
1st 
hemoglobin. 
35 
45 
50 
52 
55 
55 
60 
60 
65 
75 
2nd 
hemoglobin. 
60 
75 
65 
80 
80 
70 
70 
65 
75 
80 
Increase. 
per ~e~ 
+71 
+67 
+30 
+54 
+45 
+27 
+17 
+8 
+15 
+7 
The  white  cells in  practically  all  cases  were  within  normal  limits 
after retreatment  as shown in Table XVIII.  3 patients,  N'Keta  #42, 
Bajaka  #41, and Mago  #28, who originally had a  leukopenia, showed an 
increase in the number  of white cells of 100, 88, and 40 per cent respec- 
tively-in  the others,  the white  cells remained  or approached  normal. L. PEARCE  55 
These observations are in accord with those noted after single doses 
and indicate that the blood picture of patients suffering with trypano- 
somiasis tends to return to normal limits after treatment with trypar- 
samide. 
Effect upon the Welght.--The changes in weight of 12 patients during 
the period of peripheral sterilization and subsequently after retreat- 
ment with repeated doses of tryparsamide, are shown in Table XIX. 
The majority of observations extend 'over a period of 10 weeks during 
which time from 2 to 6 doses were given.  Doses of 2.0,  3.0,  and 4.0 
gm. were used in most instances. 
TABLE XVIII.' 
Changes in White Blood Cell Counts of Patients Previously Treated with Single 
Doses--Re~reated with Repeated Doses• 
Case  Name, 
No. 
42  N'Keta  .... 
41  Bajaka  ............ 
28  Mago  ...... 
38  Daie... 
55  Bikoko  ..... 
47  Mondeke  ..... 
36  Sudila. 
48  M'Bondo. 
50  Moangolo. 
39  Mulamba. 
Total 
amount 
trYm~P.~rsa- 
rag. per kg. 
•  .I  171 
•  I  209 
•.  297 
154 
244.7 
i65 
154 
120 
201 
162 
Interval 
between 1st 
and 2nd 
W. B. C. 
days 
65 
6O 
68 
67 
33 
55 
65 
53 
50 
59 
1st W.B.C. 
before 
treatment. 
4,000 
4,800 
5,700 
7,000 
8,000 
8,400 
8,600 
9,200 
11,200 
12,800 
2ndW. B. C. 
after 
treatment. 
8,000 
9,000 
8,000 
6,000 
8,000 
8,000 
8,000 
8,000 
10,000 
7,000 
Change. 
per  Cen~ 
+IO0 
+  88 
+4O 
-  14 
-  5 
-  7 
-  13 
-  11 
-  45 
The  effect of  tryparsamide treatment upon  the  weight  of  these 
patients was as follows:  6  patients gained from 1.5  to 3.5  kilos, 4 
showed no  change,  and  2  showed  a  loss  of  1.5  kilos.  Concurrrent 
infections were present in 5 of the 6 patients who did not gain, while 
in the case of Daie #38 the explanation is not entirely clear. 
In general, it may be said that the physical improvement of these 
patients which occurred after treatment with single doses of tryparsa- 
mide continued during the course of repeated" doses as shown by an 
increase of weight in uncomplicated cases and by the beneficial effect 
upon the blood picture. TABLE  XIX. 
Changes in Weight of Relapsed Early Cases after Retreatment with Repeated Doses 
of Tryparsamide. 
28 
50 
39 
36 
42 
43 
53 
38 
48 
47 
41 
55 
Name. 
lV[ago ...... 
Moangolo ....  1  x  0.5 
3x2.0 
Mulamba ....  1 x 3.0" 
3x3.0 
Sudila...  1 x 2.0 
lx3.0 
2x2.0 
N'Keta..  1 x 2.0" 
2x2.0 
Mambula ....  1 x  1.0" 
lx2.0 
Ganzema ......  1  x  3.0 
3x4.0 
Daie .....  1 x  1.0 
lx3.0 
4xl.0 
M'Bondo.  1 x  1.0 
3x2.5 
Mondeke.  1 x 2.0 
3x4.0 
Bajaka.  l x 3.0* 
2x4.0 
Bikoko..  .j  lx0.3 
3x5.0 
Origl-  2nd  4th  6th  8th  10th  Total  Total no.  nal 
of doses,  weight, week.  week.  week.  week.  week.  change. 
gm.  kg.  kg.  kg.  kg.  I  kg.  kg.  kg. 
lx1.0  33.0  32.5  33.0  34.5 I 33.5  34.5  +1.5 
4x2.0 
29.5  30.0  30.5  31.5  31.5  +2.0 
55.5  57.0  57.5  58.0  58.5  59.0  +3.5H 
46.0  46.5  49.0  48.0  47.5  46.0  0t  I 
i 
36..0  33.5  34.0  34.5  35.5  36.0  O§ 
I 
27.0  26.5  26.0  27.5  27.5  27.0  0:~ 
36.0  37.0  37.0  37.0  37.5  +1.5 
46.0  44.0  44.5  44.5  44.5  44.5  --1.5 
I 
I 
4 
50.0  51.0  52.0  52.0J  52.5  53.5  +3.5[l 
I 
I 
61.0  61.0  60.5  61.0 i  61.0  61.0  Oil 
i 
I 
53.0  52.5  53.0  53.0i  53.0  51.5  --1.5"* 
i 
I 
64.5  63.5  65.0  66.0  +1.55 
* Intramuscular  administration. 
t  Malaria (?). 
~: Malaria. 
§ Intramuscular abscess; craw-craw. 
II Filariasis. 
** Filariasis; malaria (?) 
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Previously  Untreated Early  Cases. 
13  previously untreated patients in  the  first period  of  trypano- 
somiasis were treated with repeated doses of from 1.0 to 5.0 gin. of 
tryparsamide given at weekly and fortnightly intervals (Tables XX 
T~Ia~ XX. 
Repeated Dose Treatment of Early Previously Untreated Cases. 
Weekly Administration. 
Case 
No° 
72 
78 
71 
64 
69 
77 
58 
70 
62 
Nalne ° 
No. cells 
Weight,  spinal fluid 
per c.mm. 
kg, 
N'Ganzobo..  26  Normal. 
Doses of tryparsamlde adm. i. v. 
1.0 gin. 
1.0  " 
(38 rag. per kg.) Oct. 6, 13, 20, 27 
to be given on Nov. 3, 10 
Itoma ......  52  1.0  "  (19 rag. per kg.) Oct. 29 
2.0  "  (38  "  "  "  )Nov.  4,  11,  18, 
25, Dec. 2, 9, 16 
Madeele ....  24  Normal.  1.0  "  (42  "  "  "  )  Oct. 6, 13, 20, 27 
Dano ......  40  0.6  2.0  "  (50  "  "  "  )  Oct. 4, 21, 28 
2.0  "  to be given Nov. 4, 11 
Sabole .....  67.5  7.5  3.0  "  (44 rag. per kg.) Oct. 5, 12, 19, 26 
1 1.m.  Nov. 2 
V. Makau..  57.0  3.8 
1 l.m. 
Kanild ......  42.5  1.2 
1.0  "  (18  "  "  ")Oct.  28 
3.0  "  (54  "  "  "  )Oct.  29 
3.0  "  to be given Nov. 5, 12, 19, 26 
2.5  "  (58mg. perkg.)  Sept.  28, Oct. 7, 
14, 21, 28 
2.5  "  to be given Nov. 4 
i 3.0  "  (63 nag. per kg.) Oct. 6, 13, 20, 27 
4.0  "  (70  "  "  "  )Oct. 4,12,19 
4.0  "  to be given Nov. 3 
Yala  48.0  8.0 
Sawa..  57.0  5.3 
gm. 
6.( 
15 .q 
4.C 
10.C 
15.C 
16.( 
15.C 
12.0 
16.0 
and XXI).  Trypanosomes were found in lymph gland juice before 
treatment in all instances; spinal fluid examination showed a normal 
cell count in 6 cases and a slight increase of ceils in 5; lumbar puncture 
was not done in 2 cases. 58  TREATMENT OF  HUMAN  TRYPANOSOMIASIS 
The observations of this group at present available were made during 
the first month of treatment and are  summarized as follows:  The 
preliminary sterilization of lymph glands and blood together with a 
sharp  drop in the accelerated pulse rate and fever occurred as pre- 
vious]y described and in those patients under observation for 3 or 4 
weeks a decrease in size and induration of the cervical lymph glands 
was  observed;  subsequent  examinations for  trypanosomes in  each 
patient made at various times were uniformly negative.  With the 
TABLE XXI. 
Repeated Dose Treatment of Early Previously Untreated Cases. 
Fortnightly Administration. 
Case  Name° 
No. 
56  Yaya  ....... 
65  Kakuma 
67  M'Bwongo.. 
66  Popa... 
cells 
Weight.  spinal 
fluid 
per 
C~lln. 
kg. 
•  49.5  1 
40.0  4 
27.0 
42.5  2.5 
Doses  of  tryparsamidc adm.  i.  v. 
2.0 gin. (40 rag. per kg.) Sept. 24, 
Oct. 8, 25 
2.0  "  to be given Nov. 8, 22 
4.0  "  (100 rag. per kg.) Oct. 4, 18, 
Nov. 1 
4.0  "  to be given  Nov. 15, 29 
3.0  "  (111 rag. per kg.) Oct. 4, 18 
Nov. 1 
3.0  "  to be given  Nov. 15, 29 
5.0  "  (118 rag. per kg.) Oct. 4, 18 
5.0  "  to be given  Nov. 3, 15 
To~l. 
gr~° 
i0 
20 
15 
20 
exception of Kaniki ~$8,  who had syphilis, and Yaya #56,  who had 
malaria,  there  was  prompt  cessation  of  the  pains,  weakness,  and 
general malaise complained of on admittance. 
The changes in weight of 11  patients are given in Table XXII; 6 
patients gained from 0.S to 2.5  kilos, 1 lost 2 kilos from no apparent 
cause, while 4 showed no change.  It was not possible to carry out a 
detailed study of this group and blood counts of only 2 patients were 
made;  these,  however, showed  a  marked  improvement during  the 
period of treatment comparable to that previously described. L.  PE~CE.  59 
This group of patients has been included in the present paper to 
illustrate the application of a  preliminary system of repeated  dose 
therapy based upon the information obtained from the use of single 
doses.  It is probable that various modifications will be made in the 
future; but just as it was necessary to determine the effect of single 
doses before proceeding to the use of repeated doses, so it is imperative 
to study the results ot a  few repeated doses in a certain number of 
cases  before  attempting  a  more  complicated method  of  therapy. 
Further observations on these patients will be reported later. 
TABLE XXII. 
Changes in Weight of Early Cases Treated u~h Repeated Doses of Tryparsamide. 
Case  Name. 
]No. 
72  N'Ganzobo.. 
71  Madeele ...... 
~  Dano.. 
Kanikl.. 
70  Yala ......... 
62  Sawa. 
69  Sabole. 
56  Yaya. 
65  Kakuma.. 
67  M'Bwonga.. 
55  i Popa ..... 
Doees. 
gm. 
3xl.0 
4xl.0 
2x2.0 
5x2.5 
4X3.0 
3x4.0 
4x3;0 
3x2.0 
2x4.0 
2x3.0 
2x5.0 
Initial 
weight. 
kg. 
26 
24 
40 
42.5 
48 
57 
67.5 
49.5 
40.0 
27.0 
42.5 
1st 
week. 
kg. 
27 
24.5 
42.5 
48.5 
57.8 
66.0 
49.5 
27.5 
43.0 
2nd 
week, 
kg. 
27.5 
24.5 
40.0 
44.0 
49.0 
58.0 
66.5 
48.5 
40.0 
27.5 
42.5 
3rd 
week. 
kg. 
27.5 
24.5 
38.0 
44.5 
49.0 
67.0 
49.0 
27.5 
4th 
week. 
kg. 
45.0 
49.5 
67.5 
49.5 
28.0 
Total 
change, 
+i.5 
+0.5 
--2.0 
+2.5  ~ 
+1.5 
+1.o 
0 
ot 
0 
+1.0 
0 
* Syphilis. 
t Malaria. 
ADMINISTRATION OF REPEATED DOSES IN ADVANCED CASES. 
35 patients whose spinal fluid showed that the disease had involved 
the  cerebrospinal  system represent  the  second group  treated  with 
repeated  doses  of  tryparsamide  given  intravenously.  Of  these,  2 
patients deserted after the first injection of the drug, 2 were practically 
moribund on admittance,  and  3  others were under observation for 
such a short time that their records are not included.  The remaining 
28 patients may be conveniently considered in two subdivisions: 18 
who had not previously been treated so far as known and 10 who had 
been treated before.  The spinal fluids of the patients examined before 60  TREATMENT  OF  HUMAN  TRYPANOSOMTASIS 
the administration of tryparsamide showed from 15 to 572 lympho- 
cytes per cram., and large mononudears and cellules en m~re in most 
instances,  while  most  of  the  patients  suffered  from  pronounced 
nervous  and  mental  symptoms and  were  anemic and  debilitated. 
Trypanosomes were found in the cervical lymph nodes of 21 patients; 
they were not found in 7 patients who were being treated with atoxyl 
and tartar emetic at  the time of transfer to  tryparsamide therapy. 
Certain outstanding effects of the tryparsamide treatment as measured 
by changes in  the spinal fluid,  the blood, and body weight will be 
considered in the following sections and the size and number of doses 
of tryparsamide given to each patient will be described in connection 
with these observations. 
Previously  Untreated  Advanced  Cases. 
1  Course of Treatment. 
Effect upon the Spinal Fluid.--The most conspicuous concrete effect 
of  the treatment of advanced cases of trypanosomiasis with trypar- 
samide was the marked and rapid decrease in the cell content of the 
spinal  fluid accompanied by  a  definite clinical improvement.  The 
cell changes  observed in  7 previously untreated, advanced patients 
are  shown in Table XXIII.  The first examination before treatment 
showed an increase of lymphocytes in the spinal fluid varying from 
17.5 to 285 per cram. and in addition large mononuclear and mulberry 
cells  were seen  in  4  instances, indicating a  considerable degree  of 
cerebrospinal  involvement.  The  diagnosis  of  trypanosomiasis was 
made by finding the organisms in the cervical lymph glands of all 7 
patients; negative examinations followed the first treatment as pre- 
~ously described. 
The system of therapy employed in these patients consisted of 3 
to 9 intravenous injections of tryparsamide of from 1.0 to 5.0 gin. doses 
usually at weekly or semi-weekly intervals over an average period of 
30 days.  The following abstracts  indicate the outstanding features 
of individual cases. 
Loyoko ~ 18.--Soldier  on sick  leave  from a "virulent" region. Good  state of  nutri- 
tion but very anemic. Mental condition  normal. Marked fil~riasis. 60 kilos. Gen- 
eral glandular enlargement. Gland  puncture  ++.  Spinal  fluid 17.5 lympho- L. PE~CE  51 
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cytes per cram.  He was given 3 doses of 3.0 gm. (150 rag. pe  r kilo) at intervals 
of 2 weeks or a  total of  9.0 gm.; 5 weeks after the beginning of treatment, the 
cell count had fallen to 3.4 per cram., a  decrease of 80 per cent.  As his general 
condition had materially  improved, he returned to his military duties and during 
the following 2 months he continued to work each day.  A  third lumbar puncture 
done 12 weeks after the first dose of tryparsamide showed a  cell content of 2.5 
lymphocytes per cmm. with, however, 1 large mononuclear;  at this time, a  few 
tiny hard cervical lymph glands could be palpated; his blood count had materially 
improved.  No further treatment is to be given this patient unless trypanosomes 
are found in the blood or lymph glands or unless there is an increase in the cells 
of the spinal fluid. 
Makal~mba/~ 49.--Fisherman.  Good physical and mental condition; had not 
stopped work.  52.5 kilos.  General glandular enlargement.  Gland puncture 4-. 
Spinal fluid 22 lymphocytes per cmm.  He was treated with 9  doses of 1.0 gin. 
each (19 rag. per kilo) administered twice a week, or a total of 9.0 gin. in 29 days. 
The second lUmbar puncture done 38 days after the first showed a cell content of 
4.2 lymphocytes per cmm. or a decrease of 80 per cent.  After the course of try- 
parsamide was finished, he wished to return home but as the duration of the effect 
of his treatment was not known, a second course was begun.  Despite an acute 
attack of malaria which developed under observation and the detection of a posi- 
tive Wassermann reaction, he remained in excellent physical condition.  There 
was a marked regression of the cervical adenitis. 
Bolero ~ 9.--Wife of a soldier.  Well nourished but anemic and weak and had 
been unable to work.  Mental condition normal.  49 kilos.  General glandular 
enlargement.  Gland puncture  4-Jr.  Spinal fluid 47.5  lymphocytes per  cram. 
She was given 5 doses of 2.0 gin. in 34 days--a total of 10.0 gin. or 204 rag. per kilo. 
39 days after the first dose of tryparsamide, her spinal fluid contained 10 lympho- 
cytes per cram., a decrease of 70 per cent, with 1 large mononuclear seen in the 
counting chamber.  After a month's intermission, a  second course of 3 doses of 
4.0 gin. each was given in 18 days;  a subsequent lumbar puncture was refused. 
There was a  noticeable physical improvement, with a  marked  gain  in  weight 
during the first course of treatment which continued during the period of observa- 
tion.  The cervical lymph glands became very small and indurated. 
N'Kusu//44.--Laborer from a  "virulent" region.  Undernourished and ane- 
mic; unable to work.  Uncertain mental state.  38.5 kilos.  Typical chains of en- 
larged lymph glands on both sides of neck.  Gland puncture  4- 4-.  Spinal fluid 
47.5 lymphocytes per cram.; large mononuclears 4.  He was given 4 doses of 4.0 
gln. of tryparsamide at 14, 7, and 8 day intervals or 416 rag. per kilo in 29 days, 
with n° untoward effects.  A  second lumbar puncture,  32 days after the  first, 
showed a cell content of 15 lymphocytes with 1 mononuclear,  a decrease of 68 per 
cent.  A third examination, 55 days after admittance, showed 22 lymphocytes per 
cram. indicating that the effect of the drug had not continued to produce a further 
diminution of cells but on the other hand had sufficed to prevent a return  to the 
original condition.  A  second course of  tryparsamide was  begun.  Physically, L.  PEAI~CE  63 
there was  a moderate improvement during  the period  of  observation and he 
wished to return home; the cervical glands decreased markedly in size and became 
very indurated; mentally, there was definite improvement to a normal status. 
N'S~oI~ ~ 32.--Workman;  suspected case.  Good state of nutrition.  Mental 
condition normal.  40 kilos.  General glandular enlargement.  Gland puncture ~. 
Spinal fluid 52.5 lymphocytes per cram.; large mononuclears @.  Treatment con- 
sisted of 4 doses of 4.0 gin. at 8, 17, and 7 day intervals or 400 rag. per kilo in 
32 days.  There were no Untoward effects and during the period of observation 
patient was in excellent physical condition.  The cervical lymph glands were re- 
duced to a few shotty masses.  A second examination of spinal fluid 5 weeks after 
the first showed 15 lymphocytes  per cmm. and no large mononuclears were seen--a 
decrease of 70 per cent.  A third examination, 66 days after admittance, showed 
a practically normal count of 3.1 lymphocytes  per cmm., and no large mononuclears, 
and this value represented a decrease of 95 per cent from the original count.  No 
further treatment is to be given this patient unless trypanosomes are found in the 
lymph giands.or blood or the cell content of the spinal fluid increases. 
A  comparison  of  the  amount  of drug  administered  to  the  last  3 
patients and the effect upon the spinal fluid obtained in  each  shows 
that in the case of Bolendo ~  10.0 mg. given in 5  doses of 2.0 gm. 
over a  period of 34 days accomplished the same numerical result as 
16.0 gm. in 4 doses of 4.0 gm. in 29 and 32 days given to N'Kusu #44 
and N'Siola #32--that  is, decreases of 68 and 70 per cent in the cell 
counts..  However, it should be noted that  the original examination 
of the spinal  fluids of N'Kusu #44  and N'Siola #32 showed a  more 
serious  cerebrospinal  involvement  as  indicated  by  the  presence  of 
large mononuclears.  In addition, the effect Of the treatment given to 
N'Siola  #32  extended  over  a  longer period  than  that  of  the  same 
amount  given  to N'Kusu #44;  the  latter patient,  however, presum- 
ably  had  a  more d~fl~cult  infection to influence  as he  came  from a 
"virulent" district. 
Futu ~t 29.--Small, undernourished, debilitated, and anemic boy.  Mental con- 
dition  normal;  tongue  tremor.  Scabies;  pustular  skin  infection;  filariasis. 
25.5 kilos.  Marked general glandular enlargement.  Gland puncture -l- -b.  Spinal 
fluid 142.5 lymphocytes  per cram.; large mononuclears +.  He was given 8 doses 
of 1.0 gm. at intervals of 3 to 9 days over a period of 33 days--so that he received 
a total amount of 8.0 gin. or 314 nag. per kilo.  The second lumbar puncture, 5 
weeks after the beginning of treatment, showed a cell count of 22.5 lymphocytes 
per cmm.--a decrease of 84 per cent and no large mononuclears were seen.  A 
second course of treatment of 1.0 gin. per week for 7 injections was begun a month 
later.  During the period of observation, the tongue tremor disappeared, and there 64  TREATM~ENT  OF  HUMAN  TRYPANOSOMJ.ASIS 
was a marked reduction in size and induration of the lymph glands with a moderate 
improvement in general physical condition. 
Koloski ~ 35.--Laborer.  Very weak and anemic; unable to work.  Dull mental 
state.  Slight edema of upper eyelids and suggestive fullness of lower jaw.  Marked 
tongue tremor;  slight tremor of extended hands;  greatly exaggerated knee jerks. 
Ankylostomiasis;  chronic amcebiosis.  44.5 kilos.  Slight general glandular en- 
largement.  Gland puncture +.  Spinal fluid  285 lymphocytes per cram.; largv 
mononuclears +; mulberry cells +.  He was given 4 doses of 5.0 gin. at intervals 
of 7, 15, and 7 days, or 20.0 gin. in 29 days (449 rag. per kilo).  No untoward effects 
were observed after individual doses or following the course  of treatment.  5 weeks 
after the beginning of treatment, a second spinal fluid examination showed a celt 
count of 12.5 lymphocytes per cram.,  a decrease of 96 per cent, and in additior~ 
only 1 large mononuclear cell was seen.  Clinically,  there was also a marked im- 
provement;  the tremors had disappeared, the knee jerks were practically normal, 
the edema of the eylids and lower jaw had disappeared, his mental  conditio~ 
appeared normal, and he was much stronger.  The change was so striking that it 
was decided to defer further treatment until a third examination of the spinal  fluid 
could be made.  This was accomplished a month later and showed a cell count of 
8 lymphocytes per cram. with 1 large mononuclear seen in the counting chamber. 
Apparently the disease had not advanced during this time and~ therefore, it was 
decided to omit further treatment until indicated by lymph gland, blood, or spinal 
fluid findings. 
These patients represent typical cases of various degrees of advanced 
trypanosomiasis.  The outstanding  features of the  treatment of the 
group are the marked and rapid  diminution of the cells of the spinal 
fluid  after  3  or  4  medium  sized  doses  of  tryparsamide  and  a  con- 
spicuous physical and  mental  improvement.  Amounts  of from  150 
to 449  rag.  per kilo of body weight given in  an average of 4  weeks 
caused a prompt decrease in the cell content of from 68 to 96 per cent 
in 3 patients representing slight, moderate, and marked cerebrospinal 
involvement  who  showed  continued  improvement  with  no  further 
treatment  as  indicated  by lumbar  punctures  12  and  9  weeks  after 
admittance.  In one patient, a  third count showed a  slight increase in 
cells above the second so that treatment was resumed.  The 3 remain- 
ing patients  of the group were given further treatment as the spinal 
fluids  were slightly  abnormal  after  the  first  course of tryparsamide 
and there was no means of ascertaining the duration of the therapeutic 
effect. v..  PEARCE  65 
Previously  Untreated  Advanced  Cases. 
2  Courses of Treatment. 
The effect of repeated doses of tryparsamide upon the spinal fluid 
of a  second group of previously untreated patients is shown in Table 
XXIV.  The  cell content  of the  spinal  fluid varied fr0m  15  to  450 
lymphocytes per cram. and 6 specimens contained large mononuclears 
and mulberry cells.  The order of arrangement of cases in the accom- 
panying table corresponds to theiuitial cell count.  In general, those 
patients  with less marked  abnormality  of the  spinal fluid showed a 
secondary anemia,  some loss of weight, weakness, an increased pulse 
rate,  and  fever  with  slight  nervous  symptoms,  while  in  the  more 
advanced cases these symptoms were markedly exaggerated with the 
. addition  in  certain  individuals  of pronounced  mental  disturbances. 
Trypanosomes  were  found  in  the  cervical  lymph  glands  of  each 
patient. 
Two general  systems of treatment  were followed in  this  group-- 
the administration of 2 to 5 doses of 2.0 to 4.0 gm. at weekly intervals 
or semi-weekly injections of 2.0 gin.  A second course of treatment was 
giv6n approximately a  month latex.  The first dose of the drug pro- 
duced a sterilization of lymph glands and peripheral blood as previously 
described.  The following abstracts include the important features of 
individual  cases. 
Effect upon the Spinal Fluid.--The  first 3 patients in Table XXIV 
showed a slight increase in the cells of the spinal fluids, while the second 
3 showed more of an increase and in addition  came from a "virulent" 
district.  The last 5  patients are examples of very advanced cases of 
trypano.somiasis  as the cell counts of the  spinal fluid indicate. 
Bose ~ 22.--Adult woman complaining of indefinite pains and general malaise. 
Fair state of nutrition;  markedly  anemic;  exaggerated  deep  reflexes; mental 
condition normal.  Marked cervical adenitis.  Gland puncture  +.  Spinal fluid 
15 lymphocytes per cram.  56 kilos.  She was given 6.0 gin. of tryparsamide  or 
107 rag. per kilo in 2 doses of 3.0 gin. a week apart.  33 days after the first dose, a 
second lumbar puncture was done;  as the spinal fluid was considerably contami- 
nated with blood, the only comment upon the approximate count of 22 lympho- 
cytes per cram., is that  the pathological condition of the spinal fluid had not 
materially  altered.  Physically, there was considerable improvement during this 66  TREATM]~I~T  OF ~A~  TRYPAI~OSONIIASIS 
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period and the reflexes had become normal.  A  second course of approximately 
3 times the amount of the first was begun after an intermission of 4 weeks;  4 doses 
of  5.0 gin. or 357 rag. per  kilo were  given in 19 day  s.  Her  general  condition 
continued to be good and she left the hospital.  The cervical lymph glands were 
reduced to small, indurated masses.  The third lumbar puncture 10 weeks after 
the  beginning  of  treatment  showed  6.2  lymphocytes per cram.  in  the spinal 
fluid--a decrease of, 59 per cent from the original cell count. 
M'Pala ~ 26.--Wife of a laborer.  Good general physical and mental condition; 
anemic;  malaria;  general glandular enlargement.  Gland puncture  +.  Spinal 
fluid 15 lymphocytes per cmm.  62 kilos.  She was given 3 weekly doses of 3.0 gin., 
or 145 rag. per kilo in 14 days.  The second examination of the spinal fluid, 30 
days after the beginning of treatment, showed a  cell content of 5.6 lymphocytes 
per cram., or a decrease of 63 per cent.  The second course of tryparsamide con- 
sisted of 4 weekly doses of 5.0 gin. or 323  rag. per kilo  in  27  days--double  the 
amount of the first course and given in twice the time.  The succeeding spinal fluid 
examination 10 weeks after admittance was practically  normal, 4 lymphocytes per 
cram.  During the period of observation, she was in excellent physical condition 
except for a short malarial attack;  there was a marked regression of the adenitis. 
Nembezi ~ 6.--Wife of a  soldier.  Complained of deep pains in forearms and 
legs and  of feeling sick for 2  months.  Well nourished but  markedly anemic; 
normal mental  status.  Slight  cervical adenltis.  Gland puncture  +.  Spinal 
fluid contaminated with blood.  46 kilos.  Treatment was begun with 5 weekly 
doses of 2.0 gm. or 220 rag. per kilo in 27 days;  the subjective symptoms rapidly 
disappeared and there was a marked improvement in the blood count.  A lumbar 
puncture 6 weeks after admittance showed a cell count of 20 lymphocytes per cram. 
A second course of tryparsamide of 4 weekly doses of 4.0 gin. was started after an 
intermission of 5 weeks;  16.0 gin. or 348 rag. per kilo was given in 21 days.  The 
third lumbar puncture, 14 weeks after admittance, revealed a normal cell count--2 
lymphocytespercmm.  She continued in excellent physical condition;  the cervical 
lymph nodes became small and indurated. 
Tono  ~14.--Boy  from  a  "virulent"  region.  Fair  state  of  nutrition  but 
extremely  weak and anemic.  Discrete papulo-vesicular eruption over arms, wrists, 
backs of hands, and thighs.  Normal mental status.  Marked  cervical adenitis. 
Gland puncture +  4-.  Spinal fluid 20.2 lymphocytes per cmm.  45 kilos.  He was 
given 5 weekly doses of 2.0 gin. or 193 rag. per kilo in 28 days (one injection incom- 
plete).  The eruption cleared during the first 2 weeks and there was a well marked 
general physical improvement;  the cervical lymph glands became small and in- 
durated.  The second spinal fluid  examination made  5  weeks after  admittance 
showed  7.5 lymphocytes per  cram. (1 large mononuclear)--a decrease of 62 per 
cent.  After an intermission of 2 weeks,  treatment was resumed with 3  weekly 
doses of 4.0 gin. or 267 rag. per kilo, a slightly larger amount than the first course 
and administered in 2  weeks as contrasted with 4.  The third lumbar puncture, 
11 weeks after admittance and approximately 3 weeks after the last dose of trypar- 
samide  showed  practically no  change in  the spinal fluid--9.4 iymphocytes per L. PEAI~CE  69 
cmm.  No trypanosomes were found in the centrifuged  specimens of the spinal 
fluid.  Tryparsamide treatment was resumed. 
Masin~ngo  ~ 16.--Laborer from a  "virulent" region.  Fair state of nutrition 
but  anemic  and weak;  unable  to work.  Dulled  mental condition;  tremor of 
tongue and  extended  hands;  marked  exaggeration  of deep  reflexes.  Cervical 
glands enlarged and firm.  Gland'puncture + +.  Spinal fluid 35 lymph6cytes per 
cram. 48 kilos.  He was given 5 weekly doses of 2.0 gin. or 208 rag. per kilo in 28 
days.  There was a prompt physieal and mental improvement  with disappearance 
of tremors and exaggerated reflexes during the period of treatment.  A second lum- 
barpuncture 5 weeks after admittance showed 7 lymphocytes  per cram., a decrease 
of 80 per cent.  After an interval of 2 weeks, a second course was begun in which 
3 doses of 4.0 gin. or 250 rag. per kilo were given in 14 days.  A third lumbar punc- 
ture was done 11 weeks after admittance and approximately 3 weeks after the last 
dose of tryparsamide;  the spinal fluid contained 9.4 lymphocytes per cram. and 
4 large mononuclears  were  seen;  no trypanosomes were found in centrifuged 
specimens.  Although the third spinal fluid examination  showed no improvement 
beyond that observed in the second, the clinical change was well marked, and the 
patient returned to work during the second course of treatment.  Tryparsamide 
treatment was resumed. 
BabuU g 15.--Laborer from a "vi/ulent" district.  Weak and anemic but not 
emaciated;  unable to work.  Irritable mental state;  leg abscess and malaria; 
enlarged soft cervical glands.  Gland puncture + +.  Spinal fluid 70 lymphocytes 
per cram.; large mononuclears  +.  57.5  kilos.  He was given 5 weekly doses of 
2.0 gin. or 174 rag. per kilo in 28 days.  In spite of a large leg abscess which de- 
veloped during this period, there was a pronounced physical and mental improve- 
ment and a lumbar puncture 5 weeks after admittance showed a  cell count of 
30 lymphocytes  per cmm.--a decrease of 57 per cent and in addition,  only 2 large 
mononudears were seen.  No trypanosomes were found in centrifuged  specimens 
of spinalfluid.  The cervical adenitis had disappeared  leaving a few tiny indurated 
glands.  Treatment was resumed  ~  2 weeks with a  second course of 4 weekly 
doses of 4.0 gin. or 278 nag. per kilo in 21 days, that is, 6.0 gm. more than his first 
course.  His spinal  fluid examined  12 weeks after admittance showed a further 
diminution of lymphocytes from 30 to 20 per cram. or a decrease of 71 per  cent 
from the original count of 70. In this last examination,  moreover,  only 1  large 
mononuclear was seen as compared with several  in the first  and 2 in the second 
examination.  The clinical improvement was weU marked and patient was able 
to return to work.  Tryparsamide treatment was  resumed  because of the con- 
tinued  abnormal cell content of the spinal fluid. 
Miaku ~g 24.--Soldier on sick leave.  Complained of headache,  indefinite pains 
in arms and legs, general malaise.  Thin but not emaciated; very weak and anemic; 
dull mental status;  beginning lethargy (?),marked tongue tremor, and inconstant 
tremor of extended hand; greatly exaggerated knee jerks;  marked general glandu- 
lar enlargement.  Gland puncture + + +.  Spinal fluid 305 lymph0cytes  per cram.; 
large mononuclears  + +; mulberry cells + +.  46.5  kilos.  He was given 2 doses of 70  TI~EATME~T  0]?  II~T~AN  TRYPA.IqOSO~IASIS 
4.0 gin. or 172 mg. per kilo of body weight in 7 days.  Treatment was then stopped 
because of the development of visual disturbances;  the nervous and mental symp- 
toms, however, had materially improved and he felt much better physically.  A 
second lumbar puncture 5 weeks after admittance showed a remarkable drop in the 
cells of the spinal fluid, from 305 to 25 or 92 per cent, and in addition no mulberry 
ceils and only 2 large mononuclears were seen.  Following an intermission of 6 
weeks, treatment was resumed during a febrile attack which had lasted 2 weeks 
(trypanosom/asis?). Weekly doses of 2.0 gin. were given with beneficial results, for 
after 2 doses, there was a  definite general improvement with cessation of fever. 
After 5 doses had been given in 29 days, a third lumbar puncture showed a further 
diminution of cells~16 lymphocytes per cmm. with 4 large mononuclears seen. 
Madina/~ 25.--Laborer.  Well nourished but very anemic; mentally affected 
with  beginning lethargy;  pronounced  tremors of tongue  and  extended hands; 
malaria; marked cervical adenitis.  Gland puncture 4- 4-.  Spinal fluid 300 lymph- 
oeytes per cmm.; large mononuclears 4- 4-; mulberry cells 4- 4-.  48 kilos.  He was 
given 3 doses of 4.0 gin. in 14 days or 250 mg. per kilo, which caused a decrease 
from 300 to 57.5 lymphocytes or 81 per cent.  In addition, there was a gradual dis- 
appearance of the tremors present on admission and a  pronounced mental and 
physical improvement.  The  cervical lymph glands were reduced to a  few tiny 
indurated nodules.  A  second course of smaller doses was begun after an inter- 
mission of 4 weeks, consisting of 8 semi-weekly doses of 2.0 gin. or 333  mg. per 
kilo in 24 days.  The .third lumbar puncture 74 days after admittance showed the 
further marked diminution of cells to 14 lymphocytes per cram., a drop of 95 per 
cent from the original count;  4 large mononuclears, however, were seen;  no try- 
panosomes were found in centrifuged specimens.  The clinical improvement begin- 
ning with the first course of tryparsamid  e was particularly  marked and he returned 
to work, although in view of the residual abnormality of his spinal fluid further 
treatment was recommended. 
Kiale/¢ 20.--House servant.  Complained of generalized pains and feeling very 
ill; not emaciated but weak and asthenic.  Extremely dull mental state; marked 
tremor of tongue and of hands at rest;  deep reflexes greatly exaggerated;  tinea 
versicolor.  Pronounced  cervical  adenitis.  Gland  puncture  4-.  Spinal  fluid 
387.5 lymphocytes per cram.;  large mononuclears 4-;  2 mulberry cells.  47 kilos. 
He was given 4 weekly doses of 4.0 gin. or 340 rag. per kilo in 21 days.  The second 
examination of his spinal fluid made 5 weeks after the first showed a decrease from 
387.5  to 35 lymphocytes per cram. or 91 per cent.  At this time his mental con- 
dition appeared normal, there were no tremors and the knee jerks were but slightly 
exaggerated; therewasalsoaweUmarkedphysicalimprovement.  A second course 
of treatment, begun 25 days after the first, consisted of 2 doses of 2.0 gin. per week 
for 8 injections so that he received the same amount of drug, 16.0 gin., in practically 
the same time as the first course.  The third lumbar puncture  11  weeks after 
admittance showed no further change in the number of lymphocytes, 33 per cmm.; 
but 3 or 4 large mononuclear cells were seen and further treatment was recom- 
mended.  He returned to work and seemed mentally and physically able to do so. L. PE~CE  71 
Bwaba ~ 17.--Laborer from a "virulent" region.  Poor state of nutrition, very 
weak and anemic.  Discrete papulo-vesicular eruption over extensor surfaces of 
forearms.  Mental deterioration but no lethargy;  marked tremor of tongue and 
hands  at rest;  greatly exaggerated knee jerks;  slightly  enlarged firm cervical 
glands.  Gland puncture ~.  Spinal fluid 450 lymphocytes per cmm.; large mono- 
nuclears +  +; mulberry cells  -t-+.  51.5 kilos.  He was given 4 weekly doses of 
3.0 gm. or 233 mg. per kilo in 21 days with a marked initial clinical improvement. 
The tremors disappeared, his knee jerks became normal, and the eruption cleared 
rapidly.  During the week following the last dose, however, visual disturbances 
developed and ultimately there occurred a brawny, indurated swelling of the lower 
left leg of an uncertain nature and a considerable loss of weight;  lumbar puncture 
was deferred.  A  second course of smaller doses was begun 5 weeks later;  2 days 
after the first injection of 2,0 gm., a lumbar puncture was done.  It was found that 
tl~e spinal fluid contained only 22.5 lymphocytes per cmm., a decrease of 95 per 
cent;  2 large mononuclears were seen.  Treatment was continued for 5 additional 
weekly injections with no further ill effects.  There was definite improvement of 
the mental and nervous symptoms of this patient but less physical benefit than in 
the other patients of the group. 
Makengo ~ 10.--Young adult laborer.  Thin, anemic, and weak; slight edema 
upper  eyelids;  discrete  papular  eruption  over forearms,  thighs,  and  legs;  un- 
certain confused mental state;  slight lethargy.  Tremor of tongue;  exaggerated 
deep  reflexes.  Cervical  adenitis;  gland  puncture  -l--F+.  Spinal  fluid  247.5 
lymph0cytes per cmm.; large mononuclears +  ~; mulberry cells +  ~.  41.5 kilos. 
He was given 5 doses of tryparsamide increasing in size from 1.0 to 5.0 gm. so that 
he received 15.0 gin. or 361 rag. per kilo in 24 days.  The second dose of 2.0 gm. 
was given 3 days after the first, while the succeeding doses of 3.0, 4,0, and 5.0 gin. 
were given at weekly intervals.  There were no untoward effects until after the last 
dose when visual disturbances appeared and treatment was stopped.  A marked 
clinical  improvement,  however,  had occurred,  with  disappearance  of lethargic 
symptoms, edema of eyelids, cutaneous eruption, and tongue tremor, and there was 
a considerable increase in weight.  38 days after admittance, the spinal fluid con- 
tained 70 lymphocytes per cram., a decrease of 71 per cent with no large mononu- 
clears and mulberry Ceils.  A second course of smaller doses of tryparsamide was 
begun after an interval of 5 weeks, consisting of one 2.0, one 0.5, and five 1.0 gin. 
doses given on an average of every 5 days so that the patient received 7.5 gm. or 
180 mg. per kilo in 30 days.  A third lumbar puncture, 12 weeks after admittance, 
showed a further marked diminution of cells--20.4 lymphocytes per cmm., or a 
decrease of 92 per cent from the original cell count (3 large mononuclears were seen 
in the last examination).  The physical improvement of this  patient  was  pro- 
nounced as indicated by a gain in weight of 7.5 kilos, while the tongue tremor and 
mental symptoms present on admittance were alleviated. 
Considering  this  group  as a  whole,  the  outstanding  feature  of the 
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of cells of the spinal fluid together with  a  physical and  mental  im- 
provement  after short  courses of tryparsarnlde.  Decreases of from 
37 to 92 per cent in the cell counts occurred in from 4 to 3 weeks after 
the beginning  of treatment which in most cases consisted of 2, 3,  or 
4 doses of 3.0 to 4.0 gin. given at weekly intervals.  Second courses of 
treatment given to 10 patients were followed by further improvement 
of the  spinal  fluid in  7  cases  while in  3  the  diminished  cell  count 
remained approximately unchanged.  Associated with the changes of 
the cell content of the spinal fluid was a pronounced beneficial effect 
upon the physical  condition  and  a  similar improvement  of nervous 
and mental symptoms. 
Previously  Treated Advanced Cases. 
This group consisted of 10 patients,  7 of whom were being treated 
with  atoxyl and  tartar  emetic and  3 the nature  of whose previous 
treatment  was unknown.  The cell counts of the spinal fluid ranged 
from  32  to  372  lymphocytes  per  cram.  and  in  6  instances  large 
mononuclears  and  mulberry  cells  were  seen.  The  majority  of the 
patients  showed pronounced  clinical  manifestations  of an  advanced 
condition.  Trypanosomes were found in the  cervical lymph glands 
of the 3 patients who had been treated at some previous time, so they 
may be considered  both as relapsed and  non-cured  cases;  the usual 
preliminary sterilizing action of tryparsamide was shown by negative 
examinations  of  the  lymph  gland  juice of  these patients.  No  one 
system of treatment  was followed in  this group but in general  doses 
of various sizes were given at weekly or semi-weekly intervals. 
Effect upon the Spinal Ftuid.--The effect of treatment  with trypar- 
samide will be considered first in regard to the changes produced  in 
the spinal fluid as shown in Table X.XV. 
Yali ~ 13 had received 2.0 gin. soamin and 0.4 gm. tartar emetic during  the 
4 weeks previous to his admittance.  He was weak, anemic, and unable to work. 
Dull mental condition;  marked coarse tremor of the tongue and extended hands; 
exaggerated  deep reflexes.  Spinal fluid  contained  32  lymphocytes  per  cram. 
31.5 kilos. He was treated at weekly intervals with 2 doses of 3.0 gin. and 2 doses 
of 4.0 gin. of tryparsamide,  a total of 14.0 gin. or 272 rag. per kilo in 21 days. 
Clinical improvement was extremely striking by the third week; he was appreci- 
ably stronger and mentally seemed normal 7 there were no tremors and the reflexes r..  PEARCE  73 
were normal.  A second lumbar puncture, 32 days after the first showed 4.6 lym- 
phocytes per cmm. or a decrease of 86 per cent.  He remained in excellent condition 
over an observation period of 3 months during which time examinations  of gland 
juice  and centrifuged  blood were negative.  A  third ex~mlnation  of the spinal 
fluid  74 days after admittance showed the practically normal cell count of 3.4 
lymphocytes  per cmm.  He was able to return to work. 
E~,/i ~ 1 had received 1 d6se of 0.75 gin. of atoxyl 4 days previously.  On that 
day, his spinal fluid contained 80 lymphocytes per cmro.  He was thin, weak, and 
anemic;  general  glandular enlargement  and slightly  exaggerated  deep  reflexes. 
Mental condition normal.  57 kilos.  He was given 2 doses of 2.0 gin. of tryparsa- 
mide with a two weeks' interval,  or 70 rag. per kilo.  Spinal fluid examination  4 
weeks after beginning  treatment showed a cell content of 62,5 lymphocytes per 
cmna.--a decrease of 22 per cent, thus indicating that small amounts of tryparsa- 
mide, may, in certain eases, have a slight but definite effect upon the spinal fluid 
and that this effect may endure for an appreciable  time.  The patient's physical 
condition had definitely improved;  there was a marked reduction of the cervical 
adenitis and the red cells and hemoglobin of the blood had increased considerably. 
Treatment was resumed at weekly intervals with 1 dose of 2.0 gin. and 2 doses of 
4.0 gin., a total of 10 gm. or 175 nag. per kilo in 14 days.  2 days after  the  last 
dose, patient complained of visual dimness and treatment was stopped.  During 
the next 3 weeks, he became quite ill;  the condition was diagnosed clinically as 
an exacerbation  of trypanosomiasis  and death occurred 5 weeks after the cessa- 
tion of treatment. 
Bibaba  g~ 2 had been  treated with 2.5 gm. soamin  and 0.4 gin. tartar emetic 
for 43  clays but still  showed marked weakness,  anemia,  general  glandular  en- 
largement,  greatly  exaggerated  deep  reflexes,  and mental  apathy.  59  kilos. 
Spinal fluid contained 37.5 lymphocytes  per crnrn.  He was given 4 doses of 3.0 gin. 
at 2, 4, and 3 day intervals,  a total of 12.0 gin. or 203 nag. per kilo in 9 days.  2 days 
after the last dose~ patient complained  of visual impairment and treatment was 
stopped.  A second lumbar puncture done 4 weeks after the beginning of treat- 
ment showed 20 lymphocytes per cmm.--a decrease  of 47 per cent.  A month 
later,  the patient became ill  (trypanosomiasis relapse?)  and 2 weekly  doses of 
2.0 gin. were given.  There was no increase of residual visual symptoms but the 
general condition became worse and death occurred. 
M'Boyo ~ 3  had received  2.0  gm.  soamin  and 0.2 gin.  tartar emetic  during 
26 days preceding tryparsamide treatment.  She was undernourished , anemic, and 
weak;  there was  a coarse  tremor of the hands  and  greatly exaggerated deep 
reflexes; she showed  mental  deterioration  and  apathy and  frequent  periods  of 
lethargy;  cervical  lymph glands  barely palpable.  49 kilos.  Spinal  fluid  con- 
talned  92.5 lymphocytes per  cram.  with  many large mononuclears  (+++). 
She was given 4 doses of 3.0 gin. at 2, 4, and 3 day intervals--a total of 12.0 gm. 
or 245 rag. per kilo in 9 days.  Visual disturbance began 2 to 3 days after the last 
dose and the drug was stopped.  The spinal fluid examined 4 weeks after beginning 
treatment was found to contain only 7.5 lymphocytes per cmm.--a decrease of 74  TREATMENT  OF  I-IU~A:N"  TRYPANOSOMIASIS 
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92 per cent and in addition no large mononuclear or mulberry cells were seen. 
By this time the visual disturbance had completely disappeared and there was a 
noticeable mental and physical improvement.  She no longer showed any tendency 
toward a  lethargic state and  the tremors had  disappeared  although  the  deep 
reflexes continued to be exaggerated.  Treatment was resumed after 3 weeks and 
3 doses of 4.0 gin. were given at weekly intervals, so that the same amount of drug, 
12.0 gin. or 245 mg. per kilo was given again but during a period of 14 instead of 
9  days;  No visual or other disturbances occurred and  there was  a  continued 
striking clinical improvement.  She appeared cheerful and happy, was able to 
take care of herself and answered questions intelligently, all of which contrasted 
sharply with her condition when first seen.  A  third examination of the spinal 
fluid 3 months after  admittance  contained 3.1  lymphocytes per cmm.--a prac- 
ticaUy normal count. 
Etumbu I#4 had been treated with 1.5  gln. soamin and 0.2 gm. tartar emetic 
during a  period, of 22  days.  He was  somewhat  emaciated and  very anemic. 
Mentally apathetic.  48.5 kilos.  Spinal fluid contained 142.5  lymphocytes per 
cmm.; large mononuclears  +.  He was given 3 doses of 2.0 gin. and  1 dose of 
3.0 gm. at 2, 4, and 3 day intervals--a total of 9.0 gin. or 185 rag. per kilo in 9 days. 
Visual impairment developed 3 to 4 days after the last dose and no further treat- 
ment was given.  This effect was transitory and his sight became normal within 
2 weeks.  A second spinal fluid examination made 4 weeks after the first showed 
17.5 lymphocytes per cmm.  or a decrease of 88 per cent.  At this time, however, 
amoebic dysentery developed and although emetine treatment resulted in negative 
stool examinations, he died 3  weeks later.  The question of a  trypanosomiasis 
exacerbation must also be considered as a possible cause of death. 
Tokamba  ~ 8  was an old advanced case, who had been in the hospital for 9 
months, during which time he had received 27 injections of 0.5 gm. soamin (13.5 
gm.), and 29 injections of 0.1 gin. tartar emetic (2.7 gm.).  His general state had 
not been improved.  Ther  e was marked emaciation and weakness; anemia;  greatly 
exaggerated deep reflexes;  tremors of the tongue, hands, and feet; a typical shuf- 
fling gait and rharked mental deterioration and apathy.  39 kilos.  Spinal fluid 
contained 100 lymphocytes per cmm.; large mononuclears  4-4-.  He was given 
one dose of 4.0 gin, tryparsamide, followed by 8 doses of 2.0 gin. at 3 and 4 day 
intervals so that a total of 20.0 gm. or 513 mg. per kilo was administered in 28 days. 
No untoward effects were observed.  A second spinal fluid examination, 39 days 
after the beginning of treatment, showed a markedly diminished number of cells-- 
7.5 lymphocytes per cram., or a decrease of 93 per cent and only 1 large mononu- 
clear was seen.  At this time, patient's physical condition was distinctly  improved; 
he had gained weight and seemed brighter mentally but his nervous symptoms were 
still marked.  Treatment was resumed 5 weeks later and he was given 6 weekly 
doses of 2.0 gin. or 286 mg. per kilo.  The clinical improvement in this patient was 
not as striking as in the case of M'Boyo ~ 3 but the mental deterioration and ner- 
vous symptoms at the time he was transferred to tryparsamide treatment were 
of a more advanced and serious character as well as of longer duration.  In addi- 
tion, he had been previously treated for many months. L.  PEAI~CE  77 
Engondo ~ 7 had been under  more or less constant observation for  7  years. 
She had been originally treated with salvarsan-copper, followed by atoxyl and 
tartar emetic, after which she deserted.  She was readmitted to the hospital 4½ 
years later in a  markedly advanced stage of the disease." During 2½ years, she 
received 63 injections of 0.5  gm. of atoxyl (31.5 gin.), 53 injections of 0.5 grn. 
soamin (26.5 gra.), and 114 injections of 0.1  gin. tartar emetic (11.4 gin.).  Ex- 
amination showed an extreme mental deterioration, typical shuffling gait, marked 
tremors of tongue, hands, and feet, and greatly exaggerated reflexes. She waswhoUy 
irresponsible with hallucinations and violent hysterical attacks and in addition 
wa~ in a lethargic state much of the time.  Thin but otherwise fair general physical 
condition.  45  kilos.  Spinal fluid contained  572  lymphocytes per  cram.  with 
numerous large mononuclears and mulberry cells.  4 doses of 4.0 gin. tryparsamide 
were given at weekly intervals, a total of 16.0 gm. or 356 rag. per kilo, in 32 days. 
There were no  untoward  effects but  little mental improvement was observed. 
A second course of 6 weekly doses of 2.0 gin. was begun a month later and after 
4 of these had been given a lumbar puncture was done (12 weeks after the begin- 
ning of tryparsamide  treatment).  The spinal  fluid showed the markedly  diminished 
cell count of 25 lymphocytes per cram., a decrease of 96 per cent, and only 3 large 
mononuciears were seen.  The patient's mental condition, however, was still very 
abnormal; her disposition was unchanged and she still showed periods of lethargy. 
Her  gait,  however,  had  materially improved, the deep reflexes were less exag- 
gerated;  there were no  tremors and 3  months after the beginning of treatment, 
there was a gain in weight of 4 kilos.  The cerebrospinal  involvement of this patient 
was extreme and of long duration, persistingin spite of continued atoxyl and tartar 
emetic treatment, and she thus represents a  type of case considered as hopeless 
of therapeutic influence.  Under these circumstances, therefore, a marked diminu- 
tion of the cells of the spinal fluid with a  certain degree of clinical improvement 
may be considered as a definite effect of tryparsamide treatment. 
Monololo ~ 21, a soldier on sick leave, gave a history of having been treated for 
several months about a year before admittance.  He was a well developed, well 
nourished man, with normal reflexes and no mental or nervous symptoms.  Cervical 
adenitis; gland puncture -~ -~.  60 kilos.  Spinal fluid contained 37.5 lymphocytes 
per cram. He was given 4 weekly doses of tryparsamide of 4.0 gm. each, or 267 
nag. per kilo in 21 days with no untoward effects.  32 days after the administration 
of the first dose, a second exaraination of the spinal fluid showed a cell content of 
17.5 lymphocytes per cmm.--a decrease of 53 per cent;  3 large mononuclear cells 
were seen.  A second course of treatment was begun 2 weeks after the first because 
the decrease of the spinal fluid cells had not been as great as in most of the other 
cases.  Because of his size and excellent physical condition, the dose was increased 
to 6.0 gm. and he was given 2 doses 10 days apart.  10 days after the second dose, 
he complained of slight visual dimness which had occurred 2 or 3 days before. 
He did not return for 3 weeks and was then given 4.0 gm.  12 days later, or 11 
weeks after the administration of the first dose of tryparsamide, the spinal fluid 
contained 33 lymphocytes per cram. with several large mononuclears, a  similar 
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The correct interpretation of the last spinal fluid examination must take into 
account the type and nature of the infection, but, atall events, it is possible that 
with a  greater number of regularly spaced doses, a more favorable effect might 
have been obtained.  With this in view, it was decided to continue the treatment 
with weekly doses of 3.0 gm. over a longer period of time. 
K. Lukas/~ 27, a  house servant, had been treated for a  long time in various 
localities.  He was unable to work and complained of pains in his legs.  Well 
nourished but anemic with a general glandular enlargement, tongue tremor and 
greatly exaggerated deep reflexes.  Mental state normal.  Gland puncture  q--k 
48 kilos.  Spinal fluid contained 327.5  lymphocytes per cmm.; large mononuclears 
-k +  +; mulberry cells -b +.  He was given 15.0 gin. or 313 mg. per kilo in 3 weekly 
doses of 5.0 gm. with no untoward effects.  31 days after admittance,  his spinal 
fluid contained 15 lymphocytes per cmm., a  decrease of 95 per cent.  A  second 
course of tryparsamide, consisting of 2 doses of 2.0 gm. per week, was begun 4 
weeks later and he received 8 doses, a  total of 16.0 gm. in 26 days, practically 
the same amount of the drug as in the first course but in 26 instead of 14 days. 
The third spinal fluid examination made 11 weeks after admittance showed a cell 
content of 41.5 lymphocytes per cmm., a decrease of 87 per cent from the original 
count but an increase above the second, and in addition 8 to 9 large mononuclears 
were seen.  The physical condition of this patient was excellent and therefore it 
was decided to begin a  third course of larger doses of 4.0 gm. administered once 
a week for at least 5 doses.  Although the second course of tryparsamide had not 
been sufficient to produce a continued diminution of the spinal fluid cells, he was 
able to return to his work. 
Langomo // 34 was a  "vagabond"  appearing first in one district and then in 
another and had been treated for an unknown period of time.  He was  a large, 
strong, powerfully built man,  with a  slight general glandular enlargement and 
markedly exaggerated deep reflexes.  He showed great mental deterioration and 
apathy but was not l~thargic.  Gland puncture -k.  Spinal fluid contained 467.5 
lymphocytes  per  cram.;  large  mononuclears  ++-k;  mulberry  cells  -k-k+. 
62.5 kilos.  He was given 3 doses of 7.0 gm. of tryparsamide in 21  days at 13 and 
8 day intervals, a  total of 21.0 gm. or 336 mg. per kilo with no untoward  effects 
of any kind.  There was a very evident mental improvement, however, shown by 
his rational answers to questions and the disappearance of mental apathy.  The 
second spinal fluid examination, 5 weeks after the first, showed a cell content of " 
only 10 lymphocytes per cmm., a decrease of 98 per cent and in addition no large 
mononuclear or mulberry cells were seen.  Unfortunately no further observations 
on this patient could be made, as he ran away. 
The  striking  feature  of  the  treatment  of  this  group  of  advanced 
cases  is  the  marked  and  rapid  diminution  of  the  cells in  the  spinal 
fluid induced by a  few doses of tryparsamide.  Decreases in  the  cell 
count  of from  47  to  98  per cent  occurred  in  4  to  5  weeks with  the L.  PEAI~CE  79 
exception of one patient, Eali  #1, who was given only 2 fortnightly 
doses, and here there was a decrease of 22 per cent. 
The  system  of  therapy  employed in  the  majority  of  instances 
consisted of 3  or 4  injections of 2.0 to 7.0 gm. at various intervals 
ranging from 3 to 14 days.  The administration of doses at weekly or 
10 day intervals was well borne with two exceptions but more frequent 
dosage caused visual disturbances in 3 instances which for the most 
part were transitory.  In the case of Yali #13, the decrease of the cells 
in the spinal fluid induced by one course of tryparsamide continued 
over the observation period of 7½ weeks after cessation of treatment; 
regarding Langomo #34, only the early effect of one course of treatment 
was observable as he deserted.  The second course of treatment given 
to M'Boyo #3  caused a further diminution in the cell count of the 
spinal fluid and it is probable that a  similar condition existed in the 
case of Engondo #7.  It was not possible to obtain additional lumbar 
punctures from the 3 patients who died, and with Tokamba #8, it.was 
deferred  until  further  treatment  had  been  given.  In  2  patients, 
Monololo ~.21 andK. Lukas #27,  the diminished cell content of the 
spinal fluid was not further influenced by the second course of trypar- 
samide  and  in  one instance  this  may be partly  explained by  the 
irregular spacing and in'strfficient number of doses.  Further, in judging 
the results of the treatment of this group of patients, the type and 
stage of the disease and the fact that prolonged previous treatment 
had been given must also be taken into consideration. 
The mental and physical improvement  which paralleled the changes 
in the spinal fluid were likewise striking and it should be pointed out 
that  they occurred in  all  patients with 3  exceptions in whom the 
treatment was stopped. 
GENERAL OBSERVATIONS. 
Effect upon the Blood.--The changes in the blood counts of advanced 
cases of trypanosomiasis treated with one or two courses of repeated 
doses of tryparsamide were studied in 24 patients as shown in Tables 
XXVI  to XXVIII.  The first  17 patients in these tables were pre- 
viously untreated,  while  the  last  7  had  been treated before.  The 
amount of tryparsamide given to these patients ranged from 70  to 
680 rag. per kilo; in general this was given in weekly doses of 2.0 to 80  TI~ATMENT  O1~  ]R'Lr~AN  TRYPANOSO~IASIS 
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5.0 gm.  The seconc~ blood count was made from 3 to 14 weeks after 
the first.  The red and white cell counts and hemoglobin determina- 
tion  before  and  after  treatment  are  also  tabulated  separately  for 
convenience of comparison (Tables XXIX, XXX, XXXI). 
The striking  feature of  the initial  blood  counts was  the marked 
degree of secondary anemia.  17 patients had red cell counts Of below 
4 million, 6 between 4 and 4½ million, and only 1 had a normal number 
of red cells.  The hemoglobin was likewise diminished; 14 determina- 
tions were 50 per cent or lowerl 8 were between 50 and 60 per cent, and 
2  were 70  per cent.  There was a  leukopenia of below 6,000  white 
cells in 12 instances, in 3 between 6 and 8 thousand, while 9 patients 
had counts of between 8 and 12 thousand. 
The effect of tryparsamide treatment upon the red cell count is seen 
in Table XXIX.  In only one instance (Fulu #29) was an improvement 
not observed, while in 23 patients, the red cells were increased from 7 
to 100 per cent.  In 13 patients  this increase amounted to more than 
20 per cent and in 10 patients from 7 to 19 per cent. 
The hemoglobin changes were even more striking  (Table XXX). 
There was an increase of 7 to 78 per cent in 23 patients and a decrease 
of 9 per cent in one patient (Fulu #29).  11 patients showed an increase 
of 40 per cent or more, while in  6  others the increase was above  20 
per cent. 
The  white  cell  counts  were also influenced by  the  tryparsamide 
treatment as shown in Table XXXI.  There were both increases and 
decreases but in general there was a definite tendency toward a normal 
count as may be seen by comparing the 4th and 5th columns in this 
table. 
These  results  are  in  accord  with  the  observations  on  the  blood 
picture of patients in  the earlier stages of the disease treated with 
single or repeated doses of tryparsamlde and are indicative of a favor- 
able response to the drug. 
Effect upon  the Weight.--The  changes  in weight of  28  advanced 
cases treated with repeated doses of tryparsamide are given in Tables 
XXXII  and  XXXIII.  The  18  patients  in  Table" XXXII  are 
those who had  had  no  previous  treatment,  while  the  10  in  Table 
XXXIII had been treated before for varying periods of time.  The 
first 7 patients in Table XXXII were given 1 course of tryparsamide, 82  TREATM~ENT  O~F  HIIM.AN  TRYPANOSO~flASIS 
tt~ 
e~ 
te~ 
¢o 
eo 
o.  o. 
e~  .~  eq  to  ~  e~ 
~  oo  ~O 
to 
to 
t~ L. PEA~CE  83 
,d, 
oO  oO 
+++  +++  ++1  ++I 
o~ 84  TREATMENT  OF HIYMA~  TRYPANOSOMIASIS 
r,b 
oo  oo 
oO  oO 
c~  r~ 
++1 
~r'a  ,L".q ¢'~ 
++l  H-++ 
.¢.-q 
Q  ok." 
•  ° 
^ 
~  ~  ~  M.~  ~  ~  .~  • 
do 
eo  ¢q 
=. 
.-g L.  VEAI~C~S  85 
while the remainder, 21  (Tables XXXII  and XXXIII),  received 2 
courses averaging 1 month each and separated in most instances by 
an interval of 4 to 6 weeks.  The observation periods range from 4 to 
i6 weeks. 
Taking up  first  the weight changes in  the previously untreated 
patients, it is seen that 14 showed a gain of from 0.5 to 8.5 kilos during 
8  to  14  weeks; 2  patients showed no change--Loyoko #18,  a  well 
nourished adult,  and Fulu #29,  a  small boy with an extensive skin 
infection and fflariasis; and 2 others lost weight--Babula #15, who had 
a  large leg abscess  and  an  attack  of estivo-autumnal malaria,  and 
Bwaba #17, who probablyhad an exacerbation of the disease together 
with visual disturbances.  The  smaller increases of 0.5  to  1.0  kilo 
occurred in 7 patients, 2 of whom had malaria, 1 visual disturbances 
and  probably  an  exacerbation  of  trypanosomiasis, and  1  chronic 
amoebic dysentery and  ankylostomiasis, while 7  patients showed a 
gain of from 3.0 to 8.5 kilos. 
The 10 patients in Table XXXlII were previously treated with other 
drugs as has already been described.  3 of them became very ill during 
the period of observation, lost weight, and eventually died (Eali #1, 
Bibaba #2, and Etumbu #4).  The other 7 patients showed increases 
of weight of from 3.0 to 7.0 kilos except Langomo #34, who was in a 
good state of nutrition on admittance and gained only 0.5 kilo during 
6 weeks. 
The general beneficial effect of tryparsamide in advanced cases of 
trypanosomiasis, as indicated by increases of weight in the majority 
of patients,  is  similar to  that observed after  the administration of 
single and repeated doses in early stages of the disease.  However, 
since the advanced cases were usually more emaciated, the improve- 
ment is relatively more pronounced. 
Untoward Effects.--The administration of single or repeated doses 
of tryparsamide in all types of human trypanosomiasis represented by 
the 77 cases treated in L6opoldville  was singularly free from immediate 
or delayed so  called  toxic symptoms or reactions,  such as nausea, 
fever,  headaches,  diarrhoea,  renal  disturbances, jaundice, petechial 
hemorrhages, cutaneous reactions of various types, and syncope which 
may  occur  after  the  administration  of  various  arsenical  agents. 
A  continued clinical improvement was characteristic of the tryparsa- 86  TREATMENT  OF  HUMAl~  TRYPANOSOMIASIS 
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mide treatment  in  practically every  patient,  with  the  exception  of 
those  who  had  complicating infections  and  those who presented  the 
only  untoward  effect  observed.  This  consisted  in  the  occurrence 
of  a  visual impairment  in 9  advanced  cases. 
TABLE  XXIX. 
Changes in the Red Blood Cells of Advanced Cases Treated with Repeated Doses of 
Tryparsamide. 
Case 
No. 
18 
35 
29 
32 
49 
17 
22 
9 
10 
16 
24 
14 
6 
25 
15 
20 
26 
4 
2 
1 
3 
13 
22 
21 
The 
Name. 
R.B.C. 
before 
treatment 
Loyoko  ....  2,720,000 
Koloshi.  3,840,000 
Fulu  4,160,000 
N'Siola...  4,160,000 
Makalamba.  4,320,000 
Bwaba ....  2,400,000 
Bose .....  2,560,000 
Bolendo.  2,912,000 
Makengo.  2,940,000 
Masimango  ....  3,040,000 
Miaku...  3,104,000 
Tono .....  ]  3,352,000 
Nembezi.  I  3,616,000 
Madina ....  3,728,000 
Babuli ....  3,840,000 
Kiale..  4,000,000 
M'Pala.  4,136,000 
Etumbu .... 
Bibaba  ........ 
Eali.. 
M'Boyo... 
Total 
amount 
tryparsa- 
mide. 
rag. per kg. 
150 
449 
314 
400 
171 
427 
464 
449 
541 
458 
.,  411 
460 
"l  568 
583 
452 
68O 
468 
185 
203 
70 
490 
272 
646 
6O0 
YaU.. 
K. Lukas... 
Monololo ..... 
2,280,000 
2,480,000 
2,720,000 
2,780,000 
3,360,000 
4,000,000 
4,800,000 
Last R. B.C.  Interval 
after  Change.  between 
treatment,  counts. 
per cent  days 
4,800,000  +  76  82 
5,120,000  +  33  45 
4,160,000  --  46 
5,120,000  +  23  73 
4,640,000  +  7  47 
4,060,000  +  69  87 
5,120,000  +100  85 
4,000,000  +  37  88 
4,480,000  +  52  88 
5,040,000  +  66  84 
3,200,000  +  3  78 
4,000,000  +  19  81 
4,160,000  +  15  93 
4,000,000  +  7  74 
4,320,000  +  13  81 
4,320,000  +  8  81 
5,120,000  +  24  71 
2,480,000  +  9 
3,616,000  +  46 
4,160,000  +  49 
3,680,000  +  32 
4,800,000  +  43  [ 
4,600,000  +  15 
5,120,000  +  7 
24 
35 
20 
99 
88 
'79 
84 
first 5  patients were treated with  1  course of tryparsamide; the next  12 
with2 courses; the last 7 had been previously treated with other drugs. 
Before  discussing  the  significant  features  of  this  disturbance,  a 
brief description of its occurrence in each patient  will be given.  The 
first 5  patients were known  to have received previous treatment  with L.  P~.ARC~.  89 
arsenical drugs and we suspected that one other, Miaku #24, had been 
treated before.  All  had  marked  involvement  of  the  cerebrospinal 
system on admittance  as  shown  clinically and  by spinal fluid exami- 
nation  with  the  exception  of  3/[onololo #21. 
TABLE  XXX. 
Changes in the Hemoglobin Content of the Blood of Advanced Cases Treated witk 
Repeated Doses of Tryparsamide. 
Case 
No. 
18 
35 
29  ~ 
32 
49 
6 
17 
15 
14 
10 
16 
25 
22 
24 
26 
9 
20 
4 
1 
3 
13 
2 
27 
21 
Name. 
Loyoko.. 
Koloshi ....... 
Fulu. 
N'Siola. 
Makalamba.  .. 
Nembezi ..... 
Bwaba .... 
Babuli ........ 
Tono.. 
Makengo... 
Masimango ........ 
Madina... 
Bose. 
Miaku.. 
M'Pala~ .. 
Bolendo.  .. 
Kiale. 
]  Etumbu. 
Earl.. 
M'Boyo  ........... 
Yali ..... 
Bibaba ..... 
K. Lukas. 
Monololo. 
Total 
amount 
tryparsa- 
mlde. 
rag. per kg. 
150 
449 
314 
400 
171 
568 
427 
452 
460 
541 
458 
583 
464 
411 
468 
449 
680 
185 
70 
•  490 
272 
203 
646 
600 
Hemoglobin 
, before 
treatment. 
45 
45 
55 
60 
70 
40 
42 
46 
48 
48 
50 
50 
52 
52 
55 
55 
60 
34 
35 
35 
45 
48 
60 
70 
Hemoglobin 
after 
treatment. 
80 
60 
50 
75 
75 
65 
55 
65 
75 
60 
70 
70 
75 
65 
80 
65 
70 
40 
51 
60 
75 
55 
75 
75 
Change. 
per cecil 
+78 
--}-34 
--9 
+25 
+7 
+63 
+31 
+41 
+56 
-t-25 
+4O 
+4O 
+44 
+25 
+45 
-t-18 
+17 
+18 
+46 
+71 
+67 
+14 
+25 
+7 
Interval 
between 
countso 
dffys 
82 
45 
46 
73 
47 
93 
87 
81 
81 
88 
84 
74 
85 
78 
71 
88 
81 
24 
20 
99 
88 
35 
79 
84 
The first 5 patients were treated with  1 course of tryparsamide;  the next 12 
with 2 courses; the last 7 had been previously treated with other drugs. 
Eali ~/.--Previous treatment, 0.75 gin. atoxyl.  Lumbar puncture, 80 lympho- 
cytes per cmm.  Slightly exaggerated deep reflexes;  mental condition normal. 
He was given 3 doses of 2.0 gin. in 27 days, followed after a week's interval by 2 
doses of 4.0 gm. in 7 days.  2 days after the last dose, he complained of indis- 90  TREATMENT  OF  .t:tuMAN TRYPANOSOMIASIS 
tinctness of vision of both eyes;  walked unsteadily  but could count fingers; treat- 
ment stopped.  A month later he could count fingers with left eye but not with 
right;  he could distinguish light with both.  General condition became worse, 
with  fever, etc.  (exacerbation of trypanosomiasis?), and death occurred. 
TABLE  XXXI. 
Changes in the White Blood Cells of Advanced Cases Treated with Repeated Doses 
of Tryparsamide. 
Case 
No. 
29 
35 
18 
32 
49 
15 
22 
24 
25 
14 
9 
16 
6 
26 
10 
17 
20 
13 
3 
2 
27 
1 
21 
4 
Naive. 
I  Fulu  ..... 
[  Koloshi. 
Loyoko .... 
N'Si01a  ..... 
Makahmba. 
Babuli. 
Bose ..... 
Miaku.. 
Madina... 
Tono. 
Botendo .... 
Masimango  .. 
Nembezi. 
M'Pala... 
Makengo... 
Bwaba ........ 
Kiale. 
Yali. 
M'Boyo... 
Bibaba .... 
K. Lukas 
Eali.. 
Monololo ...... 
Etumbu  ..... 
Total 
aino~L~t 
tryparsa- 
mide. 
rag. per kg. 
314 
449 
150 
400 
171 
452 
464 
411 
583 
460 
449 
458 
568 
468 
541 
427 
680 
W. B. C. 
before 
treatment. 
4,500 
5,000 
7,500 
8,500 
11,000 
4,000 
5,200 
5,400 
5,550 
6,000 
6,200 
7,500 
8,500 
9,600 
10,000 
12,000 
12,000 
Last W. B. C. 
after 
treatrcenf. 
Change. 
Interval 
between 
COWlf~. 
per cent  days 
ii,000  +144  46 
8,000  +  60  45 
8,000  +  7  82 
8,900  --  6  73 
10,000  --  9  47 
+100 
+  61 
--  18 
+  40 
--  13 
+  13 
+  20 
--  22 
+  4 
--  28 
--  33 
--  25 
81 
85 
78 
74 
81 
88 
272 
490 
203 
646 
70 
600 
185 
2,300 
2,700 
3,500 
4,000 
4,400 
8,000 
9,500 
8,000 
8,400 
4,400 
7,800 
5,200 
7,000 
9,000 
6,600 
10,000 
7,200 
8,000 
9,000 
8,000 
6,000 
7,000 
7,000 
9,000 
8,000 
12,580 
+248 
+122 
+100 
+  75 
+104 
+  32 
84 
93 
71 
88 
87 
81 
88 
99 
35 
79 
20 
84 
24 
The first 5 patients were treated with 1 course of tryparsamide; the next 12 
with with 2  courses; the last 7 had been  previously treated  with other drugs. 
Bibaba f~ 2.--Previous treatment: soamin, 5 doses of 0.5 gm., and tartar emetic, 
4 doses of 0.1 gin., during 43 days.  Lumbar puncture 37.5 lymphocytes per cram. 
Greatly exaggerated deep reflexes and mental apathy.  He was given 4 doses of 
3.0 gin. or 203 mg. per kilo in 9 days.  2 days after last injection, complained of L.  P'R.ARCE  91 
TABLE  XXXII. 
Weigkt  Changes  of  Advanced  Cases  (No  Previous  Tr~t~nO Treated  ~t~ R@ea~ 
Doses of Tryparsamide. 
Na~e,  d 
o 
o 
gm.  kg.  kg.  kg.  kg.  kg. 
61.5 60  055 
!53.5  +1.o§~ 
18 
49 
9 
29 
32i 
35 
44 
22 ¸ 
26  ¸ 
14 
16 
15 
Loyoko ......  17.5  3 x 3.0 
Makalamba..  22.0  9 x  1.0 
Bolendo.  47.5  5 x 2.0 
3 x 4.0 
Fulu ..........  142.5  8 x  1.0 
1 x2.0 
2xl.0 
N'Siola  ......  52.5  4 x 4.0 
Koloshi ......  285.0  4 x 5.0 
N'Kusu ......  47.5  4 x 4.0 
2x2.0 
Bose .........  15  2 X 3.0 
4x 5.0 
M'Pala ......  15  3 x 3.0 
4x5.0 
Nembezi .....  +  (?)  5 x 2.0 
4 x 4.0 
Tono ....  20.2  4 x 2.0 
1 x0.7 
3x4.0 
Masimango...  35  5 x 2.0 
3 x4.0 
Babuli ........  70  5 x 2.0 
4x4.0 
56.5 57  57.5 +8.5 
26  25.5  0"* 
39  41  +1.0 
44.5 45  +0.5tl 
! 
39  39.5  +1.0 
58:5 59.5160.5  +4.5 
62  63  63  +1.0~ 
i 
I 
51  51  52  +6.0111] 
I 
J 
49  48.5  ~9  +4.0 
48  48.5  i8.5  +0.5 
56.5 57  57  --0.5§ 
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TABLE  XXXII.--Cor~t~r~ued. 
Z 
24 
25 
2C 
17 
10 
Name. 
Miaku*.. 
1V[adina  ...... 
Kiale* ....... 
B wab  a ....... 
Makengo .... 
305 
300 
387.5 
• 450 
.. 247.5 
gm. 
2x4.0 
5x2.0 
3x4.0 
8x2.0 
4x4.0 
8x2.0 
4x3.0 
5x2.0 
lx1.0 
lx2.0 
lx3.0 
lx4.0 
lx5.0 
lx2.0 
lx0.5 
5xl.O 
kg.  kg.  kg.  kg.  kg.  kg.  kg.  kg.  kg. 
46.5 47.5i46.5  t  ~  47.5  +I.OH 
48  47.5~7.548  50.5 51  51  +3.0~ 
47  48.5 50  50.5 50  51  51  +4.0*** 
51.5 52  49.5  t7  45  -6.51[ 
41.5¢3  42  41  ~:5.546.548  49  +7.5 
Previous treatment suspected. 
In bed. 
Malaria. 
§ Malaria; leg abscess. 
TI Trypanosomiasis exacerbation (?). 
** Pustular skin infection; filariasis; scabies. 
tt Chronic amoebic dysentery; ankylostomiasis. 
$$ Filariasis. 
§§ Syphilis; malaria. 
[111 Malaria  (?). 
*** Tinea versicolor. 
indistinctness of vision--worse in left than right eye;  could distinguish light with 
both eyes.  Condition improved during following 2 weeks so that patient could 
count fingers with both eyes but general condition became much worse with fever, 
etc.  (exacerbation of trypanosomiasis?).  2  doses of 2.0 gm. were given with no 
increase in visual impairment but without influence upon the course of the disegse 
and death occurred. L.  I'EARCE  93 
TABLE  XXXIII. 
Weight  Changes  of  Advanced  Previously  Treated  Cases  After  Repeated  Doses  of 
Tryparsamide. 
13  Yali.  .  32 
o~  g~ 
g~. 
2x3.0  51.5 52.5 51.551  51.5 54  54  54.5 
2x4.0 
d 
kg.  kg.  kg.  kg.  kg.  kg.  kg.  kg,  kg.  kg. 
+3.0 
Eali ......  80  2x2.0  57  56  58  56  55 
lx2.0 
2x4.0 
Bibaba ....  37.5  4x3.0  59  59 
2x2.0 
--2.0" 
52  [--7.0" 
M'Boyo..,  92.5  4x3.0  ~9  50  51  52.5 
3x4.0 
53.5  54.5 56  [+7.0 
4!Etumbu..i142.5  3x2.0  ~8.549  44 
i  1 x3.0 
21  Monololo.[ 37.5  4x4.0  50  60  62  61.5 62  62  i63 
[  2x6.0 
i 
27  K. Lukas.  327.5 
Engondo.. 572.0 
Tokamba.  100.0 
34  Langomo.  467.5 
2x4.0 
Ix3.0 
3x5.0  ~8  47  48  50.550  52.552.5 
8x2.ff 
3x4.0  ~5  49 
6x2.0 
lx4.0  39 
8x2.0 
6x2.0 
-4st 
i+3.0 
+4.5 
+4.0 
43  42.5  44  +5.0 
3x7.0  62.552  63  63  +0.5 
* Died.  Trypanosomiasis exacerbation (?). 
t  Died.  Amoebic dysentery; trypanosomiasis exacerbation (?). 94  TREAT~ENT  OF ~  T!~YPANOSOMIASIS 
M'Boyo~t 3.--Previous treatment: soamin, 4 doses of 0.5 gin., and tartar emetic, 
2 doses of 0.1  gin.,  in 26 days.  Lumbar puncture 92.5  lymphocytes per cmm.; 
large mononuclears +  + +.  Mental deterioration, apathy, and lethargy; marked 
nervous symptoms.  She was given 4 doses of 3.0 gm. or 245 rag. per kilo in 9 days. 
2 to 3 days after last dose, she complained of dimness of vision in both eyes and she 
walked unsteadily;  there was complete recovery in 18 days. 
Treatment  was resumed after 3 weeks' intermission  with  3  weekly doses of 
4.0 gm. so that the same total amount of'tryparsamide was given but in 14 instead 
of 9  days. There were no subsequent disturbances.  Ophthalmoscopic examina- 
tion  2  months  after  the last  dose of  tryparsamide  was  negative except  for a 
slight reduction in size of the optic discs. 
Etumbu ~ 4.--Previous treatment: soamin, 3 doses of 0.5 gm., and tartar emetic, 
2 doses of 0.1  gm. in 22 days.  Lumbar puncture 142.5  lymphocytes per cmm.; 
large mononuclears  +.  Mental apathy.  He was given 3 doses of 2.0 gm. and 
1 dose of 3.0 gm. or 185 mg. per kilo in 9 days.  3 to 4 days after the last  dose he 
complained of indistinctness of vision of both eyes and treatment was stopped; 
the sight became normal in about 2 weeks. 
Monololo//21.--Previous treatment unknown.  Lumbar puncture 37.5 lympho- 
cytes per cram.  No mental or nervous symptoms.  He was given 4 weekly doses 
of 4.0 gm. or 267 mg. per kilo in 21 days with no reaction of any sort.  Treatment 
was resumed 2 weeks later and 2 doses of 6.0 gm. were given 10 days apart.  A 
week later he complained of slight indistinctness of vision of both eyes.  At his 
next visit, 11 days later, vision of left eye was normal and a week later vision of 
both eyes was normal. 
Subsequent treatment with 2 doses of 4.0 gin. and 1 dose of 3.0 gin. in  19 days 
caused no visual disturbance whatever. 
Miaku ~ 24.--Previous treatment suspected.  Lumbar puncture 305 lympho- 
cytes per cram.; large mononuclears +  +; mulberry cells +  +.  Mentally apathetic, 
beginning lethargy  (?)"  Marked  nervous symptoms.  He was given 2  weekly 
doses of 4.0 gin. or 172 mg. per kilo in 7 days.  Complained of indistinctness of 
vision of both eyes and intense headache a week later.  Could.count fingers and 
gait was normal.  Treatment  stopped.  2 days later, vision of left eye normal; 
right eye slightly improved.  3 weeks later, patient became very ill with fever, 
etc.  (exacerbation of trypanosomiasis?), and he was given 5 weekly doses of 2.0 
gin. with  marked  clinical improvement and no increase of the residual visual 
impairment of the right eye. 
At the end of this course of tryparsamide, vision of the left eye was normal. 
With the right ey~ he could distinguish light but vision was poor.  Ophthalmoscopic 
examination of both eye grounds showed a pale retina with clearly defined, some- 
what pale optic discs but otherwise no abnormality. 
Bwaba  g 17.--No  previous  treatment.  Lumbar  puncture 450 lymphocytes 
per cmm.; large mononuclears  +  +; mulberry cells  +  +.  Mental deterioration; 
marked nervous symptoms.  He was given 4 weekly doses of 3.0 gm. or 233 rag. 
per kilo in 21 days.  On the last day of treatment, he complained of conjunctivitis L.  PEARCE  95 
of the right eye with pericorneal  injection  and pustular discharge;  no urethral 
discharge.  Condition responded  promptly to local  treatment.  A  week  later, 
complained  of right  eye being  "bad" 'and in 2  days there was marked visual 
impairment of both.eyes;  could count fingers and see to walk. 
During the following month, vision  of both eyes improved slightly.  Treat- 
mentwith weekly doses of 2.0 gin. was resumed after the appearance of a brawny 
indurated swelling of the left leg and foot (trypanosomiasis?)  and no intensification 
of visual symptoms was observed. 
2 months after the onset of visual impairment, ophthalmoscopic  examination 
of both eyes showed an anemic retina with a flattened white optic disc, the vessels 
of which  were  sharply  outlined  and  distinctly  seen.  Size of  disc  apparently 
enlarged.  Vision of left eye poor--of right, slight;  could see to walk. 
Makengo ~ lO.--No previous treatment.  Lumbar puncture 247.5 lymphocytes 
per cram.; large mononuclears  -4-4-; mulberry cells 4-4-.  Dull mental condition, 
slight  lethargy, marked nervous symptoms.  He was given increasing  doses of 
tryparsamide from 1.0 to 5.0 gm., a total of 15.0 gin. or 361 nag. per kilo in 24 days. 
5 days after the last dose, he complained of visual dimness of right eye;  could 
not count fingers with this eye.  Vision of left eye unimpaired.  During the follow- 
ing month, the sight improved considerably.  He could see objects but stated that 
there was a  "shadow" over them.  Treatment was resumed  with small  doses 
(2.0, 0.5, and 1.0 gm.) with no increase in visual symptoms.  A~month later, there 
was a slight visual dimness of the right eye which was gradually decreasing  and 
the left eye was normal.  Ophthalmoscopic examination of both eye  grounds showed 
a pale optic disc, the vessels of which were distinctly visible, and a pale retina with 
small vessels. 
Bandu ~ 54.--No previous treatment.  Good general  physical condition;  71 
kilos.  Marked edema of both legs from knee to toes.  No mental or nervous 
symptoms.  Lumbar puncture 117 lymphocytes  per cmm.; large mononuclears  4-; 
3 mulberry cells seen.  He was treated at weekly intervals with 5.0 and 6.0 gin. 
and 4 doses of 2.0 gin., a total of 19.0  gin. or 290 rag. per kilo in 26 days.  3 days 
after the last dose there was slight  unsteadiness  and dimness of vision of both 
eyes;  no edema except  over instep of both feet;  urine examinations  negafive~ 
2 weeks later,  vision  of both  eyes  was normal; ophthalmoscopic examination. 
showed normal retin~e and slightly enlarged, pale discs.  The pronounced edema 
of both legs had entirely disappeared  by this time and a lumbar puncture 8 weeks 
after admittance showed a normal spinal fluid. 
These observations may be summarized as follows:  There were 17 
instances of visual impairment of which 6 were slight, 7 were moderate, 
and 4 of marked degree.  In 10, recovery was complete and 3 showed 
moderate and 4 slight improvement. 
From an analysis of the above cases, certain factors in regard to the 
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were advanced cases, with marked alteration of the spinal fluid except 
2, iVionololo #21 and Bibaba #2.  No visual disturbance of any kind 
occurred in patients in the early stages of the disease or in the beginning 
of the advanced period, irrespective of the system of therapy employed. 
Next, 4 of the 9 patients were being treated with atoxyl and tartar 
emetic at  the  time  the administration  of tryparsamide was  begun, 
while  a  fifth patient,  and  we  suspected  a  sixth,  had  had  previous 
arsenical treatment.  To what extent previous  treatment may con- 
tribute to the production of visual impairment is uncertain but that 
such a  drug as atoxyl for instance may participate in this reaction is 
not improbable. 
In  the  third  place,  there  was  no  instance  of  sudden  complete 
blindness  but  the  condition  was  one  of visual  dimness  of  various 
grades or of inability to see distinctly; in every instance,  there was 
either complete recovery or improvement of some degree.  It is  of 
interest to note that a marked and moderate impairment of 2 patients 
which was similar in degree to that observed in others was entirely 
transitory. 
Finally as regards tryparsamide itself, it should be pointed out that 
no single dose of even 7.0 grn., given in this instance to a very advanced 
case (Langomo #34), produced untoward effects of any kind.  In one 
patient with a  markedly abnormal  spinal fluid,  2  doses of 4.0  gm. 
separated by an interval of a week, were followed by visual disturb- 
ances but  in the  others  more than  2 doses  were given.  Attention 
should also be drawn to the fact that in several patients administra- 
tion of considerable amounts of the drug, both before and after the 
occurrence of  visual impairment, did not  reproduce this  effect or if 
any residual symptoms were presen  t at  the time of retreatment they 
were  not  increased by further drug  administration.  For  example, 
M'Boyo  #3,  who  had  completely recovered from  the  disturbance 
which  followed  the  first  course  of  12.0  gin.,  was  afterwards  given 
exactly the same amount of drug, 3  doses of 4.0 gm. over a  slightly 
longer  period  of  time,  with  no  visual  reaction  whatever,  and 
!V[akengo #10 who had partially recovered was given a second course 
of treatment of  smaller doses with no increase of  visual impairment. 
The size of the dose together with the interval of time between doses 
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is probably the more important. Bibaba #2, M'Boyo #3, and Etumbu 
~4 were given 4 doses of 2.0 and 3.0 gm. at 2 and 3 day intervals; all of 
these patients developed a  considerable degree of visual impairment 
but it was entirely transitory with 1V['Boyo #3 and Etumbu #4, while 
Bibaba #2  showed a  moderate improvement.  These cases illustrate 
the danger of too frequent dosage.  The case of Makengo #10 is some- 
what analogous.  I-Ie was given ascending doses of from 1.0  to 5.0 
gin. in 24 days with no untoward effects until a few days after the last 
dose.  Undoubtedly with  this  type  of  treatment,  the larger  doses 
were given too closely together and it is probable that if the last dose 
of 5.0 gin. had been omitted no visual symptoms  would have occurred. 
On the other hand, 3 other patients who were given weekly doses of 
3.0 and 4.0 gin. developed visual impairment, Eali #1, Miaku #24, 
and Bwaba #17.  In contrast with these cases, it should be recalled 
that other advanced patients who were given similar or larger weekly 
doses showed no resultant visual symptoms.  For instance, Koloshi 
#35 was given 4 doses of 5.0 gm. in 29 days; K. Lukas #27, 3 doses of 
5.0 gin. in 14 days; and Langomo #34, 3 doses of 7.0 gm. in 21 days, 
as shown in Tables XXIV to XXVI.  It seems not unlikely, therefore, 
that the individual pathological condition of  the optic structures in 
advanced cases is the principal predisposing factor in the occurrence 
of this untoward effect. 
DISCUSSION. 
The purpose of the work reported in this paper was the obtaining 
of certain fundamental facts in regard to the action of tryparsam/de 
in human trypanosomiasis since experimental toxicologic and thera- 
peutic investigations with the drug had indicated its possible use in the 
treatment of patients suffering from this disease.  The observations 
of 77 patients in early and advanced stages of trypanosomiasis caused 
by Tr. gambiense and treated with tryparsamide formed the basis for 
this study.  The patients came from  various parts  of  the  Belgian 
Congo and most of them had not received previous treatment. 
It was realized that objective information on the action of single 
doses must precede the use of several doses and, further, that the effect 
of a few doses must be studied before one could devise a logical system 
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along  the  general  lines  suggested  by  these  principles.  The first 
observations  were  concerned  with  determining  the  trypanocidal 
action of various sized doses of tryparsamide by microscopic exami- 
nations of centrifuged blood and lymph gland juice and included both 
the time of occurrence of this action and its duration in relation to the 
time of treatment.  From a series of some 90 examinatioris after the 
treatment of patients in all stages of the disease with doses ranging 
from 0.3 to 7.0 gin. or 4.7 to 112 rag. per kilo of bodywelght, administered 
intravenously in most instances, it was found that tryparsamide was 
an active trypanocidal agent since its administration was consistently 
followed by negative examinations for trypanosomes in the superficial 
lymph glands and blood within 24 hours.  The smaller doses up to 
50 rag. per kilo of body weight produced negative lymph gland and 
blood examinations within 15 hours in the majority of cases and this 
number was increased after larger doses of 54  to  112 rag. per kilo. 
In certain patients, no trypanosomes were found in the blood as early 
as 3½ hours after treatment but, in general, doses of 2.0, 3.0, and 4.0 
gm. produced a peripheral sterilization in from 6 to 12 hours. 
The duration of peripheral sterilization induced by single doses of 
tryparsamide was next studied in patients in the first period of the 
disease or  as indicated  by a  slight increase in  the number of cells 
of the cerebrospinal fluid, in  the beginning of the advanced period. 
Without taking into account differences in the severity or type of the 
infections in individual patients, it was found that  the duration of 
peripheral sterilization varied from 17  to 58 days in the 12 patients 
who had been given single doses of 0.5 to 5.0 gm. or from 17 to 83 
rag. per kilo of body weight.  On the other hand, no peripheral relapse 
was detected during observation periods of from 40 to 111 days !n the 
9 patients who had been treated with single doses of 0.5 to 3.0 gm. 
or from 9 to 68 rag. per kilo.  It appears, therefore, that within the 
limits of dosage of from 0.5  to  5.0  gin., peripheral sterilization in 
relapsed patients endures on an average of from 3  to 6  weeks; but 
since there was one relapse 17 days after treatment, it seemed advisable 
in planning a system of repeated doses to begin with intervals of 1 and 
2 weeks until the results of larger series of single dose administrations 
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The effects of intramuscular administration upon the duration of 
peripheral sterilization is significant.  4 patients were treated by this 
route with single doses of from 37 to 57 rag. per kilo; the immediate 
effect upon the trypanosomes in lymph glands and blood was similar 
to that observed after the intravenous route  but on the whole the 
duration of this action was definitely more prolonged as seen by the 
average time of relapse, 7 weeks after treatment.  In 3 patients, there 
was practically no local reaction while the tenderness and induration 
which occurred in one instance was probably due to a  passing mild 
infection.  While  no  subcutaneous injections  were  given,  a  slight 
amount of drug solution escaped into the tissues surrounding the vein 
in a few instances, but no irritation or discomfort of any sort arose, 
and in a few hours complete absorption had taken place. 
The spinal fluid of early cases treated with single doses of tryparsa- 
mide was examined because of the possibility that the disease might 
progress and involve the central nervous system during the period of 
blood and lymph gland sterilization.  A lumbar puncture was made 
on an average of 5 weeks after treatment in 14 patients with initial 
normal or slightly abnormal spinal fluids who had been given single 
doses ranging from 0.5 to 3.0 gin. or 9.0 to 68.0 rag. per kilo.  In every 
instance, except one, the second cell count continued to be normal or 
was decreased to within or toward normal limits; in one patient, the 
result  was  uncertain  because  of  blood  contamination of the  first 
specimen of spinM fluid.  No trypanosomes, however, could be found 
in the lymph gland juice, centrifuged blood, or centrifuged spinal fluid 
of this patient. 
The general physical reaction of patients in the first period of the 
disease treated with single doses was prompt and satisfactory.  In 2 
or 3 days after treatment, the subjective symptoms disappeared and 
the pulse rate and temperature became normal; within a  month the 
blood count was materially improved, the patient had gained weight 
and  the  cervical lymph glands were  small and  indurated.  Inter- 
ruptions of this favorable course of events occurred in those patients 
who harbored other infections or who ultimately had a trypanosomal 
relapse but in  general  a  definite and usually a  marked  beneficial 
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were observed in these patients, either of an immediate occurrence or 
of a more delayed appearance. 
The use of repeated doses of tryparsamide was based upon the action 
of single doses, and a number of previously untreated patients as well 
as those who had suffered a relapse after single doses were given from 
4 to 7 doses of 2.0 to 5.0 gin. at weekly or fortnightly intervals.  Only 
the initial  observations  are  at  present  available.  The preliminary 
effect as regards negative trypanosome examinations of lymph glands 
and  blood  and  general  clinical  improvement indicated  by  the  dis- 
appearance of subjective symptoms, pulse  and  temperature curves, 
blood  counts,  gain  in  strength,  and  increase in  weight occurred in 
both groups  of patients.  Microscopic examinations of lymph gland 
juice and centrifuged blood made from time to time during the course 
of treatment were uniformly negative. 
Obviously  no  predictions  of  the  ultimate  therapeutic  results  in 
these patients can be made, and while it is not unlikely that future 
experience may show  that  a  more prolonged  system of  therapy is 
necessary, it seemed advisable in the beginning to determine the effect 
of a  relatively small number of doses. 
The treatment of advanced cases of trypanosomiasi  s must take into 
account not only the invasion of the cerebrospinal axis by the infecting 
organism  and  the  resultant  injuries  but  also  the  chronicity of  the 
disease, its tendency toward exacerbation and the debilitated physical 
state of many patients.  With  these facts in  view,  some system of 
repeated  dose  therapy  appears  obligatory  and  the  treatment with 
tryparsamide,  therefore,  based  upon  the  action  of  single  doses, 
consisted in the administration of several doses ranging from 1.0  to 
to 7.0 gin. at intervals of from 3 to 14 days.  28 patients who presented 
a  wide variety of nervous and mental symptoms and  whose spinal 
fluid showed an increased cell content of from 15 to 572 lymphocytes 
per  cram.,  together with  large mononuclears and  mulberry cells in 
most instances, were under observation for a sufficient length of time 
after treatment to permit of subsequent lumbar punctures as well as 
other clinical  examination.  The  cell content of the spinal fluid was 
used as a criterion of the degree of cerebrospinal involvement as well 
as a therapeutic guide and also as an index of the effect of treatment, L. PEAXCE  I01 
The immediate sterilizing action of tryparsamide was noted in those 
patients whose lymph gland examination was positive on adm!ttance; 
trypanosornes were not found in 7 patients who were being treated 
with atoxyl and tartar emetic at the time of transfer to tryparsamide 
therapy.  Repeated microscopic examinations of lymph gland juice 
and  centrifuged blood made during the period of observation were 
negative in all patients.  In general, the physical status of the patients 
was materially benefited as was shown by the return of the pulse and 
temperature  to  normal  limits,  the  prompt  disappearance  of  the 
subjective symptoms and  by  improved blood  counts and  gains in 
weight.  The improvement in  habits  and  personal  appearance  of 
several patients was also noticeable.  The early termination of treat- 
ment in 3 patients was followed by a clinical exacerbation of the disease 
and ensuing death; in one of the 3 there was a complicating  acute amoe- 
bic dysentery:  The nervous and mental symptoms which were present 
in many instances were greatly improved or completely eliminated 
except in 2 very advanced patients with marked mental deterioration 
who had been treated with other drugs for long periods of time and 
in whom the change was slight. 
The  effect  of  tryparsamide  upon  advanced  trypanosomiasis  as 
illustrated by this group of patients is further evidenced by the marked 
and rapid diminution of the cells of the spinal fluid.  In general, .3 or 
4 weekly doses of 3.0, 4.0, or 5.0 gm. produced decreases of from 57 to 
98 per cent in an average of 5 weeks.  In 5 patients whose treatment 
was limited to one such course, the cell content continued to decrease 
in 4  instances as  shown by a  practically normal third examination 
made 9 to 12 weeks after admittance, while in 1 patient, there was no 
further  decrease.  16  patients  who  were  given  second  courses  of 
treatment showed a  continued decrease of cells; 3 showed practically 
no change from the count made after the first course of treatment; in 
one, there was a slight increase in cells and in another, after 3 irregu- 
larly spaced doses, the cells had returned to practically the original 
count.  In  this  limited number  of  cases,  it  was  apparently more 
difficult  to  accomplish  a  further  decrease  of  the  spinal  fluid  cell 
content by a  second course of treatment than it was to produce the 
initial and marked diminution by the first course, but at any rate, in 
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arrested.  Considering the  pathological  conditions of  cerebrospinal 
trypanosomiasis, it seems not unlikely that a  longer first course of 
treatment than that employed in most of these patients would give 
more satisfactory results.  Regarding the effect produced by more 
frequent smaller doses  as contrasted with larger doses separated by 
longer intervals of time, it appears that the use of semi-weekly doses 
of 2.0 gin.  for instance had apparently no advantage over a weekly 
dose of 3.0 or 4.0 gin. 
Finally, we wish to consider the only untoward effect encountered 
during the course of this work.  Dimness of vision of various degrees 
occurred in  9  advanced  cases,  5  of  whom  had  received previous 
arsenical  treatment.  It  should be  pointed  out  that  there was  no 
instance of visual disturbance of any kind in the early cases or in the 
first stages of the cerebrospinal period of the disease or after any single 
dose of tryparsanfide.  The largest dose given in our cases was 7.0 
gm.  In the majority of instances, this effect was entirely transitory 
and  in  the  others  various  degrees of improvement took place.  3 
patients who were given too frequent an administration of medium 
sized doses showed considerable degrees of impairment and  of  these 
2  recovered completely; of 3  other patients  with  about  the  same 
degree  of  impairment  one  showed  slight  improvement,  another 
moderate improvement and the third complete recovery., while in the 
remaining 3  a  less marked visual disability was transitory.  It would 
seem from a study of these cases that too frequent administration of 
medium and large doses  to  patients  suffering from very advanced 
trypanosomiasis is one factor that contributed to this condition.  It 
is significant to note in this connection that resumption of treatment 
with  smaller  or more widely spaced doses  was not  followed  by  a 
return of the condition or by an intensification of residual symptoms: 
In addition, the time  of  occurrence of  this untoward effect, 2 to 7 
days after treatment, together with  the nature of the pathological 
injury to  the optic structures in  cerebrospinal trypanosomiasis and 
the fact that improvement of some degree always occurred, suggests 
that the cause of the visual impairment is related to the processes of 
resolution and healing of the lesion already present rather than to a 
direct  toxic  action  upon  the  nerve  itself.  The  ophthalmoscopic 
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recovered from this condition also lends support to this view.  The 
experimental work with  tryparsamide  showed  that  apparently  the 
drug possesses the power of tissue penetrability to a  marked degree 
since a characteristic feature of the treatment of rabbit trypanosomiasis 
was the rapidity and completeness with which extensive cutaneous 
and subcutaneous lesions regressed and healed.  Individual variations 
in the extent or degree of lesions is the probable explanation of the 
fact that several patient,  s  with as markedly altered spinal fluids and 
as pronounced nervous  and  mental symptoms developed no visual 
disturbances whatever after similar treatment. 
From the facts at our disposal, it would appear that the occasional 
occurrence of visual disturbances, which may perhaps be avoided by 
a  slightly different system of dose repetition,  does  not at  present 
constitute an objection to the use of the drug.  The impression which 
one has  after  treating advanced cases with tryparsamide is  that  a 
suitable interval between doses of a certain size is probablythe most 
important factor in  preventing the  occurrence of  untoward visual 
effects.  Doses  of 3.0  gm.  or over should preferably not be  given 
oftener than once a  week, and since longer intervals between doses 
have been followed by clinical improvement and marked decreases 
in the cells of the spinal fluid, further use of a system of wider spaced 
repeated doses may show similar beneficial therapeutic effects without 
concomitant visual disturbances. 
SUMMARY. 
The present study of the action of tryparsamlde in human trypano- 
somiasis concludes a series of chemical and biological investigations in 
a  particular problem of chemotherapy and thus represents the final 
step in a logical method of approach to such a problem.  It has been 
shown that tryparsamide, the sodium salt of N-phenylglycineamide- 
p-arsonic acid,  possesses a  marked try~anocidal activity in human 
trypanosomiasis caused by Tr. gambiense.  Single doses of from 0.5 
to 5.0 gin. produced a  peripheral sterilization of lymph glands and 
blood in an average of 6 to 12 hourg.  The duration of the peripheral 
sterilization following single doses of 17 to 83 mg. per kilo ranged from 
17 to 58 days in patients who ultimately showed a return of trypano- 
somes to the peripheral blood.  In a  number of patients, however, 104.  TREATMENT  OF  HUMA!~  TRYPANOSO]~IASIS 
treated with single doses of 9 to 68 mg. per kilo, no such relapse was 
detected during an observation period of from 40 to 111  days.  The 
drug is  extremely soluble in water and may be' administered intra- 
muscularly as  well as  intravenously.  The  immediate  trypanocidal 
action  after  intramuscular  administration  was  as  rapid  as  that 
following  the  intravenous  route  while  the  duration  of  peripheral 
sterilization was appreciably longer. 
Relatively few repeated doses produced in advanced cases a marked 
and rapid diminution of the cells of the spinal fluid and were associated 
with definite improvement of mental and nervous symptoms.  The 
occurrence of visual disturbances in certain advanced cases was the 
only untoward effect detected during the course of the work, and was 
apparently related to a too frequent administration of the drug.  The 
condition was transitory in the majority of instances and resumption 
of treatment was not followed by a recurrence of this symptom. 
The general beneficial effect of the drug was a noticeable feature of 
its action in both early and advanced cases as shown by the disappear- 
ance of  subjective symptoms,  by the return of  the pulse  and  tem- 
perature  to  normal limits,  by  the  pronounced improvement of  the 
blood picture, and by well marked gains in weight. 
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